Q2FALSE202212/310001831631P1YP2Y00018316312022-01-012022-06-300001831631us-gaap:CommonClassAMember2022-08-09xbrli:shares0001831631us-gaap:CommonClassBMember2022-08-090001831631us-gaap:CommonClassCMember2022-08-090001831631ldi:CommonClassDMember2022-08-0900018316312022-06-30iso4217:USD00018316312021-12-310001831631us-gaap:AssetPledgedAsCollateralMember2022-06-300001831631us-gaap:AssetPledgedAsCollateralMember2021-12-310001831631us-gaap:CommonClassAMember2022-06-30iso4217:USDxbrli:shares0001831631us-gaap:CommonClassAMember2021-12-310001831631us-gaap:CommonClassBMember2021-12-310001831631us-gaap:CommonClassBMember2022-06-300001831631us-gaap:CommonClassCMember2021-12-310001831631us-gaap:CommonClassCMember2022-06-300001831631us-gaap:CommonClassCMemberus-gaap:CommonStockMember2021-12-310001831631ldi:CommonClassDMember2021-12-310001831631ldi:CommonClassDMember2022-06-300001831631ldi:CommonClassDMemberus-gaap:CommonStockMember2021-12-3100018316312022-04-012022-06-3000018316312021-04-012021-06-3000018316312021-01-012021-06-300001831631us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-03-310001831631us-gaap:CommonClassCMemberus-gaap:CommonStockMember2021-03-310001831631ldi:CommonClassDMemberus-gaap:CommonStockMember2021-03-310001831631us-gaap:TreasuryStockMember2021-03-310001831631us-gaap:AdditionalPaidInCapitalMember2021-03-310001831631us-gaap:RetainedEarningsMember2021-03-310001831631us-gaap:NoncontrollingInterestMember2021-03-3100018316312021-03-310001831631us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-300001831631us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-04-012021-06-300001831631us-gaap:CommonClassCMemberus-gaap:CommonStockMember2021-04-012021-06-300001831631ldi:CommonClassDMemberus-gaap:CommonStockMember2021-04-012021-06-300001831631ldi:ClassAAndDCommonStockMember2021-04-012021-06-300001831631ldi:ClassAAndDCommonStockMemberus-gaap:RetainedEarningsMember2021-04-012021-06-300001831631ldi:ClassAAndDCommonStockMemberus-gaap:NoncontrollingInterestMember2021-04-012021-06-300001831631us-gaap:RetainedEarningsMemberus-gaap:CommonClassCMember2021-04-012021-06-300001831631us-gaap:CommonClassCMemberus-gaap:NoncontrollingInterestMember2021-04-012021-06-300001831631us-gaap:CommonClassCMember2021-04-012021-06-300001831631us-gaap:NoncontrollingInterestMember2021-04-012021-06-300001831631us-gaap:RetainedEarningsMember2021-04-012021-06-300001831631us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-06-300001831631us-gaap:CommonClassCMemberus-gaap:CommonStockMember2021-06-300001831631ldi:CommonClassDMemberus-gaap:CommonStockMember2021-06-300001831631us-gaap:TreasuryStockMember2021-06-300001831631us-gaap:AdditionalPaidInCapitalMember2021-06-300001831631us-gaap:RetainedEarningsMember2021-06-300001831631us-gaap:NoncontrollingInterestMember2021-06-3000018316312021-06-300001831631us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-03-310001831631us-gaap:CommonClassCMemberus-gaap:CommonStockMember2022-03-310001831631ldi:CommonClassDMemberus-gaap:CommonStockMember2022-03-310001831631us-gaap:TreasuryStockMember2022-03-310001831631us-gaap:AdditionalPaidInCapitalMember2022-03-310001831631us-gaap:RetainedEarningsMember2022-03-310001831631us-gaap:NoncontrollingInterestMember2022-03-3100018316312022-03-310001831631us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300001831631us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-04-012022-06-300001831631us-gaap:CommonClassCMemberus-gaap:CommonStockMember2022-04-012022-06-300001831631ldi:CommonClassDMemberus-gaap:CommonStockMember2022-04-012022-06-300001831631us-gaap:TreasuryStockMember2022-04-012022-06-300001831631us-gaap:NoncontrollingInterestMember2022-04-012022-06-300001831631ldi:ClassAAndDCommonStockMemberus-gaap:RetainedEarningsMember2022-04-012022-06-300001831631ldi:ClassAAndDCommonStockMemberus-gaap:NoncontrollingInterestMember2022-04-012022-06-300001831631ldi:ClassAAndDCommonStockMember2022-04-012022-06-300001831631us-gaap:RetainedEarningsMember2022-04-012022-06-300001831631us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-06-300001831631us-gaap:CommonClassCMemberus-gaap:CommonStockMember2022-06-300001831631ldi:CommonClassDMemberus-gaap:CommonStockMember2022-06-300001831631us-gaap:TreasuryStockMember2022-06-300001831631us-gaap:AdditionalPaidInCapitalMember2022-06-300001831631us-gaap:RetainedEarningsMember2022-06-300001831631us-gaap:NoncontrollingInterestMember2022-06-300001831631us-gaap:CommonClassAMemberus-gaap:CommonStockMember2020-12-310001831631us-gaap:CommonClassCMemberus-gaap:CommonStockMember2020-12-310001831631ldi:CommonClassDMemberus-gaap:CommonStockMember2020-12-310001831631us-gaap:TreasuryStockMember2020-12-310001831631us-gaap:AdditionalPaidInCapitalMember2020-12-310001831631us-gaap:RetainedEarningsMember2020-12-310001831631us-gaap:NoncontrollingInterestMember2020-12-3100018316312020-12-310001831631us-gaap:NoncontrollingInterestMember2021-01-012021-02-1100018316312021-01-012021-02-110001831631ldi:ClassXCommonUnitMemberus-gaap:NoncontrollingInterestMember2021-01-012021-02-110001831631ldi:ClassXCommonUnitMember2021-01-012021-02-110001831631us-gaap:AdditionalPaidInCapitalMember2021-01-012021-02-110001831631us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-02-110001831631us-gaap:CommonClassCMemberus-gaap:CommonStockMember2021-02-110001831631ldi:CommonClassDMemberus-gaap:CommonStockMember2021-02-110001831631us-gaap:AdditionalPaidInCapitalMember2021-02-110001831631us-gaap:NoncontrollingInterestMember2021-02-1100018316312021-02-110001831631us-gaap:CommonClassAMemberus-gaap:IPOMemberus-gaap:CommonStockMember2021-02-122021-06-300001831631us-gaap:IPOMemberus-gaap:CommonClassCMemberus-gaap:CommonStockMember2021-02-122021-06-300001831631us-gaap:IPOMemberldi:CommonClassDMemberus-gaap:CommonStockMember2021-02-122021-06-300001831631us-gaap:IPOMember2021-02-122021-06-300001831631us-gaap:OverAllotmentOptionMemberus-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-02-122021-06-300001831631us-gaap:OverAllotmentOptionMemberus-gaap:CommonClassCMemberus-gaap:CommonStockMember2021-02-122021-06-300001831631us-gaap:OverAllotmentOptionMemberldi:CommonClassDMemberus-gaap:CommonStockMember2021-02-122021-06-300001831631us-gaap:OverAllotmentOptionMember2021-02-122021-06-300001831631us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-02-122021-06-300001831631us-gaap:CommonClassCMemberus-gaap:CommonStockMember2021-02-122021-06-300001831631ldi:CommonClassDMemberus-gaap:CommonStockMember2021-02-122021-06-300001831631us-gaap:AdditionalPaidInCapitalMember2021-02-122021-06-3000018316312021-02-122021-06-300001831631ldi:ClassAAndDCommonStockMember2021-01-012021-06-300001831631us-gaap:NoncontrollingInterestMember2021-02-122021-06-300001831631us-gaap:RetainedEarningsMember2021-02-122021-06-300001831631us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-12-310001831631us-gaap:TreasuryStockMember2021-12-310001831631us-gaap:AdditionalPaidInCapitalMember2021-12-310001831631us-gaap:RetainedEarningsMember2021-12-310001831631us-gaap:NoncontrollingInterestMember2021-12-310001831631us-gaap:AdditionalPaidInCapitalMember2022-01-012022-06-300001831631us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-01-012022-06-300001831631us-gaap:CommonClassCMemberus-gaap:CommonStockMember2022-01-012022-06-300001831631ldi:CommonClassDMemberus-gaap:CommonStockMember2022-01-012022-06-300001831631us-gaap:TreasuryStockMember2022-01-012022-06-300001831631us-gaap:NoncontrollingInterestMember2022-01-012022-06-300001831631ldi:ClassAAndDCommonStockMember2022-01-012022-06-300001831631ldi:ClassAAndDCommonStockMemberus-gaap:RetainedEarningsMember2022-01-012022-06-300001831631ldi:ClassAAndDCommonStockMemberus-gaap:NoncontrollingInterestMember2022-01-012022-06-300001831631us-gaap:RetainedEarningsMemberus-gaap:CommonClassCMember2022-01-012022-06-300001831631us-gaap:CommonClassCMemberus-gaap:NoncontrollingInterestMember2022-01-012022-06-300001831631us-gaap:CommonClassCMember2022-01-012022-06-300001831631us-gaap:RetainedEarningsMember2022-01-012022-06-30xbrli:pure0001831631ldi:LoanDepotcomLLCMemberldi:LDHoldingsGroupLLCMember2022-06-300001831631ldi:LDSettlementServicesLLCMemberldi:LDHoldingsGroupLLCMember2022-06-300001831631ldi:MCSMemberldi:LDHoldingsGroupLLCMember2022-06-300001831631ldi:LDHoldingsGroupLLCMemberldi:MelloHoldingsLLCMember2022-06-300001831631ldi:ArtemisManagementLLCMemberldi:LDHoldingsGroupLLCMember2022-06-300001831631stpr:CAus-gaap:GeographicConcentrationRiskMemberldi:LoanOriginationsBenchmarkMember2022-01-012022-06-300001831631ldi:Investor1Memberldi:MortgageLoansBenchmarkMemberldi:InvestorConcentrationRiskMember2022-01-012022-06-300001831631ldi:Investor2Memberldi:MortgageLoansBenchmarkMemberldi:InvestorConcentrationRiskMember2022-01-012022-06-300001831631ldi:Investor3Memberldi:MortgageLoansBenchmarkMemberldi:InvestorConcentrationRiskMember2022-01-012022-06-300001831631ldi:Lender1Memberldi:WarehouseLinesOfCreditBenchmarkMemberus-gaap:LenderConcentrationRiskMember2022-01-012022-06-300001831631ldi:WarehouseLinesOfCreditBenchmarkMemberus-gaap:LenderConcentrationRiskMemberldi:Lender2Member2022-01-012022-06-300001831631us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:SecuredDebtMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:SecuredDebtMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:SecuredDebtMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:SecuredDebtMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:MediumTermNotesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MediumTermNotesMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MediumTermNotesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MediumTermNotesMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:SeniorNotesMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:SeniorNotesMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:SeniorNotesMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:SeniorNotesMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:SecuredDebtMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:SecuredDebtMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:SecuredDebtMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:SecuredDebtMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:MediumTermNotesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MediumTermNotesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MediumTermNotesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MediumTermNotesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:SeniorNotesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:SeniorNotesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:SeniorNotesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:SeniorNotesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:FairValueInputsLevel1Memberus-gaap:InterestRateLockCommitmentsMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:InterestRateLockCommitmentsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:InterestRateLockCommitmentsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:InterestRateLockCommitmentsMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:FairValueInputsLevel1Memberus-gaap:ForwardContractsMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:FairValueInputsLevel2Memberus-gaap:ForwardContractsMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:FairValueInputsLevel3Memberus-gaap:ForwardContractsMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:ForwardContractsMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberldi:MortgageBackedSecuritiesPutOptionsMember2022-06-300001831631us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberldi:MortgageBackedSecuritiesPutOptionsMember2022-06-300001831631us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberldi:MortgageBackedSecuritiesPutOptionsMember2022-06-300001831631us-gaap:FairValueMeasurementsRecurringMemberldi:MortgageBackedSecuritiesPutOptionsMember2022-06-300001831631us-gaap:FairValueInputsLevel1Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:FairValueInputsLevel3Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:FairValueInputsLevel1Memberldi:PutOptionsOnTreasuriesMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631ldi:PutOptionsOnTreasuriesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:FairValueInputsLevel3Memberldi:PutOptionsOnTreasuriesMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631ldi:PutOptionsOnTreasuriesMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001831631us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:FairValueInputsLevel1Memberus-gaap:InterestRateLockCommitmentsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:InterestRateLockCommitmentsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:InterestRateLockCommitmentsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:InterestRateLockCommitmentsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:FairValueInputsLevel1Memberus-gaap:ForwardContractsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:FairValueInputsLevel2Memberus-gaap:ForwardContractsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:FairValueInputsLevel3Memberus-gaap:ForwardContractsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:ForwardContractsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:FairValueInputsLevel1Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:FairValueInputsLevel3Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:FairValueInputsLevel1Memberldi:PutOptionsOnTreasuriesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631ldi:PutOptionsOnTreasuriesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:FairValueInputsLevel3Memberldi:PutOptionsOnTreasuriesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631ldi:PutOptionsOnTreasuriesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001831631us-gaap:InterestRateLockCommitmentsMember2022-03-310001831631ldi:ServicingRightsMember2022-03-310001831631us-gaap:InterestRateLockCommitmentsMember2021-12-310001831631ldi:ServicingRightsMember2021-12-310001831631us-gaap:InterestRateLockCommitmentsMember2022-04-012022-06-300001831631ldi:ServicingRightsMember2022-04-012022-06-300001831631us-gaap:InterestRateLockCommitmentsMember2022-01-012022-06-300001831631ldi:ServicingRightsMember2022-01-012022-06-300001831631us-gaap:InterestRateLockCommitmentsMember2022-06-300001831631ldi:ServicingRightsMember2022-06-300001831631us-gaap:InterestRateLockCommitmentsMember2021-03-310001831631ldi:ServicingRightsMember2021-03-310001831631us-gaap:InterestRateLockCommitmentsMember2020-12-310001831631ldi:ServicingRightsMember2020-12-310001831631us-gaap:InterestRateLockCommitmentsMember2021-04-012021-06-300001831631ldi:ServicingRightsMember2021-04-012021-06-300001831631us-gaap:InterestRateLockCommitmentsMember2021-01-012021-06-300001831631ldi:ServicingRightsMember2021-01-012021-06-300001831631us-gaap:InterestRateLockCommitmentsMember2021-06-300001831631ldi:ServicingRightsMember2021-06-300001831631us-gaap:InterestRateLockCommitmentsMemberus-gaap:FairValueInputsLevel3Member2022-04-012022-06-300001831631ldi:ServicingRightsMemberus-gaap:FairValueInputsLevel3Member2022-04-012022-06-300001831631us-gaap:InterestRateLockCommitmentsMemberus-gaap:FairValueInputsLevel3Member2022-01-012022-06-300001831631ldi:ServicingRightsMemberus-gaap:FairValueInputsLevel3Member2022-01-012022-06-300001831631us-gaap:InterestRateLockCommitmentsMemberus-gaap:FairValueInputsLevel3Member2021-04-012021-06-300001831631ldi:ServicingRightsMemberus-gaap:FairValueInputsLevel3Member2021-04-012021-06-300001831631us-gaap:InterestRateLockCommitmentsMemberus-gaap:FairValueInputsLevel3Member2021-01-012021-06-300001831631ldi:ServicingRightsMemberus-gaap:FairValueInputsLevel3Member2021-01-012021-06-300001831631us-gaap:InterestRateLockCommitmentsMemberldi:MeasurementInputPullThroughRateMembersrt:MinimumMember2022-06-300001831631srt:MaximumMemberus-gaap:InterestRateLockCommitmentsMemberldi:MeasurementInputPullThroughRateMember2022-06-300001831631srt:WeightedAverageMemberus-gaap:InterestRateLockCommitmentsMemberldi:MeasurementInputPullThroughRateMember2022-06-300001831631us-gaap:InterestRateLockCommitmentsMemberldi:MeasurementInputPullThroughRateMembersrt:MinimumMember2021-12-310001831631srt:MaximumMemberus-gaap:InterestRateLockCommitmentsMemberldi:MeasurementInputPullThroughRateMember2021-12-310001831631srt:WeightedAverageMemberus-gaap:InterestRateLockCommitmentsMemberldi:MeasurementInputPullThroughRateMember2021-12-310001831631ldi:ServicingRightsMemberus-gaap:MeasurementInputDiscountRateMembersrt:MinimumMember2022-06-300001831631srt:MaximumMemberldi:ServicingRightsMemberus-gaap:MeasurementInputDiscountRateMember2022-06-300001831631srt:WeightedAverageMemberldi:ServicingRightsMemberus-gaap:MeasurementInputDiscountRateMember2022-06-300001831631ldi:ServicingRightsMemberus-gaap:MeasurementInputDiscountRateMembersrt:MinimumMember2021-12-310001831631srt:MaximumMemberldi:ServicingRightsMemberus-gaap:MeasurementInputDiscountRateMember2021-12-310001831631srt:WeightedAverageMemberldi:ServicingRightsMemberus-gaap:MeasurementInputDiscountRateMember2021-12-310001831631ldi:ServicingRightsMembersrt:MinimumMemberus-gaap:MeasurementInputPrepaymentRateMember2022-06-300001831631srt:MaximumMemberldi:ServicingRightsMemberus-gaap:MeasurementInputPrepaymentRateMember2022-06-300001831631srt:WeightedAverageMemberldi:ServicingRightsMemberus-gaap:MeasurementInputPrepaymentRateMember2022-06-300001831631ldi:ServicingRightsMembersrt:MinimumMemberus-gaap:MeasurementInputPrepaymentRateMember2021-12-310001831631srt:MaximumMemberldi:ServicingRightsMemberus-gaap:MeasurementInputPrepaymentRateMember2021-12-310001831631srt:WeightedAverageMemberldi:ServicingRightsMemberus-gaap:MeasurementInputPrepaymentRateMember2021-12-310001831631ldi:ServicingRightsMemberldi:MeasurementInputCostToServiceMembersrt:MinimumMember2022-06-30iso4217:USDldi:loan0001831631srt:MaximumMemberldi:ServicingRightsMemberldi:MeasurementInputCostToServiceMember2022-06-300001831631srt:WeightedAverageMemberldi:ServicingRightsMemberldi:MeasurementInputCostToServiceMember2022-06-300001831631ldi:ServicingRightsMemberldi:MeasurementInputCostToServiceMembersrt:MinimumMember2021-12-310001831631srt:MaximumMemberldi:ServicingRightsMemberldi:MeasurementInputCostToServiceMember2021-12-310001831631srt:WeightedAverageMemberldi:ServicingRightsMemberldi:MeasurementInputCostToServiceMember2021-12-310001831631us-gaap:ForwardContractsMember2022-06-300001831631ldi:MortgageBackedSecuritiesPutOptionsMember2022-06-300001831631ldi:AllDerivativeInstrumentsExceptInterestRateLockCommitmentsMember2022-06-300001831631ldi:PutOptionsOnTreasuriesMember2022-06-300001831631us-gaap:InterestRateSwapMember2022-06-300001831631us-gaap:LineOfCreditMember2022-06-300001831631us-gaap:SecuredDebtMember2022-06-300001831631us-gaap:ForwardContractsMember2021-12-310001831631us-gaap:InterestRateSwapMember2021-12-310001831631ldi:AllDerivativeInstrumentsExceptInterestRateLockCommitmentsMember2021-12-310001831631ldi:PutOptionsOnTreasuriesMember2021-12-310001831631us-gaap:LineOfCreditMember2021-12-310001831631us-gaap:SecuredDebtMember2021-12-310001831631us-gaap:ConventionalLoanMemberus-gaap:FixedRateResidentialMortgageMember2022-06-300001831631us-gaap:ConventionalLoanMemberus-gaap:ProductConcentrationRiskMemberldi:ReceivablesBenchmarkMemberus-gaap:FixedRateResidentialMortgageMember2022-01-012022-06-300001831631us-gaap:ConventionalLoanMemberus-gaap:FixedRateResidentialMortgageMember2021-12-310001831631us-gaap:ConventionalLoanMemberus-gaap:ProductConcentrationRiskMemberldi:ReceivablesBenchmarkMemberus-gaap:FixedRateResidentialMortgageMember2021-01-012021-12-310001831631us-gaap:ConventionalLoanMemberus-gaap:AdjustableRateResidentialMortgageMember2022-06-300001831631us-gaap:ConventionalLoanMemberus-gaap:ProductConcentrationRiskMemberus-gaap:AdjustableRateResidentialMortgageMemberldi:ReceivablesBenchmarkMember2022-01-012022-06-300001831631us-gaap:ConventionalLoanMemberus-gaap:AdjustableRateResidentialMortgageMember2021-12-310001831631us-gaap:ConventionalLoanMemberus-gaap:ProductConcentrationRiskMemberus-gaap:AdjustableRateResidentialMortgageMemberldi:ReceivablesBenchmarkMember2021-01-012021-12-310001831631us-gaap:FixedRateResidentialMortgageMemberldi:GovernmentMortgageLoanMember2022-06-300001831631us-gaap:ProductConcentrationRiskMemberldi:ReceivablesBenchmarkMemberus-gaap:FixedRateResidentialMortgageMemberldi:GovernmentMortgageLoanMember2022-01-012022-06-300001831631us-gaap:FixedRateResidentialMortgageMemberldi:GovernmentMortgageLoanMember2021-12-310001831631us-gaap:ProductConcentrationRiskMemberldi:ReceivablesBenchmarkMemberus-gaap:FixedRateResidentialMortgageMemberldi:GovernmentMortgageLoanMember2021-01-012021-12-310001831631us-gaap:AdjustableRateResidentialMortgageMemberldi:GovernmentMortgageLoanMember2022-06-300001831631us-gaap:ProductConcentrationRiskMemberus-gaap:AdjustableRateResidentialMortgageMemberldi:ReceivablesBenchmarkMemberldi:GovernmentMortgageLoanMember2022-01-012022-06-300001831631us-gaap:AdjustableRateResidentialMortgageMemberldi:GovernmentMortgageLoanMember2021-12-310001831631us-gaap:ProductConcentrationRiskMemberus-gaap:AdjustableRateResidentialMortgageMemberldi:ReceivablesBenchmarkMemberldi:GovernmentMortgageLoanMember2021-01-012021-12-310001831631ldi:OtherResidentialMortgageMember2022-06-300001831631us-gaap:ProductConcentrationRiskMemberldi:OtherResidentialMortgageMemberldi:ReceivablesBenchmarkMember2022-01-012022-06-300001831631ldi:OtherResidentialMortgageMember2021-12-310001831631us-gaap:ProductConcentrationRiskMemberldi:OtherResidentialMortgageMemberldi:ReceivablesBenchmarkMember2021-01-012021-12-310001831631us-gaap:ConsumerLoanMember2022-06-300001831631us-gaap:ProductConcentrationRiskMemberus-gaap:ConsumerLoanMemberldi:ReceivablesBenchmarkMember2022-01-012022-06-300001831631us-gaap:ConsumerLoanMember2021-12-310001831631us-gaap:ProductConcentrationRiskMemberus-gaap:ConsumerLoanMemberldi:ReceivablesBenchmarkMember2021-01-012021-12-310001831631us-gaap:ProductConcentrationRiskMemberldi:ReceivablesBenchmarkMember2022-01-012022-06-300001831631us-gaap:ProductConcentrationRiskMemberldi:ReceivablesBenchmarkMember2021-01-012021-12-310001831631us-gaap:ConventionalLoanMember2022-06-300001831631us-gaap:ConventionalLoanMember2021-12-310001831631ldi:GovernmentMortgageLoanMember2022-06-300001831631ldi:GovernmentMortgageLoanMember2021-12-310001831631us-gaap:FinancialAssetNotPastDueMember2022-06-300001831631us-gaap:FinancialAssetNotPastDueMember2021-12-310001831631ldi:FinancialAsset30To89DaysPastDueMember2022-06-300001831631ldi:FinancialAsset30To89DaysPastDueMember2021-12-310001831631us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember2022-06-300001831631us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember2021-12-310001831631us-gaap:InterestRateLockCommitmentsMemberldi:GainOnOriginationAndSaleOfLoansNetMember2022-04-012022-06-300001831631us-gaap:InterestRateLockCommitmentsMemberldi:GainOnOriginationAndSaleOfLoansNetMember2021-04-012021-06-300001831631us-gaap:InterestRateLockCommitmentsMemberldi:GainOnOriginationAndSaleOfLoansNetMember2022-01-012022-06-300001831631us-gaap:InterestRateLockCommitmentsMemberldi:GainOnOriginationAndSaleOfLoansNetMember2021-01-012021-06-300001831631us-gaap:ForwardContractsMemberldi:GainOnOriginationAndSaleOfLoansNetMember2022-04-012022-06-300001831631us-gaap:ForwardContractsMemberldi:GainOnOriginationAndSaleOfLoansNetMember2021-04-012021-06-300001831631us-gaap:ForwardContractsMemberldi:GainOnOriginationAndSaleOfLoansNetMember2022-01-012022-06-300001831631us-gaap:ForwardContractsMemberldi:GainOnOriginationAndSaleOfLoansNetMember2021-01-012021-06-300001831631us-gaap:InterestRateSwapMemberldi:GainOnOriginationAndSaleOfLoansNetMember2022-04-012022-06-300001831631us-gaap:InterestRateSwapMemberldi:GainOnOriginationAndSaleOfLoansNetMember2021-04-012021-06-300001831631us-gaap:InterestRateSwapMemberldi:GainOnOriginationAndSaleOfLoansNetMember2022-01-012022-06-300001831631us-gaap:InterestRateSwapMemberldi:GainOnOriginationAndSaleOfLoansNetMember2021-01-012021-06-300001831631us-gaap:PutOptionMemberldi:GainOnOriginationAndSaleOfLoansNetMember2022-04-012022-06-300001831631us-gaap:PutOptionMemberldi:GainOnOriginationAndSaleOfLoansNetMember2021-04-012021-06-300001831631us-gaap:PutOptionMemberldi:GainOnOriginationAndSaleOfLoansNetMember2022-01-012022-06-300001831631us-gaap:PutOptionMemberldi:GainOnOriginationAndSaleOfLoansNetMember2021-01-012021-06-300001831631us-gaap:ForwardContractsMemberldi:ChangeInFairValueOfServicingRightsNetMember2022-04-012022-06-300001831631us-gaap:ForwardContractsMemberldi:ChangeInFairValueOfServicingRightsNetMember2021-04-012021-06-300001831631us-gaap:ForwardContractsMemberldi:ChangeInFairValueOfServicingRightsNetMember2022-01-012022-06-300001831631us-gaap:ForwardContractsMemberldi:ChangeInFairValueOfServicingRightsNetMember2021-01-012021-06-300001831631ldi:ChangeInFairValueOfServicingRightsNetMemberus-gaap:InterestRateSwapMember2022-04-012022-06-300001831631ldi:ChangeInFairValueOfServicingRightsNetMemberus-gaap:InterestRateSwapMember2021-04-012021-06-300001831631ldi:ChangeInFairValueOfServicingRightsNetMemberus-gaap:InterestRateSwapMember2022-01-012022-06-300001831631ldi:ChangeInFairValueOfServicingRightsNetMemberus-gaap:InterestRateSwapMember2021-01-012021-06-300001831631us-gaap:PutOptionMemberldi:ChangeInFairValueOfServicingRightsNetMember2022-04-012022-06-300001831631us-gaap:PutOptionMemberldi:ChangeInFairValueOfServicingRightsNetMember2021-04-012021-06-300001831631us-gaap:PutOptionMemberldi:ChangeInFairValueOfServicingRightsNetMember2022-01-012022-06-300001831631us-gaap:PutOptionMemberldi:ChangeInFairValueOfServicingRightsNetMember2021-01-012021-06-300001831631us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-06-300001831631us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2021-12-310001831631us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberldi:MSRFacilitiesMember2022-06-300001831631us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberldi:MSRFacilitiesMember2021-12-310001831631us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberldi:ServicingAdvancedFacilitiesMember2022-06-300001831631us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberldi:ServicingAdvancedFacilitiesMember2021-12-310001831631us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:MediumTermNotesMember2022-06-300001831631us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:MediumTermNotesMember2021-12-310001831631us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMemberus-gaap:AssetPledgedAsCollateralMember2022-06-300001831631us-gaap:CorporateJointVentureMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2022-06-300001831631us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2022-06-300001831631us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMemberus-gaap:AssetPledgedAsCollateralMember2021-12-310001831631us-gaap:CorporateJointVentureMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2021-12-310001831631us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2021-12-310001831631us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember2022-06-300001831631us-gaap:CorporateJointVentureMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2022-04-012022-06-300001831631us-gaap:CorporateJointVentureMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2022-01-012022-06-300001831631us-gaap:CorporateJointVentureMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2021-04-012021-06-300001831631us-gaap:CorporateJointVentureMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2021-01-012021-06-30ldi:lineOfCredit0001831631ldi:WarehouseAndRevolvingCreditFacilitiesMember2022-06-300001831631us-gaap:WarehouseAgreementBorrowingsMemberus-gaap:BaseRateMembersrt:MinimumMember2022-01-012022-06-300001831631srt:MaximumMemberus-gaap:WarehouseAgreementBorrowingsMember2022-01-012022-06-300001831631us-gaap:WarehouseAgreementBorrowingsMembersrt:MinimumMember2022-01-012022-06-300001831631ldi:SecuritizationFacilitiesMembersrt:MinimumMember2022-01-012022-06-300001831631srt:MaximumMemberldi:SecuritizationFacilitiesMember2022-01-012022-06-300001831631us-gaap:WarehouseAgreementBorrowingsMember2022-06-300001831631us-gaap:WarehouseAgreementBorrowingsMember2021-12-310001831631ldi:A20201SecuritizationFacilityMemberldi:SecuritizationFacilitiesMember2020-10-310001831631ldi:A20201SecuritizationFacilityMemberldi:SecuritizationFacilitiesMember2020-10-012020-10-310001831631ldi:SecuritizationFacilitiesMemberldi:A20202SecuritizationFacilityMember2020-12-310001831631ldi:SecuritizationFacilitiesMemberldi:A20202SecuritizationFacilityMember2020-12-012020-12-310001831631ldi:SecuritizationFacilitiesMemberldi:A20202SecuritizationFacilityMember2022-03-012022-03-310001831631ldi:SecuritizationFacilitiesMemberldi:A20202SecuritizationFacilityMember2022-06-300001831631ldi:SecuritizationFacilitiesMemberldi:A20211SecuritizationFacilityMember2021-02-280001831631ldi:SecuritizationFacilitiesMemberldi:A20211SecuritizationFacilityMember2021-02-012021-02-280001831631ldi:A20212SecuritizationFacilityMemberldi:SecuritizationFacilitiesMember2021-04-300001831631ldi:A20212SecuritizationFacilityMemberldi:SecuritizationFacilitiesMember2021-04-012021-04-300001831631ldi:SecuritizationFacilitiesMemberldi:A20213SecuritizationFacilityMember2021-10-310001831631ldi:SecuritizationFacilitiesMemberldi:A20213SecuritizationFacilityMember2021-10-302021-10-300001831631ldi:WarehouseAndRevolvingCreditFacilitiesMemberldi:Facility1Member2022-06-300001831631ldi:WarehouseAndRevolvingCreditFacilitiesMemberldi:Facility1Member2021-12-310001831631ldi:Facility2Memberldi:WarehouseAndRevolvingCreditFacilitiesMember2022-06-300001831631ldi:Facility2Memberldi:WarehouseAndRevolvingCreditFacilitiesMember2021-12-310001831631ldi:Facility3Memberldi:WarehouseAndRevolvingCreditFacilitiesMember2022-06-300001831631ldi:Facility3Memberldi:WarehouseAndRevolvingCreditFacilitiesMember2021-12-310001831631ldi:WarehouseAndRevolvingCreditFacilitiesMemberldi:Facility4Member2022-06-300001831631ldi:WarehouseAndRevolvingCreditFacilitiesMemberldi:Facility4Member2021-12-310001831631ldi:WarehouseAndRevolvingCreditFacilitiesMemberldi:Facility5Member2022-06-300001831631ldi:WarehouseAndRevolvingCreditFacilitiesMemberldi:Facility5Member2021-12-310001831631ldi:WarehouseAndRevolvingCreditFacilitiesMemberldi:Facility6Member2022-06-300001831631ldi:WarehouseAndRevolvingCreditFacilitiesMemberldi:Facility6Member2021-12-310001831631ldi:WarehouseAndRevolvingCreditFacilitiesMemberldi:Facility7Member2022-06-300001831631ldi:WarehouseAndRevolvingCreditFacilitiesMemberldi:Facility7Member2021-12-310001831631ldi:Facility8Memberldi:WarehouseAndRevolvingCreditFacilitiesMember2022-06-300001831631ldi:Facility8Memberldi:WarehouseAndRevolvingCreditFacilitiesMember2021-12-310001831631ldi:WarehouseAndRevolvingCreditFacilitiesMemberldi:Facility9Member2022-06-300001831631ldi:WarehouseAndRevolvingCreditFacilitiesMemberldi:Facility9Member2021-12-310001831631ldi:WarehouseAndRevolvingCreditFacilitiesMemberldi:Facility10Member2022-06-300001831631ldi:WarehouseAndRevolvingCreditFacilitiesMemberldi:Facility10Member2021-12-310001831631ldi:WarehouseAndRevolvingCreditFacilitiesMemberldi:Facility11Member2022-06-300001831631ldi:WarehouseAndRevolvingCreditFacilitiesMemberldi:Facility11Member2021-12-310001831631ldi:Facility12Memberldi:WarehouseAndRevolvingCreditFacilitiesMember2022-06-300001831631ldi:Facility12Memberldi:WarehouseAndRevolvingCreditFacilitiesMember2021-12-310001831631ldi:WarehouseAndRevolvingCreditFacilitiesMemberldi:Facility13Member2022-06-300001831631ldi:WarehouseAndRevolvingCreditFacilitiesMemberldi:Facility13Member2021-12-310001831631ldi:Facility14Memberldi:WarehouseAndRevolvingCreditFacilitiesMember2022-06-300001831631ldi:Facility14Memberldi:WarehouseAndRevolvingCreditFacilitiesMember2021-12-310001831631ldi:Facility15Memberldi:WarehouseAndRevolvingCreditFacilitiesMember2022-06-300001831631ldi:Facility15Memberldi:SecuritizationFacilitiesMember2022-06-300001831631ldi:Facility15Memberldi:WarehouseAndRevolvingCreditFacilitiesMember2021-12-310001831631ldi:WarehouseAndRevolvingCreditFacilitiesMember2021-12-310001831631ldi:FinanceServicingRightsMember2022-06-300001831631us-gaap:WarehouseAgreementBorrowingsMember2022-04-012022-06-300001831631us-gaap:WarehouseAgreementBorrowingsMember2021-04-012021-06-300001831631us-gaap:WarehouseAgreementBorrowingsMember2022-01-012022-06-300001831631us-gaap:WarehouseAgreementBorrowingsMember2021-01-012021-06-300001831631us-gaap:AssetPledgedAsCollateralMemberus-gaap:WarehouseAgreementBorrowingsMember2022-06-300001831631us-gaap:AssetPledgedAsCollateralMemberus-gaap:WarehouseAgreementBorrowingsMember2021-06-300001831631ldi:MSRFacilitiesMemberus-gaap:SecuredDebtMember2022-06-300001831631ldi:MSRFacilitiesMemberus-gaap:SecuredDebtMember2021-12-310001831631ldi:SecuritiesFinancingFacilitiesMemberus-gaap:SecuredDebtMember2022-06-300001831631ldi:SecuritiesFinancingFacilitiesMemberus-gaap:SecuredDebtMember2021-12-310001831631ldi:ServicingAdvanceFacilitiesMemberus-gaap:SecuredDebtMember2022-06-300001831631ldi:ServicingAdvanceFacilitiesMemberus-gaap:SecuredDebtMember2021-12-310001831631us-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredDebtMember2022-06-300001831631us-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredDebtMember2021-12-310001831631us-gaap:MediumTermNotesMemberus-gaap:SecuredDebtMember2022-06-300001831631us-gaap:MediumTermNotesMemberus-gaap:SecuredDebtMember2021-12-310001831631us-gaap:SecuredDebtMember2022-06-300001831631us-gaap:SecuredDebtMember2021-12-310001831631us-gaap:UnsecuredDebtMemberus-gaap:SeniorNotesMember2022-06-300001831631us-gaap:UnsecuredDebtMemberus-gaap:SeniorNotesMember2021-12-310001831631us-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredDebtMember2014-10-310001831631us-gaap:RevolvingCreditFacilityMemberus-gaap:AssetPledgedAsCollateralMemberus-gaap:SecuredDebtMember2022-06-300001831631ldi:ThirdSecuredCreditFacilityMemberus-gaap:SecuredDebtMember2022-06-300001831631ldi:FourthSecuredCreditFacilityMemberus-gaap:SecuredDebtMember2022-06-300001831631ldi:GNMAMortgageServicingRightsMemberldi:GMSRVFNMemberus-gaap:SecuredDebtMember2022-06-300001831631srt:MaximumMemberldi:GMSRVFNMemberus-gaap:SecuredDebtMember2017-08-310001831631srt:MinimumMember2022-06-300001831631srt:MaximumMember2022-06-300001831631ldi:A2020VF1NotesMemberus-gaap:SecuredDebtMemberldi:LoanDepotAgencyAdvanceReceivableTrustMember2020-09-300001831631ldi:A2020VF1NotesMemberldi:ReimbursementForAdvancesMadeMemberus-gaap:SecuredDebtMember2022-06-300001831631ldi:ServicingAdvanceReimbursementAmountsMemberldi:GMSRVFNMemberus-gaap:SecuredDebtMember2021-11-30ldi:debt_instrument0001831631srt:MaximumMemberldi:ServicingAdvanceReimbursementAmountsMemberldi:GMSRVFNMemberus-gaap:SecuredDebtMember2021-11-300001831631ldi:ServicingAdvanceReimbursementAmountsMemberldi:GMSRVFNMemberus-gaap:SecuredDebtMember2022-06-300001831631us-gaap:UnsecuredDebtMemberldi:A650SeniorUnsecuredNotesDue2025Member2020-10-310001831631us-gaap:UnsecuredDebtMemberldi:A650SeniorUnsecuredNotesDue2025Member2020-10-012020-10-310001831631us-gaap:UnsecuredDebtMemberldi:A650SeniorUnsecuredNotesDue2025Memberus-gaap:DebtInstrumentRedemptionPeriodOneMember2020-10-012020-10-310001831631us-gaap:UnsecuredDebtMemberldi:A650SeniorUnsecuredNotesDue2025Member2022-06-300001831631us-gaap:UnsecuredDebtMemberldi:A6125SeniorUnsecuredNotesDue2028Member2021-03-310001831631us-gaap:UnsecuredDebtMemberldi:A6125SeniorUnsecuredNotesDue2028Member2021-03-012021-03-310001831631us-gaap:UnsecuredDebtMemberus-gaap:DebtInstrumentRedemptionPeriodTwoMemberldi:A6125SeniorUnsecuredNotesDue2028Member2021-03-012021-03-310001831631us-gaap:UnsecuredDebtMemberldi:A6125SeniorUnsecuredNotesDue2028Member2022-01-012022-03-310001831631us-gaap:UnsecuredDebtMemberldi:A6125SeniorUnsecuredNotesDue2028Member2022-03-310001831631us-gaap:UnsecuredDebtMemberldi:A6125SeniorUnsecuredNotesDue2028Member2022-06-300001831631us-gaap:LondonInterbankOfferedRateLIBORMembersrt:MinimumMember2022-01-012022-06-300001831631srt:MaximumMemberus-gaap:LondonInterbankOfferedRateLIBORMember2022-01-012022-06-300001831631us-gaap:CorporateJointVentureMember2022-04-012022-06-300001831631us-gaap:CorporateJointVentureMember2021-04-012021-06-300001831631us-gaap:CorporateJointVentureMember2022-01-012022-06-300001831631us-gaap:CorporateJointVentureMember2021-01-012021-06-300001831631us-gaap:CorporateJointVentureMember2022-06-300001831631us-gaap:CorporateJointVentureMember2021-12-310001831631ldi:ShareholderMember2021-01-012021-06-300001831631ldi:ShareholderMember2022-04-012022-06-300001831631ldi:ShareholderMember2021-04-012021-06-3000018316312021-02-122021-02-120001831631ldi:LDHoldingsGroupLLCMemberldi:LoanDepotIncMember2022-06-300001831631ldi:LDHoldingsGroupLLCMemberldi:ContinuingLLCMembersMember2022-06-300001831631ldi:LDHoldingsGroupLLCMember2022-06-300001831631us-gaap:CommonClassBMember2021-06-300001831631us-gaap:CommonClassAMember2022-04-012022-06-300001831631ldi:CommonClassDMember2022-04-012022-06-300001831631us-gaap:CommonClassAMember2022-01-012022-06-300001831631ldi:CommonClassDMember2022-01-012022-06-300001831631us-gaap:CommonClassAMember2021-04-012021-06-300001831631ldi:CommonClassDMember2021-04-012021-06-300001831631us-gaap:CommonClassAMember2021-01-012021-06-300001831631ldi:CommonClassDMember2021-01-012021-06-300001831631us-gaap:CommonStockMemberus-gaap:CommonClassCMember2022-04-012022-06-300001831631us-gaap:CommonStockMemberus-gaap:CommonClassCMember2022-01-012022-06-300001831631us-gaap:RestrictedStockUnitsRSUMemberus-gaap:CommonClassAMember2022-04-012022-06-300001831631us-gaap:RestrictedStockUnitsRSUMemberus-gaap:CommonClassAMember2022-01-012022-06-300001831631us-gaap:CommonStockMemberus-gaap:CommonClassCMember2021-04-012021-06-300001831631us-gaap:CommonStockMemberus-gaap:CommonClassCMember2021-02-122021-06-300001831631us-gaap:RestrictedStockUnitsRSUMemberus-gaap:CommonClassAMember2021-04-012021-06-300001831631us-gaap:RestrictedStockUnitsRSUMemberus-gaap:CommonClassAMember2021-02-122021-06-300001831631ldi:EmploymentLitigationMember2022-01-012022-06-300001831631us-gaap:CommitmentsToExtendCreditMember2022-06-300001831631us-gaap:CommitmentsToExtendCreditMember2021-12-310001831631ldi:MSRFacilitiesMember2022-06-300001831631ldi:MSRFacilitiesMember2021-12-31

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2022
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _____to _____
Commission File Number: 001-40003

loanDepot, Inc.
(Exact Name of Registrant as Specified in Its Charter)
Delaware 85-3948939
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)
     
26642 Towne Centre Drive,
Foothill Ranch,California 92610
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (888) 337-6888
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol
Name of each exchange
on which registered
Class A Common Stock, $0.001 per value per shareLDIThe New York Stock Exchange


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒  No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company
  Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of August 9, 2022, 64,282,684 shares of the registrant’s Class A common stock, par value $0.001 per share, were outstanding. No shares of registrant’s Class B common stock were outstanding, 152,010,113 shares of registrant’s Class C common stock were outstanding and 97,026,671 shares of registrant’s Class D common stock were outstanding.
 




SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This report contains forward-looking statements that are based on our management’s beliefs and assumptions and on information currently available to our management. Forward-looking statements include information concerning our possible or assumed future results of operations, business strategies, including our Vision 2025 plan, technology developments, financing and investment plans, financial condition and liquidity, dividend policy, competitive position, industry and regulatory environment, potential growth opportunities and the effects of competition. Forward-looking statements include statements that are not historical facts and can be identified by terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” "seek," “should,” “will,” “would” or similar expressions and the negatives of those terms.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Given these uncertainties, you should not place undue reliance on forward-looking statements. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date of this report. You should read this report with the understanding that our actual future results may be materially different from what we expect.

Important factors that could cause actual results to differ materially from our expectations are included in Part I, Item 2 “Management's Discussion and Analysis of Financial Condition and Results of Operations” and Part II, Item 1A "Risk Factors" in this report as well as Part I, Item 1A “Risk Factors” and Part II, Item 7 “Management's Discussion and Analysis of Financial Condition and Results of Operations” in our annual report on Form 10-K for the year ended December 31, 2021 filed with the Securities and Exchange Commission (“SEC”) on March 18, 2022.

Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.


loanDepot, Inc.

Table of Contents

PART 1. FINANCIAL INFORMATION
Item 1. Financial Statements
Consolidated Balance Sheets as of June 30, 2022 and December 31, 2021
Consolidated Statements of Operations for the three and six months June 30, 2022 and 2021
Consolidated Statements of Equity for the three and six months ended June 30, 2022 and 2021
Consolidated Statements of Cash Flows for the six months ended June 30, 2022 and 2021
Notes to Consolidated Financial Statements
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Item 4. Controls and Procedures
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
Item 1A. Risk Factors
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Item 3. Defaults Upon Senior Securities
Item 4. Mine Safety Disclosures
Item 5. Other Information
Item 6. Exhibits
Signatures





PART I - FINANCIAL INFORMATION
Item 1. Financial Statements
loanDepot, Inc.
CONSOLIDATED BALANCE SHEETS
(Dollars in thousands)
June 30,
2022
December 31,
2021
ASSETS(Unaudited)
Cash and cash equivalents$954,930 $419,571 
Restricted cash194,645 201,025 
Accounts receivable, net91,766 56,183 
Loans held for sale, at fair value (includes $1,800,968 and $2,557,490 pledged to creditors in securitization trusts at June 30, 2022 and December 31, 2021, respectively)
4,656,338 8,136,817 
Derivative assets, at fair value153,607 194,665 
Servicing rights, at fair value (includes $484,393 and $400,678 pledged to creditors in securitization trusts at June 30, 2022 and December 31, 2021, respectively)
2,213,700 2,006,712 
Trading securities, at fair value105,308 72,874 
Property and equipment, net111,443 104,262 
Operating lease right-of-use assets48,443 55,646 
Prepaid expenses and other assets140,145 140,315 
Loans eligible for repurchase506,454 363,373 
Investments in joint ventures18,408 18,553 
Goodwill and intangible assets, net— 42,317 
        Total assets$9,195,187 $11,812,313 
LIABILITIES AND EQUITY
Warehouse and other lines of credit$4,265,343 $7,457,199 
Accounts payable, accrued expenses and other liabilities643,144 624,444 
Derivative liabilities, at fair value72,758 37,797 
Liability for loans eligible for repurchase506,454 363,373 
Operating lease liability66,485 71,932 
Debt obligations, net2,427,140 1,628,208 
        Total liabilities7,981,324 10,182,953 
Commitments and contingencies (Note 15)
Class A common stock, $0.001 par value, 2,500,000,000 authorized, 65,257,349 and 38,060,302 issued at June 30, 2022 and December 31, 2021, respectively
$65 $38 
Class B common stock, $0.001 par value, 2,500,000,000 authorized, none issued at June 30, 2022 and December 31, 2021, respectively
— — 
Class C common stock, $0.001 par value, 2,500,000,000 authorized, 152,191,394 and 172,729,168 issued at June 30, 2022 and December 31, 2021, respectively
152 173 
Class D common stock, $0.001 par value, 2,500,000,000 authorized, 97,026,671 and 100,822,084 issued at June 30, 2022 and December 31, 2021, respectively
97 101 
Preferred stock, $0.001 par value, 50,000,000 authorized, none issued at June 30, 2022 and December 31, 2021, respectively
— — 
Treasury stock at cost, 1,664,301 and 1,593,366 shares at June 30, 2022 and December 31, 2021, respectively
(13,087)(12,852)
Additional paid-in capital762,635 565,073 
Retained deficit(205,235)(28,976)
Noncontrolling interest669,236 1,105,803 
Total equity1,213,863 1,629,360 
Total liabilities and equity$9,195,187 $11,812,313 
See accompanying notes to the unaudited consolidated financial statements.

1


loanDepot, Inc.
CONSOLIDATED STATEMENTS OF OPERATIONS
(Dollars in thousands except per share amounts)
(Unaudited)


Three Months Ended
June 30,
Six Months Ended
June 30,
2022202120222021
REVENUES:
Interest income$62,722 $61,874 $115,687 $116,605 
Interest expense(39,923)(54,848)(79,813)(108,346)
Net interest income
22,799 7,026 35,874 8,259 
Gain on origination and sale of loans, net146,562 692,479 509,692 1,826,054 
Origination income, net39,108 92,624 98,181 194,223 
Servicing fee income117,326 94,742 228,385 177,309 
Change in fair value of servicing rights, net(33,507)(145,098)(101,890)(188,733)
Other income16,351 38,141 41,707 78,810 
Total net revenues308,639 779,914 811,949 2,095,922 
EXPENSES:
Personnel expense296,569 470,125 642,563 1,073,861 
Marketing and advertising expense60,837 114,133 162,350 223,759 
Direct origination expense33,996 50,017 87,153 96,993 
General and administrative expense63,927 48,654 113,675 99,972 
Occupancy expense9,388 9,283 18,784 19,270 
Depreciation and amortization11,323 8,686 21,867 17,139 
Servicing expense10,741 27,241 32,252 53,851 
Other interest expense33,140 21,266 47,533 34,438 
Goodwill impairment40,736 — 40,736 — 
Total expenses560,657 749,405 1,166,913 1,619,283 
(Loss) income before income taxes
(252,018)30,509 (354,964)476,639 
Income tax (benefit) expense
(28,196)4,225 (39,823)22,502 
Net (loss) income
(223,822)26,284 (315,141)454,137 
Net (loss) income attributable to noncontrolling interests
(122,894)17,723 (179,472)400,701 
Net (loss) income attributable to loanDepot, Inc.
$(100,928)$8,561 $(135,669)$53,436 
(Loss) earnings per share:
Basic$(0.66)$0.07 $(0.93)$0.42 
Diluted$(0.66)$0.07 $(0.93)$0.42 
Weighted average shares outstanding:
Basic153,822,380 126,726,876 146,415,135 126,392,949 
Diluted153,822,380 126,726,876 146,415,135 126,392,949 

See accompanying notes to the unaudited consolidated financial statements.

2


loanDepot, Inc.
CONSOLIDATED STATEMENTS OF EQUITY
(Dollars in thousands)

Common stock issuedCommon stock $Treasury SharesAdditional paid-in capitalRetained Earnings (Deficit)Non-controlling InterestsTotal Equity
Class AClass CClass DClass AClass CClass D
Balance at March 31, 20216,643,187 179,746,190 119,694,200 $$180 $119 $— $561,494 $42,412 $1,169,746 $1,773,958 
Deferred taxes and other tax adjustments associated with the Reorganization and IPO— — — — — — — 370 — — 370 
Net issuance of common shares under stock based compensation plans5,897,899 1,521,965 (4,715,556)(4)— (3)— — — 
Dividends to Class A and Class D shareholders ($0.69 per share)
— — — — — — — — (36,062)(51,938)(88,000)
Distributions to Class C shareholders— — — — — — — — (56,497)(81,368)(137,865)
Stock-based compensation— — — — — — — 797 — 1,138 1,935 
Distributions for taxes on behalf of shareholders, net— — — — — — — — (3,235)(4,613)(7,848)
Net income
— — — — — — — — 8,561 17,723 26,284 
Balance at June 30, 202112,541,086 181,268,155 114,978,644 $13 $181 $115 $— $562,658 $(44,821)$1,050,688 $1,568,834 
Balance at March 31, 202243,600,418 170,690,888 97,026,671 $45 $171 $97 $(13,015)$656,267 $(77,151)$944,755 $1,511,169 
Deferred taxes and other tax adjustments associated with the Reorganization and IPO— — — — — — — (18,426)— — (18,426)
Net issuance of common stock under stock-based compensation plans19,992,630 (18,499,494)— 20 (19)— (72)122,452 — (122,453)(72)
Forfeiture of dividends on unvested Class A RSUs— — — — — — — — 37 45 82 
Stock-based compensation— — — — — — — 2,342 — 2,369 4,711 
Distributions for taxes on behalf of shareholders, net— — — — — — — — (27,193)(32,586)(59,779)
Net loss
— — — — — — — — (100,928)(122,894)(223,822)
Balance at June 30, 202263,593,048 152,191,394 97,026,671 $65 $152 $97 $(13,087)$762,635 $(205,235)$669,236 $1,213,863 

See accompanying notes to the unaudited consolidated financial statements.

3



loanDepot, Inc.
CONSOLIDATED STATEMENTS OF EQUITY
(Dollars in thousands)
Common stock issuedCommon stock $Treasury StockAdditional paid-in capitalRetained Earnings (Deficit)Non-controlling InterestsTotal Equity
Class AClass CClass DClass AClass CClass D
Balance at December 31, 2020— — — $— $— $— $— $— $— $1,656,613 $1,656,613 
Distributions prior to the Reorganization— — — — — — — (160,617)(160,617)
Equity compensation prior to the Reorganization— — — — — — — 338 338 
Net income prior to the Reorganization— — — — — — — 294,598 294,598 
Deferred taxes and other tax adjustments associated with the Reorganization and IPO— — — — — — — (203,370)— — (203,370)
Effect of the Reorganization2,215,687 181,789,329 121,368,600 182 121 — 740,629 — (740,934)— 
Effect of the IPO3,850,000 (2,394,000)(1,456,000)(2)(2)— — — — — 
Effect of the Greenshoe577,500 (359,100)(218,400)(1)— — — — — — 
Net issuance of common stock under stock-based compensation plans5,897,899 2,231,926 (4,715,556)(4)— (4)— — — 
Dividends to Class A and Class D shareholders ($0.69 per share)
— — — — — — — — (36,062)(51,938)(88,000)
Distributions to Class C shareholders — — — — — — — — (56,497)(81,368)(137,865)
Stock-based compensation— — — — — — — 25,403 — 36,011 61,414 
Distributions for taxes on behalf of shareholders, net— — — — — — — — (5,698)(8,118)(13,816)
Net income subsequent to the Reorganization and IPO— — — — — — — — 53,436 106,103 159,539 
Balance at June 30, 202112,541,086 181,268,155 114,978,644 $13 $181 $115 $— $562,658 $(44,821)$1,050,688 $1,568,834 
Balance at December 31, 202136,466,936 172,729,168 100,822,084 $38 $173 $101 $(12,852)$565,073 $(28,976)$1,105,803 $1,629,360 
Deferred taxes and other tax adjustments associated with the Reorganization and IPO— — — — — — — (17,744)— — (17,744)
Net issuance of common stock under stock-based compensation plans27,126,112 (20,537,774)(3,795,413)27 (21)(4)(235)211,930 — (211,932)(235)
Dividends to Class A and Class D shareholders ($0.08 per share)
— — — — — — — — (5,273)(6,397)(11,670)
Distributions to Class C shareholders— — — — — — — — (6,338)(7,665)(14,003)
Stock-based compensation— — — — — — — 3,376 — 3,645 7,021 
Distributions for taxes on behalf of shareholders, net— — — — — — — — (28,979)(34,746)(63,725)
Net loss
— — — — — — — — (135,669)(179,472)(315,141)
Balance at June 30, 202263,593,048 152,191,394 97,026,671 $65 $152 $97 $(13,087)$762,635 $(205,235)$669,236 $1,213,863 
See accompanying notes to the unaudited consolidated financial statements.

4


loanDepot, Inc.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars in thousands)
(Unaudited)



Six Months Ended
June 30,
20222021
CASH FLOWS FROM OPERATING ACTIVITIES
Net (loss) income
$(315,141)$454,137 
Adjustments to reconcile net (loss) income to net
cash provided by (used in) operating activities:
Depreciation and amortization expense21,867 17,139 
Amortization of operating lease right-of-use asset11,272 11,594 
Amortization of debt issuance costs8,067 6,744 
Gain on origination and sale of loans(809,990)(2,041,979)
Gain on sale of servicing rights(20,041)(11,478)
Fair value change in trading securities13,883 — 
Provision for loss obligation on sold loans and servicing rights108,120 5,752 
(Decrease) increase in provision for deferred income taxes(39,643)202,871 
Fair value change in derivative assets191,682 303,639 
Fair value change in derivative liabilities34,961 (109,364)
Premium (paid) received on derivatives(150,624)5,061 
Purchase of options contracts— (10,383)
Fair value change in loans held for sale174,519 33,191 
Fair value change in servicing rights(154,290)122,120 
Stock-based compensation expense7,021 61,752 
Originations of loans(37,142,855)(75,814,894)
Proceeds from sales of loans40,992,588 75,281,888 
Proceeds from principal payments100,885 66,506 
Payments to investors for loan repurchases(376,387)(671,166)
Gain on extinguishment of debt(10,528)— 
Goodwill impairment40,736 — 
Disbursements from joint ventures4,565 5,790 
Other changes in operating assets and liabilities(19,739)(189,193)
Net cash provided by (used in) operating activities
2,670,928 (2,270,273)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment(28,844)(30,400)
Proceeds from sale of servicing rights387,968 176,995 
Cash flows received on trading securities4,109 — 
Investments in joint ventures(350)(1,115)
Return of capital from joint ventures— 189 
Net cash flows provided by investing activities
362,883 145,669 

See accompanying notes to the unaudited consolidated financial statements.

5


loanDepot, Inc.
CONSOLIDATED STATEMENTS OF CASH FLOWS - CONTINUED
(Dollars in thousands)
(Unaudited)

Six Months Ended
June 30,
20222021
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from borrowings on warehouse and other lines of credit$42,522,401 $85,132,551 
Repayment of borrowings on warehouse and other lines of credit(45,714,257)(83,211,614)
Proceeds from debt obligations2,099,247 1,044,221 
Payments on debt obligations(1,290,746)(276,947)
Payments of debt issuance costs(4,135)(13,913)
Payments on financing lease obligation— (1,367)
Treasury stock purchased to net settle and withhold taxes on vested shares(235)— 
Dividends and shareholder distributions(117,107)(400,298)
Net cash (used in) provided by financing activities
(2,504,832)2,272,633 
Net change in cash and cash equivalents and restricted cash528,979 148,029 
Cash and cash equivalents and restricted cash at beginning of the period620,596 488,689 
Cash and cash equivalents and restricted cash at end of the period$1,149,575 $636,718 
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid during the period for:
Interest$120,060 $126,497 
Income taxes24,223 7,628 
Supplemental disclosure of noncash investing and financing activities
Operating leases right-of-use assets obtained in exchange for lease liabilities$8,656 $5,285 
Trading securities retained in securitizations50,426 16,757 
Purchase of equipment under financing leases— 168 


See accompanying notes to the unaudited consolidated financial statements.

6


loanDepot, Inc.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
($ are in thousands, unless otherwise indicated)
(Unaudited)


NOTE 1 – DESCRIPTION OF BUSINESS, PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The accompanying unaudited consolidated financial statements were prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, the statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation were included. The results of operations for the three and six months ended June 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022. For further information, refer to the consolidated financial statements and footnotes thereto included in the Annual Report of loanDepot, Inc. on Form 10-K for the year ended December 31, 2021 (“2021 Form 10-K”).

Nature of Operations

loanDepot, Inc. was incorporated in Delaware on November 6, 2020 to facilitate the initial public offering (“IPO”) of its Class A common stock and related transactions in order to carry on the business of LD Holdings Group, LLC (“LD Holdings”) and its consolidated subsidiaries. loanDepot, Inc.’s common stock began trading on the New York Stock Exchange on February 11, 2021 under the ticker symbol “LDI.” loanDepot, Inc. is a holding company and its sole material asset is its equity interest in LD Holdings. As of June 30, 2022 the consolidated subsidiaries of LD Holdings included loanDepot.com, LLC, (“LDLLC”), Artemis Management, LLC (“ART”), LD Settlement Services, LLC (“LDSS”), mello Holdings, LLC (“Mello”), and mello Credit Strategies LLC (“MCS”). Unless otherwise noted or indicated by the context, the term, the “Company,” refers (1) prior to the consummation of the IPO to LD Holdings and its consolidated subsidiaries, and (2) after the IPO to loanDepot, Inc. and its consolidated subsidiaries, including LD Holdings.

The Company engages in the originating, financing, selling, and servicing of residential mortgage loans, and engages in title, escrow, and settlement services for mortgage loan transactions. The Company derives income primarily from gains on the origination and sale of loans to investors, income from loan servicing, and fees charged for settlement services related to the origination and sale of loans.

Summary of Significant Accounting Policies

Our accounting policies are described below and in Note 1- Description of Business, Presentation and Summary of Significant Accounting Policies, of our audited consolidated financial statements included in our 2021 Form 10-K.

Consolidation and Basis of Presentation

The Company's consolidated financial statements are prepared in accordance with U.S. GAAP as codified in the Financial Accounting Standards Board's (“FASB”) Accounting Standards Codification (“ASC” or the “Codification”).

ASC 250 requires that a change in the reporting entity or the consummation of a transaction accounted for in a manner similar to a pooling of interests, i.e., a reorganization of entities under common control, be retrospectively applied to the financial statements of all prior periods when the financial statements are issued for a period that includes the date the change in reporting entity or the transaction occurred. Prior to the IPO, the Company completed a reorganization where LLC units in LD Holdings held by certain members (“Continuing LLC Members) were exchanged on a one-for-one basis for Class A holding units (“Holdco Units”) and Class C common stock. LD Holdings continues to be a holding company and has no material assets other than its equity interests in its direct subsidiaries consisting of a 99.99% ownership in LDLLC (the majority asset of the group), and 100% equity ownership in ART, LDSS, Mello, and MCS. As a result of the IPO and reorganization, loanDepot, Inc. became a holding company, its sole material asset is its equity interest in LD Holdings and as the sole managing member of LD Holdings, loanDepot, Inc. indirectly operates and controls all of LD Holdings’ business and affairs. The IPO and reorganization were considered transactions between entities under common control. The financial results of LD Holdings and


7



its subsidiaries are consolidated with loanDepot, Inc, and the consolidated net earnings or loss are allocated to the noncontrolling interest to reflect the entitlement of the Continuing LLC Members.

The accompanying consolidated financial statements include all of the assets, liabilities, and results of operations of the Company and consolidated variable interest entities (“VIEs”) in which the Company is the primary beneficiary. VIEs are entities that have a total equity investment at risk that is insufficient to permit the entity to finance its activities without additional subordinated financial support, whose equity investors at risk lack the ability to control the entity's activities, or is structured with non-substantive voting rights. The Company evaluates its associations with VIEs, both at inception and when there is a change in circumstance that requires reconsideration, to determine if the Company is the primary beneficiary and consolidation is required. A primary beneficiary is defined as a variable interest holder that has a controlling financial interest. A controlling financial interest requires both: (a) the power to direct the activities that most significantly impact the VIEs’ economic performance, and (b) the obligation to absorb losses or receive benefits of a VIE that could potentially be significant to the VIE. The Company has not provided financial or other support during the periods presented to any VIE that it was not previously contractually required to provide. Other entities that the Company does not consolidate, but for which it has significant influence over operating and financial policies, are accounted for using the equity method. All intercompany accounts and transactions have been eliminated in consolidation.

Certain items in prior periods were reclassified to conform to the current presentation. To conform to the current period presentation, servicing expense on the consolidated statements of operations includes subservicing expense and in-house servicing expense.

The Company has evaluated subsequent events for recognition or disclosure through the date of this report and has not identified any recordable or disclosable events that were not already reported in these consolidated financial statements or notes thereto.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Management has made significant estimates in certain areas, including determining the fair value of loans held for sale, servicing rights, derivative assets and derivative liabilities, trading securities, awards granted under the incentive equity plan, determining the loan loss obligation on sold loans and MSRs, and goodwill impairment. Actual results could differ from those estimates.

Concentration of Risk

The Company has concentrated its credit risk for cash by maintaining deposits in several financial institutions, which may at times exceed amounts covered by insurance provided by the Federal Deposit Insurance Corporation (“FDIC”). The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk related to cash.

Due to the nature of the mortgage lending industry, changes in interest rates may significantly impact revenue from originating mortgages and subsequent sales of loans to investors, which are the primary source of income for the Company. The Company originates mortgage loans on property located throughout the United States, with loans originated for property located in California totaling approximately 23% of total loan originations for the six months ended June 30, 2022.

The Company sells mortgage loans to various third-party investors. Three investors accounted for 32%, 27%, and 19% of the Company’s loan sales for the six months ended June 30, 2022. No other investors accounted for more than 5% of the loan sales for the six months ended June 30, 2022.

The Company funds loans through warehouse and other lines of credit. As of June 30, 2022, 14% and 15% of the Company's warehouse lines were payable to two separate lenders.



8




NOTE 2 – FAIR VALUE

The Company's consolidated financial statements include assets and liabilities that are measured based on their estimated fair values. Refer to Note 1 - Description of Business, Presentation and Summary of Significant Accounting Policies in the 2021 Form 10-K for information on the fair value hierarchy, valuation methodologies, and key inputs used to measure financial assets and liabilities recorded at fair value, as well as methods and assumptions used to estimate fair value disclosures for financial instruments not recorded at fair value in their entirety on a recurring basis.

The following tables present the carrying amount and estimated fair value of financial instruments included in the consolidated financial statements.

June 30, 2022
Carrying AmountEstimated Fair Value
Level 1Level 2Level 3
Assets
Cash and cash equivalents$954,930 $954,930 $— $— 
Restricted cash194,645 194,645 — — 
Loans held for sale, at fair value4,656,338 — 4,656,338 — 
Derivative assets, at fair value153,607 — 61,721 91,886 
Servicing rights, at fair value2,213,700 — — 2,213,700 
Trading securities, at fair value105,308 — 105,308 — 
Loans eligible for repurchase506,454 — 506,454 — 
Liabilities
Warehouse and other lines of credit$4,265,343 $— $4,265,343 $— 
Derivative liabilities, at fair value72,758 14,859 23,618 34,281 
Servicing rights, at fair value9,107 — — 9,107 
Debt obligations:
Secured credit facilities1,237,269 — 1,239,841 — 
Term Notes199,415 — 200,000 — 
Senior Notes990,456 — 657,453 — 
Liability for loans eligible for repurchase506,454 — 506,454 — 



9



December 31, 2021
Carrying AmountEstimated Fair Value
Level 1Level 2Level 3
Assets
Cash and cash equivalents$419,571 $419,571 $— $— 
Restricted cash201,025 201,025 — — 
Loans held for sale, at fair value8,136,817 — 8,136,817 — 
Derivative assets, at fair value194,665 4,924 5,358 184,383 
Servicing rights, at fair value2,006,712 — — 2,006,712 
Trading securities, at fair value72,874 — 72,874 — 
Loans eligible for repurchase363,373 — 363,373 — 
Liabilities
Warehouse and other lines of credit$7,457,199 $— $7,457,199 $— 
Derivative liabilities, at fair value37,797 31,070 2,964 3,763 
Servicing rights, at fair value7,310 — — 7,310 
Debt obligations:
Secured credit facilities343,759 — 345,596 — 
Term Notes199,133 — 200,000 — 
Senior Notes1,085,316 — 1,057,977 — 
Liability for loans eligible for repurchase363,373 — 363,373 — 

Financial Statement Items Measured at Fair Value on a Recurring Basis

The following tables presents the Company’s assets and liabilities that are measured at fair value on a recurring basis by fair value hierarchy as of the dates indicated.


10



June 30, 2022
Recurring Fair Value Measurements of Assets and Liabilities Using:
Quoted Market Prices in Active Markets for Identical Assets
 (Level 1)
Significant Other Observable Inputs
(Level 2)
Significant Unobservable Inputs
(Level 3)
Total Fair Value Measurements
Fair value through net income:
Assets:
Loans held for sale$— $4,656,338 $— $4,656,338 
Trading securities— 105,308 — 105,308 
Derivative assets:
Interest rate lock commitments— — 91,886 91,886 
Forward sale contracts— 43,926 — 43,926 
MBS put options— 17,795 — 17,795 
Servicing rights— — 2,213,700 2,213,700 
Total assets at fair value$— $4,823,367 $2,305,586 $7,128,953 
Liabilities:
Derivative liabilities:
Interest rate lock commitments$— $— $34,281 $34,281 
Interest rate swap futures5,746 — — 5,746 
Forward sale contracts— 10,694 — 10,694 
Put options on treasuries9,113 — — 9,113 
MBS put options— 12,924 — 12,924 
Servicing rights— — 9,107 9,107 
Total liabilities at fair value$14,859 $23,618 $43,388 $81,865 


11



December 31, 2021
Recurring Fair Value Measurements of Assets and Liabilities Using:
Quoted Market Prices in Active Markets for Identical Assets
 (Level 1)
Significant Other Observable Inputs
(Level 2)
Significant Unobservable Inputs
(Level 3)
Total Fair Value Measurements
Fair value through net income:
Assets:
Loans held for sale$— $8,136,817 $— $8,136,817 
Trading securities— 72,874 — 72,874 
Derivative assets:
Interest rate lock commitments— — 184,383 184,383 
Forward sale contracts— 5,358 — 5,358 
Interest rate swap futures4,924 — — 4,924 
Servicing rights— — 2,006,712 2,006,712 
Total assets at fair value$4,924 $8,215,049 $2,191,095 $10,411,068 
Liabilities:
Derivative liabilities:
Interest rate lock commitments$— $— $3,763 $3,763 
Forward sale contracts— 2,964 — 2,964 
Put options on treasuries31,070 — — 31,070 
Servicing rights— — 7,310 7,310 
Total liabilities at fair value$31,070 $2,964 $11,073 $45,107 

The following presents the changes in the Company’s assets and liabilities that are measured at fair value on a recurring basis using significant unobservable inputs (Level 3):
Three Months Ended June 30, 2022Six Months Ended June 30, 2022
IRLCs, netServicing
Rights, net
IRLCs, netServicing
Rights, net
Balance at beginning of period$12,000 $2,078,187 $180,620 $1,999,402 
Total net gains or losses included in earnings (realized and unrealized)114,197 212,777 257,154 624,546 
Sales and settlements
Sales— (86,371)— (419,355)
Settlements (1)
(38,536)— (271,458)— 
Transfers of IRLCs to closed loans(30,056)— (108,711)— 
Balance at end of period$57,605 $2,204,593 $57,605 $2,204,593 
(1)Funded amount for IRLCs.



12



Three Months Ended June 30, 2021Six Months Ended June 30, 2021
IRLCs, netServicing
Rights, net
IRLCs, netServicing
Rights, net
Balance at beginning of period$246,778 $1,766,088 $647,045 $1,124,302 
Total net gains or losses included in earnings (realized and unrealized)720,422 203,937 1,108,970 846,359 
Sales and settlements
Sales— (193,630)— (194,266)
Settlements (1)
(432,748)— (1,026,450)— 
Transfers of IRLCs to closed loans(201,371)— (396,484)— 
Balance at end of period$333,081 $1,776,395 $333,081 $1,776,395 
(1)Funded amount for IRLCs.

The following presents the gains and losses included in earnings relating to the Company’s assets and liabilities that are measured at fair value on a recurring basis using significant unobservable inputs (Level 3):
Three Months Ended June 30, 2022Six Months Ended June 30, 2022
IRLCs, net (1)
Servicing
Rights, net(2)
IRLCs, net (1)
Servicing
Rights, net(3)
Total net gains (losses) included in earnings
$45,605 $212,777 $(123,015)$624,546 
Change in unrealized gains relating to assets and liabilities still held at period end
$57,605 $215,835 $57,605 $615,444 

(1)Gains (losses) included in gain on origination and sale of loans, net.
(2)Includes $180.5 million in gains included in gain on origination and sale of loans, net and $32.3 million of gains included in change in fair value of servicing rights, net, for the three months ended June 30, 2022.
(3)Includes $450.2 million in gains included in gain on origination and sale of loans, net and $174.3 million of gains included in change in fair value of servicing rights, net, for the six months ended June 30, 2022.
Three Months Ended June 30, 2021Six Months Ended June 30, 2021
IRLCs, net (1)
Servicing
Rights, net(2)
Interest Rate Lock Commitments(1)
Servicing
Rights, net(3)
Total net gains (losses) included in earnings
$86,303 $203,937 $(313,964)$846,359 
Change in unrealized gains relating to assets and liabilities still held at period end
$333,081 $296,555 $333,081 $1,038,347 
(1)Gains (losses) included in gain on origination and sale of loans, net.
(2)Includes $427.5 million in gains included in gain on origination and sale of loans, net and $223.5 million in losses included in change in fair value of servicing rights, net, for the three months ended June 30, 2021.
(3)Includes $957.0 million in gains included in gain on origination and sale of loans, net and $110.6 million of losses included in change in fair value of servicing rights, net, for the six months ended June 30, 2021.





13



The following table presents quantitative information about the valuation techniques and unobservable inputs applied to Level 3 fair value measurements for financial instruments measured at fair value on a recurring basis:
June 30, 2022December 31, 2021
Unobservable InputRange of inputs
Weighted Average (2)
Range of inputs
Weighted Average (2)
IRLCs:
  Pull-through rate1.0%-99.9%80.2%0.3%-99.3%74.2%
Servicing rights
  Discount rate(1)
4.6%-10.5%6.2%4.5%-9.0%5.8%
  Prepayment rate(1)
5.4%-14.9%7.2%8.4%-18.7%10.2%
  Cost to service (per loan)$63-$136$85$70-$114$82
(1)The Company estimates the fair value of MSRs using an option-adjusted spread (“OAS”) model, which projects MSR cash flows over multiple interest rate scenarios in conjunction with the Company’s prepayment model, and then discounts these cash flows at risk-adjusted rates.
(2)Weighted average inputs are based on the committed amounts for IRLCs and the UPB of the underlying loans for servicing rights.

Financial Statement Items Measured at Fair Value on a Nonrecurring Basis

The Company did not have any material assets or liabilities that were recorded at fair value on a non-recurring basis as of June 30, 2022 or December 31, 2021.

Financial Statement Items Measured at Amortized Cost

Warehouse and other lines of credit - The Company’s warehouse and other lines of credit bear interest at a rate that is periodically adjusted based on a market index. The carrying value of warehouse and other lines of credit approximates fair value.

Debt obligations, net - Debt consists of secured credit facilities, Term Notes, and Senior Notes. The Company’s secured credit facilities and Term Notes accrue interest at a stated rate of 30-day or 90-day LIBOR, or other alternative base rate such as SOFR, plus a margin, they are highly liquid and short-term in nature and as a result, their carrying value approximated fair value as of June 30, 2022 and December 31, 2021. Fair value of the Company’s Senior Notes issued in October 2020 and March 2021 were estimated using the quoted market prices at June 30, 2022. The debt obligations are classified as Level 2 in the fair value hierarchy.



14



NOTE 3 – BALANCE SHEET NETTING

Certain derivatives, loan warehouse and repurchase agreements are subject to master netting arrangements or similar agreements. In certain circumstances the Company may elect to present certain financial assets, liabilities, and related collateral subject to master netting arrangements in a net position on the consolidated balance sheets.

The table below represents financial assets and liabilities that are subject to master netting arrangements or similar agreements categorized by financial instrument, together with corresponding financial instruments and corresponding collateral received or pledged. Warehouse and other lines of credit and secured debt obligations were secured by financial instruments with fair value that exceeded the liability amount recorded on the consolidated balance sheets as of June 30, 2022 and December 31, 2021, respectively.
June 30, 2022
Gross amounts recognizedGross amounts offset in consolidated balance sheetNet amounts presented in consolidated balance sheetGross amounts not offset in consolidated balance sheetNet amount
Financial instrumentsCash collateral
Assets:
Forward sale contracts$100,202 $(56,276)$43,926 $— $(40,606)$3,320 
MBS put options17,795 — 17,795 — — 17,795 
Total Assets$117,997 $(56,276)$61,721 $— $(40,606)$21,115 
Liabilities:
Forward sale contracts$66,970 $(56,276)$10,694 $— $(1,947)$8,747 
Put options on treasuries9,113 — 9,113 — — 9,113 
MBS put options12,924 — 12,924 — — 12,924 
Interest rate swap futures5,746 — 5,746 — — 5,746 
Warehouse and other lines of credit4,265,343 — 4,265,343 (4,265,343)— — 
Secured debt obligations (1)
1,439,841 — 1,439,841 (1,439,841)— — 
Total Liabilities$5,799,937 $(56,276)$5,743,661 $(5,705,184)$(1,947)$36,530 
(1)Secured debt obligations as of June 30, 2022 included secured credit facilities and Term Notes.
December 31, 2021
Gross amounts recognizedGross amounts offset in consolidated balance sheetsNet amounts presented in consolidated balance sheetsGross amounts not offset in consolidated balance sheetsNet amount
Financial instrumentsCash collateral
Assets:
Forward sale contracts$29,497 $(24,139)$5,358 $— $(1,447)$3,911 
Interest rate swap futures4,924 — 4,924 — — 4,924 
Total Assets$34,421 $(24,139)$10,282 $— $(1,447)$8,835 
Liabilities:
Forward sale contracts$27,103 $(24,139)$2,964 $— $(1,736)$1,228 
Put options on treasuries31,070 — 31,070 — — 31,070 
Warehouse and other lines of credit7,457,199 — 7,457,199 (7,457,199)— — 
Secured debt obligations (1)
545,596 — 545,596 (545,596)— — 
Total Liabilities$8,060,968 $(24,139)$8,036,829 $(8,002,795)$(1,736)$32,298 
(1)Secured debt obligations as of December 31, 2021 included secured credit facilities and Term Notes.
The Company has entered into agreements with counterparties, which include netting arrangements whereby the counterparties are entitled to settle their positions on a net basis. In certain circumstances, the Company is required to provide


15



certain counterparties financial instruments and cash collateral against derivative financial instruments, warehouse and other lines of credit, or debt obligations. Cash collateral is held in margin accounts and included in restricted cash on the Company's consolidated balance sheets.




NOTE 4 – LOANS HELD FOR SALE, AT FAIR VALUE

The following table represents the unpaid principal balance of LHFS by product type of loan as of June 30, 2022 and December 31, 2021:
June 30,
2022
December 31,
2021
Amount%Amount%
Conforming - fixed$3,018,321 64%$4,881,222 61%
Conforming - ARM26,694 1351,408 4
Government - fixed 1,003,598 211,156,890 15
Government - ARM6,951 10,906 
Other - residential mortgage loans648,560 141,576,858 20
Consumer loans1,819 1,942 
4,705,943 100%7,979,226 100%
Fair value adjustment(49,605)157,591 
  Total$4,656,338 $8,136,817 

A summary of the changes in the balance of loans held for sale is as follows:

Three Months Ended
June 30,
Six Months Ended
June 30,
2022202120222021
Balance at beginning of period$6,558,668 $8,787,756 $8,136,817 $6,955,424 
Origination and purchase of loans15,769,229 34,413,319 37,142,855 75,814,894 
Sales(17,876,229)(34,294,254)(40,681,596)(74,213,668)
Repurchases194,650 111,385 333,666 663,700 
Principal payments(40,598)(43,206)(100,885)(66,506)
Fair value gain (loss)
50,618 145,653 (174,519)(33,191)
Balance at end of period$4,656,338 $9,120,653 $4,656,338 $9,120,653 



16



Gain on origination and sale of loans, net is comprised of the following components:

Three Months Ended
June 30,
Six Months Ended
June 30,
2022202120222021
(Discount) premium from loan sales
$(437,194)$407,314 $(673,291)$877,887 
Servicing rights180,455 427,458 450,215 957,002 
Unrealized losses from derivative assets and liabilities
(190,545)(510,788)(31,803)(182,467)
Realized gains from derivative assets and liabilities
553,834 250,912 902,875 350,548 
Discount points, rebates and lender paid costs71,767 (28,603)131,834 (143,458)
Fair value gain (loss)
50,618 145,653 (174,519)(33,191)
Provision for loan loss obligation for loans sold(82,373)533 (95,619)(267)
Total gain on origination and sale of loans, net$146,562 $692,479 $509,692 $1,826,054 

The Company had $23.7 million and $28.8 million of loans held for sale on non-accrual status as of June 30, 2022 and December 31, 2021, respectively.


NOTE 5 – SERVICING RIGHTS, AT FAIR VALUE

The outstanding principal balance of the servicing portfolio was comprised of the following:
June 30,
2022
December 31,
2021
Conventional$120,545,854 $127,270,097 
Government34,671,158 34,842,868 
Total servicing portfolio$155,217,012 $162,112,965 

A summary of the unpaid principal balance underlying servicing rights is as follows:
June 30,
2022
December 31,
2021
Current loans$153,367,435 $160,302,966 
Loans 30 - 89 days delinquent520,963 504,467 
Loans 90 or more days delinquent or in foreclosure1,328,614 1,305,532 
Total servicing portfolio (1)
$155,217,012 $162,112,965 
(1)At June 30, 2022 and December 31, 2021 0.4% and 0.6%, respectively, of the servicing portfolio was in forbearance as a result of payment relief efforts afforded to borrowers as a result of the Coronavirus Aid, Relief, and Economic Security Act and other regulatory guidance.


17




A summary of the changes in the balance of servicing rights, net of servicing rights liability is as follows:
Three Months Ended
June 30,
Six Months Ended
June 30,
2022202120222021
Balance at beginning of period$2,078,187 $1,766,088 $1,999,402 $1,124,302 
Additions180,455 427,458 450,215 957,001 
Sales proceeds, net(86,464)(182,113)(399,314)(182,788)
Changes in fair value:
Due to changes in valuation inputs or assumptions98,795 (129,267)297,792 101,757 
Due to collection/realization of cash flows(66,380)(105,771)(143,502)(223,877)
Balance at end of period$2,204,593 $1,776,395 $2,204,593 $1,776,395 

The following is a summary of the components of loan servicing fee income as reported in the Company’s consolidated statements of operations:
Three Months Ended
June 30,
Six Months Ended
June 30,
2022202120222021
Contractual servicing fees$113,824 $92,164 $222,650 $171,734 
Late, ancillary and other fees3,502 2,578 5,735 5,575 
Servicing fee income$117,326 $94,742 $228,385 $177,309 

The following is a summary of the components of changes in fair value of servicing rights, net as reported in the Company’s consolidated statements of operations:
Three Months Ended
June 30,
Six Months Ended
June 30,
2022202120222021
Changes in fair value:
Due to changes in valuation inputs or assumptions$98,795 $(129,267)$297,792 $101,757 
Due to collection/realization of cash flows
(66,380)(105,771)(143,502)(223,877)
Realized (losses) gains on sales of servicing rights
(2,493)6,089 7,540 5,992 
Net (loss) gain from derivatives hedging servicing rights
(63,429)83,851 (263,720)(72,605)
Changes in fair value of servicing rights, net$(33,507)$(145,098)$(101,890)$(188,733)


18




The table below illustrates hypothetical changes in fair values of servicing rights, caused by assumed immediate changes to key assumptions that are used to determine fair value.


June 30,
2022
December 31,
2021
Fair Value of Servicing Rights, net$2,204,593 $1,999,402 
Change in Fair Value from adverse changes:
Discount Rate:
Increase 1%(79,165)(85,066)
Increase 2%(152,847)(163,255)
Cost of Servicing:
Increase 10%(19,008)(20,843)
Increase 20%(38,045)(41,727)
Prepayment Speed:
Increase 10%(29,614)(76,532)
Increase 20%(58,466)(148,556)

Sensitivities are hypothetical changes in fair value and cannot be extrapolated because the relationship of changes in assumptions to changes in fair value may not be linear. Also, the effect of a variation in a particular assumption is calculated without changing any other assumption, whereas a change in one factor may result in changes to another. Accordingly, no assurance can be given that actual results would be consistent with the results of these estimates. As a result, actual future changes in servicing rights values may differ significantly from those displayed above.



NOTE 6 – DERIVATIVE FINANCIAL INSTRUMENTS AND HEDGING ACTIVITIES

Derivatives instruments utilized by the Company primarily include interest rate lock commitments, forward sale contracts, MBS put options, put options on treasuries, and interest rate swap futures. Derivative financial instruments are recognized as assets or liabilities and are measured at fair value. The Company accounts for derivatives as free-standing derivatives and does not designate any derivative financial instruments for hedge accounting. All derivative financial instruments are recognized on the consolidated balance sheets at fair value with changes in the fair values being reported in current period earnings. The Company does not use derivative financial instruments for purposes other than in support of its risk management activities. Refer to Note 1- Description of Business, Presentation and Summary of Significant Accounting Policies and Note 2- Fair Value for further details on derivatives in the 2021 Form 10-K.



19



The following summarizes the Company’s outstanding derivative instruments:
Fair Value
NotionalBalance Sheet LocationAssetLiability
June 30, 2022:
Interest rate lock commitments $5,120,259 Derivative asset, at fair value$91,886 $— 
Interest rate lock commitments 2,569,129 Derivative liabilities, at fair value— 34,281 
Forward sale contracts 17,168,753 Derivative asset, at fair value43,926 — 
Forward sale contracts 2,335,109 Derivative liabilities, at fair value— 10,694 
Put options on treasuries — Derivative asset, at fair value— — 
Put options on treasuries 3,500 Derivative liabilities, at fair value— 9,113 
MBS put options 2,150,000 Derivative asset, at fair value17,795 — 
MBS put options 1,300,000 Derivative liabilities, at fair value— 12,924 
Interest rate swap futures — Derivative asset, at fair value— — 
Interest rate swap futures 3,339 Derivative liabilities, at fair value— 5,746 
Total derivative financial instruments$153,607 $72,758 

Fair Value
NotionalBalance Sheet LocationAssetLiability
December 31, 2021:
Interest rate lock commitments $11,530,721 Derivative asset, at fair value$184,383 $— 
Interest rate lock commitments 1,125,911 Derivative liabilities, at fair value— 3,763 
Forward sale contracts 19,482,705 Derivative asset, at fair value5,358 — 
Forward sale contracts 13,171,462 Derivative liabilities, at fair value— 2,964 
Put options on treasuries — Derivative asset, at fair value— — 
Put options on treasuries 16,980 Derivative liabilities, at fair value— 31,070 
Interest rate swap futures 2,640 Derivative asset, at fair value4,924 — 
Interest rate swap futures — Derivative liabilities, at fair value— — 
Total derivative financial instruments$194,665 $37,797 

Because many of the Company’s current derivative agreements are not exchange-traded, the Company is exposed to credit loss in the event of nonperformance by the counterparty to the agreements. The Company controls this risk through credit monitoring procedures including financial analysis, dollar limits and other monitoring procedures. The notional amount of the contracts does not represent the Company’s exposure to credit loss.



20



The following summarizes the realized and unrealized net gains or losses on derivative financial instruments and the consolidated statements of operations line items where such gains and losses are included:
Three Months Ended
June 30,
Six Months Ended
June 30,
Derivative instrumentStatements of Operations Location2022202120222021
Interest rate lock commitments, netGain on origination and sale of loans, net$45,605 $86,303 $(123,015)$(313,964)
Forward sale contractsGain on origination and sale of loans, net297,939 (317,263)962,458 507,082 
Interest rate swap futuresGain on origination and sale of loans, net(50,848)(22,217)(84,530)(52,208)
Put optionsGain on origination and sale of loans, net70,593 (6,699)116,159 27,171 
Forward sale contractsChange in fair value of servicing rights, net(23,399)33,925 (97,627)(79,004)
Interest rate swap futuresChange in fair value of servicing rights, net(38,916)48,194 (165,579)7,178 
Put optionsChange in fair value of servicing rights, net(1,114)1,732 (514)(779)
Total realized and unrealized gains (losses) on derivative financial instruments
$299,860 $(176,025)$607,352 $95,476 

NOTE 7 – GOODWILL AND OTHER INTANGIBLE ASSETS, NET

A summary of the Company’s activity related to goodwill is as follows.

GoodwillOther intangible assetsTotal
Balance, December 31, 2021$40,736 $1,581 $42,317 
Amortization— (205)(205)
Impairment loss(40,736)(1,376)(42,112)
Balance, June 30, 2022$— $— $— 

GoodwillOther intangible assetsTotal
Balance, December 31, 2020$40,736 $2,090 $42,826 
Amortization— (255)(255)
Balance June 30, 2021$40,736 $1,835 $42,571 

The Company performs its annual assessment of possible impairment of goodwill and intangible assets as of December 31, or more frequently if events and circumstances indicate that impairment may have occurred. The Company compares the fair value of each reporting unit with its carrying amount, including goodwill. If the carrying amount of a reporting unit exceeds its fair value, an impairment loss is recognized in an amount equal to that excess.

During the three months ended June 30, 2022, the Company performed an interim impairment test due to the impact of rising interest rates on the mortgage industry and the Company’s recent stock performance. The evaluation of goodwill included a market based and income based approach. Based upon the results of this evaluation, an impairment charge of $40.7 million was recognized, driven predominantly by a significant decline in our market capitalization.

In addition to goodwill, the Company had other intangible assets related to trademarks associated with prior acquisitions. The Company reviews intangible assets for possible impairment whenever events or circumstances indicate that


21



carrying amounts may not be recoverable. The factors outlined in the goodwill impairment discussion above triggered an interim impairment evaluation of other intangible assets during the three months ended June 30, 2022. Based upon the results of this evaluation, an impairment charge of $1.4 million was recognized.


NOTE 8 – VARIABLE INTEREST ENTITIES

The determination of whether the assets and liabilities of the VIEs are consolidated or not consolidated in the consolidated balance sheets depends on the terms of the related transaction and the Company’s continuing involvement, if any, with the VIE. The Company is deemed the primary beneficiary and therefore consolidates VIEs for which it has both (a) the power, through voting rights or similar rights, to direct the activities that most significantly impact the VIE's economic performance, and (b) benefits, as defined, from the VIE. The Company determines whether it holds a significant variable interest in a VIE based on a consideration of both qualitative and quantitative factors regarding the nature, size, and form of its involvement with the VIE. The Company assesses whether it is the primary beneficiary of a VIE on an ongoing basis. The Company did not provide any non-contractual financial support to VIEs for the six months ended June 30, 2022 and year ended December 31, 2021.

Consolidated VIEs

The Company is a holding company, its sole material asset is its equity interest in LD Holdings and as the sole managing member of LD Holdings, the Company indirectly operates and controls all of LD Holdings’ business and affairs. LD Holdings is considered a VIE and the financial results of LD Holdings and its subsidiaries are consolidated. A portion of net earnings or loss is allocated to noncontrolling interest to reflect the entitlement of the Continuing LLC Members.

The Company is involved in several types of securitization and financing transactions that utilize special purpose entities (“SPEs”). The Company’s principal use of SPEs is to obtain liquidity by securitizing certain of its financial and non-financial assets. SPEs involved in the Company’s securitization and other financing transactions are often considered VIEs.

The Company consolidates securitization facilities that finance mortgage loans held for sale, and SPEs established as trusts to finance mortgage servicing rights and servicing advance receivables. The Company sells assets to a securitization or trust, which issues beneficial interests which are collateralized by the transferred assets and entitle the investors to specified cash flows generated therefrom. The Company may retain beneficial interests in the assets sold. The Company’s economic exposure to loss from outstanding third-party financing is generally limited to the carrying value of the assets financed. The Company has retained risks in the securitizations including customary representations and warranties. For securitization facilities, the Company, as seller, has an option to prepay and to redeem outstanding classes of issued notes at the Company’s discretion after a set time period has elapsed. The Company generally has discretion regarding when or if it will exercise these options, but would do so only when it was in the Company’s best interest. The Company’s exposure to these entities is primarily through its role as seller, servicer, and administrator. Servicing functions include, but are not limited to, general collection activity on current and noncurrent accounts, loss mitigation efforts including repossession and sale of collateral, as well as preparing and furnishing statements. The Company also holds certain conditional repurchase options specific to these securitizations that allow it to repurchase assets from the securitization entity.

The Company sells mortgage loans to investors through private label securitizations which are accounted for either as sales or secured borrowings. The Company may retain economic interests in the securitized and sold assets, which are generally retained in the form of senior or subordinated interests, residual interests, and/or servicing rights. The Company evaluates its interests in each private label securitization for classification as a VIE. The Company accounts for a securitization as a sale when it has relinquished control over the transferred financial assets and does not hold other interests in the VIE that individually, or in the aggregate, would absorb more than an insignificant amount of the VIE’s expected losses or receive more than an insignificant amount of the VIE’s expected residual returns. The Company has an option to exercise a cleanup call to purchase the remaining mortgage loans and any trust property when the remaining aggregate principal balance is less than 10% of the initial aggregate principal balance.

The table below presents a summary of the carrying value and balance sheet classification of assets and liabilities in the Company’s securitization and SPE VIEs


22



June 30,
2022
December 31,
2021
Assets
Loans held for sale, at fair value$1,800,968 $2,557,490 
Restricted cash67,998 100,494 
Servicing rights, at fair value484,393 400,678 
Prepaid expenses and other assets37,349 17,756 
$2,390,708 $3,076,418 
Liabilities
Warehouse and other lines of credit$1,800,000 $2,600,000 
Debt obligations, net:
MSR Facilities 114,711 15,000 
Servicing advance facilities32,739 15,070 
Term notes199,415 199,133 
$2,146,865 $2,829,203 

Non-Consolidated VIEs

The nature, purpose, and activities of non-consolidated VIEs currently encompass the Company’s investments in retained interests from securitizations and joint ventures. The table below presents a summary of the nonconsolidated VIEs for which the Company holds variable interests.


June 30, 2022
Carrying valueMaximum
exposure to loss
Total assets in VIEs
AssetsLiabilities
Retained interests$105,308 $— $105,308 $2,376,297 
Investments in joint ventures18,408 — 18,408 15,061 
$123,716 $— $123,716 
December 31, 2021
Carrying valueMaximum
exposure to loss
Total assets in VIEs
AssetsLiabilities
Retained interests$72,874 $— $72,874 $1,424,857 
Investments in joint ventures18,553 — 18,553 20,783 
$91,427 $— $91,427 



23



Retained interests

In 2022 and 2021, the Company completed the sale and securitization of non-owner occupied residential mortgage loans. Pursuant to the credit risk retention requirements, the Company, as sponsor, is required to retain at least a 5% economic interest in the credit risk of the assets collateralizing the securitization transactions. The retained interests represent a variable interest in the securitizations. The Company determined it was not the primary beneficiary of the VIE. The Company’s continuing involvement is limited to customary servicing obligations as servicing administrator associated with retained servicing rights and the receipt of principal and interest associated with the retained interests. The investors and the securitization trusts have no recourse to the Company’s assets; holders of the securities issued by each trust can look only to the loans owned by the trust for payment. The retained interests held by the Company are subject principally to the credit risk stemming from the underlying transferred loans. The securitization trusts used to effect these transactions are variable interest entities that the Company does not consolidate. The Company remeasures the carrying value of its retained interests at each reporting date to reflect their current fair value which is included in trading securities, at fair value on the consolidated balance sheets, with corresponding gains or losses included in other income on the consolidated income statements. As of June 30, 2022, the remaining principal balance of loans transferred to these securitization trusts was $2.4 billion of which $0.5 million was 90 days or more past due.

Investments in joint ventures

The Company’s joint ventures include investments with home builder s, real estate brokers, and commercial real estate companies to provide loan origination services and real estate settlement services to customers referred by the Company’s joint venture partners. The Company is generally not determined to be the primary beneficiary in its joint venture VIEs because it does not have the power, through voting rights or similar rights, to direct the activities that most significantly impact the economic performance of the VIE. The Company’s pro rata share of net earnings of joint ventures was $4.2 million and $6.2 million for the three and six months ended June 30, 2022, respectively, and $2.9 million and $5.1 million for the three and six months ended June 30, 2021, respectively, and is included in other income in the consolidated statements of operations.


NOTE 9 – WAREHOUSE AND OTHER LINES OF CREDIT

At June 30, 2022, the Company was a party to 14 revolving lines of credit with lenders providing $9.9 billion of warehouse and securitization facilities. The facilities are used to fund, and are secured by, residential mortgage loans held for sale. The facilities are repaid using proceeds from the sale of loans. Interest is generally payable monthly in arrears or on the repurchase date of a loan, and outstanding principal is payable upon receipt of loan sale proceeds or on the repurchase date of a loan. Outstanding principal related to a particular loan must also be repaid after the expiration of a contractual period of time or, if applicable, upon the occurrence of certain events of default with respect to the underlying loan. Interest expense is recorded to interest expense on the consolidated statements of operations. The base interest rates on the facilities bear interest at 30-day LIBOR, or other alternative base rate such as SOFR, plus a margin. Some of the facilities carry additional fees charged on the total line amount, commitment fees charged on the committed portion of the line, and non-usage fees charged when monthly usage falls below a certain utilization percentage. As of June 30, 2022, the interest rate was comprised of the applicable base rate plus a spread ranging from 1.02% to 2.25%. The base interest rate for warehouse facilities is subject to increase based upon the characteristics of the underlying loans collateralizing the lines of credit, including, but not limited to product type and number of days held for sale. The warehouse lines are scheduled to expire through 2023 under one or two year terms. The securitization facilities are scheduled to expire through 2024 under two to three year terms. All warehouse lines and other lines of credit are subject to renewal based on an annual credit review conducted by the lender.

Certain warehouse line lenders require the Company to maintain cash accounts with minimum required balances at all times. As of June 30, 2022 and December 31, 2021, there was $7.0 million and $8.0 million, respectively, held in these accounts which are recorded as a component of restricted cash on the consolidated balance sheets.

Under the terms of these warehouse lines, the Company is required to maintain various financial and other covenants. As of June 30, 2022, the Company amended certain warehouse lines related to certain profitability covenants, following which the Company was in compliance with those financial covenants.



24



Securitization Facilities

In October 2020, the Company issued notes through a securitization facility (“2020-1 Securitization Facility”) backed by a revolving warehouse line of credit. The 2020-1 Securitization Facility is secured by newly originated, first-lien, residential mortgage loans eligible for purchase by Fannie Mae and Freddie Mac for the purchase of mortgage loans or in accordance with the criteria of Ginnie Mae for the guarantee of securities backed by mortgage loans. The 2020-1 Securitization Facility issued $600.0 million in notes and certificates that bear interest at 30-day LIBOR, or other alternative base rate such as SOFR, plus a margin. The 2020-1 Securitization Facility will terminate on the earlier of (i) the two-year anniversary of the initial purchase date, (ii) the Company exercising its right to optional prepayment in full and (iii) the date of the occurrence and continuance of an event of default. In March 2022, the Company exercised its right to optional prepayment in full and terminated the 2020-1 Securitization Facility.

In December 2020, the Company issued notes through an additional securitization facility (“2020-2 Securitization Facility”) backed by a revolving warehouse line of credit. The 2020-2 Securitization Facility is secured by newly originated, first-lien, fixed rate residential mortgage loans eligible for purchase by the GSEs or in accordance with the criteria of Ginnie Mae for the guarantee of securities backed by mortgage loans. The 2020-2 Securitization Facility issued $500.0 million in notes and certificates that bear interest at 30-day LIBOR, or other alternative base rate such as SOFR, plus a margin. The 2020-2 Securitization Facility will terminate on the earlier of (i) the three year anniversary of the initial purchase date, (ii) the Company exercising its right to optional prepayment in full and (iii) the date of the occurrence and continuance of an event of default. In March 2022, the Company exercised its right to optional prepayment and paid-off $200.0 million in notes and certificates. At June 30, 2022, $300.0 million was outstanding in the 2020-2 Securitization Facility.

In February 2021, the Company issued notes and a class of owner trust certificates through an additional securitization facility (“2021-1 Securitization Facility”) backed by a revolving warehouse line of credit. The 2021-1 Securitization Facility is secured by newly originated, first-lien, fixed-rate or adjustable-rate, residential mortgage loans which are originated in accordance with the criteria of Fannie Mae and Freddie Mac for the purchase of mortgage loans or in accordance with the criteria of Ginnie Mae for the guarantee of securities backed by mortgage loans. The 2021-1 Securitization Facility issued $500.0 million in notes that bear interest at 30-day LIBOR, or other alternative base rate such as SOFR, plus a margin. The 2021-1 Securitization Facility will terminate on the earlier of (i) the three-year anniversary of the initial purchase date, (ii) the Company exercising its right to optional prepayment in full and (iii) the date of the occurrence and continuance of an event of default.

In April 2021, the Company issued notes and a class of owner trust certificates through an additional securitization facility (“2021-2 Securitization Facility”) backed by a revolving warehouse line of credit. The 2021-2 Securitization Facility is secured by newly originated, first-lien, fixed-rate or adjustable-rate, residential mortgage loans which are originated in accordance with the criteria of Fannie Mae and Freddie Mac for the purchase of mortgage loans or in accordance with the criteria of Ginnie Mae for the guarantee of securities backed by mortgage loans. The 2021-2 Securitization Facility issued $500.0 million in notes that bear interest at 30-day LIBOR, or other alternative base rate such as SOFR, plus a margin. The 2021-2 Securitization Facility will terminate on the earlier of (i) the three-year anniversary of the initial purchase date, (ii) the Company exercising its right to optional prepayment in full and (iii) the date of the occurrence and continuance of an event of default.

In October 2021, the Company issued notes and a class of owner trust certificates through an additional securitization facility (“2021-3 Securitization Facility”) backed by a revolving warehouse line of credit. The 2021-3 Securitization Facility is secured by newly originated, first-lien, fixed-rate or adjustable-rate, residential mortgage loans which are originated in accordance with the criteria of Fannie Mae and Freddie Mac for the purchase of mortgage loans or in accordance with the criteria of Ginnie Mae for the guarantee of securities backed by mortgage loans. The 2021-3 Securitization Facility issued $500.0 million in notes that bear interest at 30-day LIBOR, or other alternative base rate such as SOFR, plus a margin. The 2021-3 Securitization Facility will terminate on the earlier of (i) the three-year anniversary of the initial purchase date, (ii) the Company exercising its right to optional prepayment in full, and (iii) the date of the occurrence and continuance of an event of default.


25




The following table presents information on warehouse borrowings and the outstanding balance as of June 30, 2022 and December 31, 2021:
Outstanding Balance
Committed
Amount
Uncommitted
Amount
Total
Facility
Amount
Expiration
Date
June 30,
2022
December 31,
2021
Facility 1(1)
$400,000 $1,100,000 $1,500,000 10/29/2022$643,618 $851,088 
Facility 2(2)
— 600,000 600,000 9/26/2022160,471 295,743 
Facility 3— 500,000 500,000 4/18/2023146,580 459,018 
Facility 4— 900,000 900,000 11/14/2022325,842 266,230 
Facility 5(2)
— 200,000 200,000 N/A852 391 
Facility 6(2)
100,000 1,000,000 1,100,000 10/10/2022149,623 583,449 
Facility 7(3)
750,000 750,000 1,500,000 5/5/2023609,506 1,410,367 
Facility 8— 750,000 750,000 N/A148,592 361,783 
Facility 9(4)(5)
— — — 10/25/2022— 600,000 
Facility 10(4)
300,000 — 300,000 12/17/2023300,000 500,000 
Facility 11(2)(6)
— 500,000 500,000 9/23/202276,629 263,516 
Facility 12(4)
500,000 — 500,000 2/2/2024500,000 500,000 
Facility 13(4)
500,000 — 500,000 4/23/2024500,000 500,000 
Facility 14— 500,000 500,000 9/22/2022203,630 365,614 
Facility 15(4)
500,000 — 500,000 10/21/2024500,000 500,000 
Total $3,050,000 $6,800,000 $9,850,000 $4,265,343 $7,457,199 
(1)The total facility is available both to fund loan originations and also provide liquidity under a gestation facility to finance recently sold MBS up to the MBS settlement date.
(2)In addition to the warehouse line, the lender provides a separate gestation facility to finance recently sold MBS up to the MBS settlement date.
(3)In addition to the outstanding balance secured by mortgage loans, the Company has $114.7 million outstanding to finance servicing rights included within debt obligations in the consolidated balance sheets.
(4)Securitization backed by a revolving warehouse facility to finance newly originated first-lien fixed and adjustable rate mortgage loans.
(5)This facility was prepaid and terminated in March 2022.
(6)This facility was prepaid and terminated in July 2022.



The following table presents certain information on warehouse borrowings:
Three Months Ended
June 30,
Six Months Ended
June 30,
2022202120222021
Maximum outstanding balance during the period$6,407,547 $9,180,276 $7,672,559 $9,180,276 
Average balance outstanding during the period4,928,772 8,164,737 5,605,996 7,838,140 
Collateral pledged (loans held for sale)4,408,362 8,919,427 4,408,362 8,919,427 
Weighted average interest rate during the period2.60 %2.21 %2.27 %2.27 %


NOTE 10 – DEBT OBLIGATIONS


26




The following table presents the outstanding debt as of June 30, 2022 and December 31, 2021:
June 30,
2022
December 31,
2021
Secured debt obligations, net:
Secured credit facilities
MSR facilities$1,105,630 $262,250 
Securities financing facilities98,900 66,439 
Servicing advance facilities32,739 15,070 
Total secured credit facilities1,237,269 343,759 
Term Notes199,415 199,133 
Total secured debt obligations, net1,436,684 542,892 
Unsecured debt obligations, net:
Senior Notes990,456 1,085,316 
Total debt obligations, net$2,427,140 $1,628,208 

Certain of the Company’s secured debt obligations require us to satisfy financial covenants including minimum levels of profitability, tangible net worth, liquidity, and maximum levels of consolidated leverage. The Company obtained amendments or received waivers relating to certain profitability covenants. As a result, the Company was in compliance with all such financial covenants as of June 30, 2022.

Secured Credit Facilities

Secured credit facilities include revolving facilities collateralized by MSRs, trading securities, and servicing advances.

MSR Facilities

In October 2014, the Company entered into a $25.0 million credit facility to finance servicing rights and for other working capital needs and general corporate purposes. The Company has entered into subsequent amendments to increase and decrease the size of the facility and extend the maturity date. The facility is secured by Freddie Mac mortgage servicing rights with a fair value of $365.7 million as of June 30, 2022 and accrues interest at a base rate per annum of 30-day LIBOR, or other alternative base rate such as SOFR, plus a margin. As of June 30, 2022, there was $268.0 million outstanding on this facility with a maturity of June 2023. At June 30, 2022, capacity under the facility was $268.0 million. Advances for servicing rights are determined using a borrowing base formula calculated against the fair market value of the pledged servicing rights.

In December 2021, the Company entered into a credit facility agreement which provides $300.0 million in borrowing capacity, with an option to increase up to $500.0 million upon mutual consent, available to the Company. The facility is secured by Freddie Mac mortgage servicing rights with a fair value of $600.9 million as of June 30, 2022, and bears interest at 30-day LIBOR, or other alternative base rate such as SOFR, plus a margin per annum. At June 30, 2022, there was $300.0 million outstanding on this facility and $0.4 million in unamortized deferred financing costs.

In January 2022, the Company entered into a credit facility agreement which provides $500.0 million in borrowing capacity. The facility is secured by Fannie Mae mortgage servicing rights with a fair value of $711.2 million as of June 30, 2022 and bears interest at SOFR, or other alternative base rate, plus a margin per annum. At June 30, 2022, there was $425.0 million outstanding on this facility and $1.7 million in unamortized deferred financing costs.

In August 2017, the Company entered into the GMSR Trust to finance Ginnie Mae mortgage servicing rights owned by the Company pursuant to the terms of a base indenture. The Company pledged participation certificates representing beneficial interests in Ginnie Mae mortgage servicing rights to the GMSR Trust. The Company is party to an acknowledgment agreement with Ginnie Mae whereby it may, from time to time pursuant to the terms of any supplemental indenture, issue to institutional investors variable funding notes or one or more series of term notes, in each case secured by the participation


27



certificates. In August 2017, the Company, issued a variable funding note in the initial amount of $65.0 million with a maximum amount of $150.0 million. The variable funding note bears interest at 30-day LIBOR, or other alternative base rate such as SOFR, plus a margin per annum. The Company has entered into subsequent agreements to amend certain terms of the variable funding note and extend the maturity date. In October 2021, the maturity date was extended to November 2022. As of June 30, 2022, there was $114.7 million in variable funding notes outstanding.


Securities Financing Facilities

The Company has entered into master repurchase agreements to finance retained interest securities related to its securitizations. The securities financing facilities have an advance rate between 60% and 90% based on classes of the securities and accrue interest at a rate of 90-day LIBOR, or other alternative base rate such as SOFR, plus a margin. The securities financing facilities are secured by the trading securities which represent our retained interests in the credit risk of the assets collateralizing certain securitization transactions. As of June 30, 2022, the trading securities had a fair value of $105.3 million on the consolidated balance sheets and there was $98.9 million in securities financing facilities outstanding.

Servicing Advance Facilities

In September 2020, the Company, through its indirect-wholly owned subsidiary loanDepot Agency Advance Receivables Trust (the “Advance Receivables Trust”), entered into a variable funding note facility for the financing of servicing advance receivables with respect to residential mortgage loans serviced by it on behalf of Fannie Mae and Freddie Mac. Pursuant to an indenture, the Advance Receivables Trust can issue up to $130.0 million in variable funding notes (the “2020-VF1 Notes”). The 2020-VF1 Notes accrue interest at 30-day LIBOR, or other alternative base rate such as SOFR, plus a margin per annum and mature in September 2022 (unless earlier redeemed in accordance with their terms). The 2020-VF1 Notes are secured by servicing advance receivables made pursuant to Fannie Mae and Freddie Mac requirements and mature in September 2022 (unless earlier redeemed in accordance with their terms). At June 30, 2022, there was $18.9 million in 2020-VF1 Notes outstanding.

In November 2021, the Company, through the GMSR Trust issued two new series of variable funding notes for the financing of principal and interest advance receivables and servicing advance receivables with respect to residential mortgage loans serviced by it on behalf of Ginnie Mae. Pursuant to an indenture, the Company can issue up to $150.00 million in variable funding notes secured by principal and interest advance reimbursement or servicing advance reimbursement amounts. The variable funding notes bear interest at 30-day LIBOR, or other alternative base rate such as SOFR, plus a margin per annum. As of June 30, 2022, there was $14.3 million outstanding balance on the variable funding notes and $0.5 million in unamortized deferred financing costs.


Term Notes

In October 2018, the Company issued the Series 2018-GT1 Term Notes (“Term Notes”) under the GMSR Trust. The Term Notes are secured by certain participation certificates relating to Ginnie Mae mortgage servicing rights that also secure the variable funding notes described above with a fair value of $484.4 million as of June 30, 2022. The Term Notes accrue interest at 30-day LIBOR, or other alternative base rate such as SOFR, plus a margin per annum and mature in October 2023 or, if extended pursuant to the terms of the related indenture supplement, October 2025 (unless earlier redeemed in accordance with their terms). At June 30, 2022, there was $200.0 million in Term Notes outstanding and $0.6 million in unamortized deferred financing costs.


Senior Notes

In October 2020, the Company issued $500.0 million in aggregate principal amount of 6.50% senior unsecured notes due 2025, (the “2025 Senior Notes”). The 2025 Senior Notes will mature on November 1, 2025. Interest on the 2025 Senior


28



Notes accrues at a rate of 6.50% per annum, payable semi-annually in arrears on May 1 and November 1 of each year. At any time prior to November 1, 2022, the Company may redeem some or all of the 2025 Senior Notes at a price equal to 100% of the principal amount of the 2025 Senior Notes, plus accrued and unpaid interest, if any, to, but not including, the date of redemption plus a make-whole premium. The Company may also redeem the 2025 Senior Notes, in whole or in part, at any time on or after November 1, 2022 at various redemption prices. In addition, subject to certain conditions at any time prior to November 1, 2022, the Company may redeem up to 40% of the principal amount of the 2025 Senior Notes with the proceeds of certain equity offerings at a redemption price of 106.50% of the principal amount of the 2025 Senior Notes, together with accrued and unpaid interest, if any, to, but not including, the date of redemption. At June 30, 2022, there was $500.0 million in 2025 Senior Notes outstanding and $5.9 million in unamortized deferred financing costs.

In March 2021, the Company issued $600.0 million in aggregate principal amount of 6.125% senior unsecured notes due 2028 (the “2028 Senior Notes” and together with the 2025 Senior Notes, the "Senior Notes"). The 2028 Senior Notes will mature on April 1, 2028. Interest on the 2028 Senior Notes accrues at a rate of 6.125% per annum, payable semi-annually in arrears on April 1 and October 1 of each year. At any time prior to April 1, 2024, the Company may redeem some or all of the 2028 Senior Notes at a price equal to 100% of the principal amount of the 2028 Senior Notes, plus accrued and unpaid interest, if any, to, but not including, the date of redemption plus a make-whole premium. The Company may also redeem the 2028 Senior Notes, in whole or in part, at any time on or after April 1, 2024 at various redemption prices. In addition, subject to certain conditions at any time prior to April 1, 2024, the Company may redeem up to 40% of the principal amount of the 2028 Senior Notes with the proceeds of certain equity offerings at a redemption price of 106.125% of the principal amount of the 2028 Senior Notes, together with accrued and unpaid interest, if any, to, but not including, the date of redemption. During the first quarter of 2022, the Company repurchased $97.5 million of 2028 Senior Notes at an average purchase price of 87.9% of par which resulted in a $10.5 million gain on extinguishment of debt recorded in other interest expense on the consolidated statement of operations. At June 30, 2022, there was $502.5 million in 2028 Senior Notes outstanding and $6.1 million in unamortized deferred financing costs.

Interest Expense

Interest expense on all outstanding debt obligations with variable rates is paid based on 30-day or 90-day LIBOR, or other alternative base rate such as SOFR, plus a margin ranging from 0.70% - 3.50%.

NOTE 11 – INCOME TAXES

The Company’s income tax expense varies from the expense that would be expected based on statutory rates due principally to its organizational structure. As part of the completion of the IPO, the Company became a C Corporation subject to federal, state, and local income taxes with respect to its share of net taxable income of LD Holdings.

As of June 30, 2022 and December 31, 2021, the Company had a deferred tax asset before any valuation allowance of $0.1 million and $0.4 million, respectively, and a deferred tax liability of $155.1 million and $193.4 million, respectively. Deferred income taxes arise from temporary differences between the tax basis of assets and liabilities and their reported amounts in the financial statements, which will result in taxable or deductible amounts in the future. The deferred tax liability as of June 30, 2022 and December 31, 2021 relate to temporary differences in the book basis as compared to the tax basis of loanDepot, Inc.’s investment in LD Holdings, net of tax benefits from future deductions for payments made under a Tax Receivable Agreement (“TRA”) as a result of the IPO. Changes in tax laws and rates may affect recorded deferred tax assets and liabilities and the Company’s effective tax rate in the future. Deferred income taxes are measured using the applicable tax rates that are expected to apply in the year when the asset is realized or the liability is settled, based on the tax rates that have been enacted at the reporting date. The Company measured its deferred tax assets and liabilities at June 30, 2022 and December 31, 2021 using the combined federal and state rate (less federal benefit) of 26%. The Company establishes a valuation allowance when it is more-likely-than-not that some portion or all of the deferred tax assets will not be realized. As of June 30, 2022, the Company did not have a valuation allowance on any deferred tax assets as the Company believes it is more-likely-than-not that the Company will realize the benefits of the deferred tax assets. The Company recognized a TRA liability of $48.8 million and $32.9 million as of June 30, 2022 and December 31, 2021, respectively, which represents the Company’s estimate of the aggregate amount that it will pay under the TRA, refer to Note 15- Commitments and Contingencies, for further information on the TRA liability.



29




NOTE 12 – RELATED PARTY TRANSACTIONS

In conjunction with its joint ventures, the Company entered into agreements to provide services to the joint ventures for which it receives and pays fees. Services for which the Company earns fees comprise loan processing and administrative services (legal, accounting, human resources, data processing and management information, assignment processing, post-closing, underwriting, facilities management, quality control, management consulting, risk management, promotions, public relations, advertising and compliance with credit agreements). The Company has entered into forward commitments with certain joint ventures to fund loans at specified interest rates for certain loan product types over a set period of time. The Company receives the commitment fee at the time of the commitment and earns the fee at the time of loan funding, The Company also originates eligible mortgage loans referred to it by the joint ventures for which the Company pays the joint ventures a broker fee.

Fees earned, costs incurred, and amounts payable to or receivable from joint ventures were as follows:
Three Months Ended
June 30,
Six Months Ended
June 30,
2022202120222021
Loan processing and administrative services fee income$4,548 $3,754 $7,878 $7,107 
Commitment fee income 1,255 — 1,255 — 
Fee income from joint ventures$5,803 $3,754 $9,133 $7,107 
Loan origination broker fees expense$29,797 $22,258 $49,926 $40,708 
June 30,
2022
December 31,
2021
Amounts (payable) receivable from joint ventures$(7,922)$1,855 

The Company paid management fees to a shareholder of the Company of $0.2 million during the six months ended June 30, 2021. The Company employed certain individuals who provided services to a shareholder whose salaries totaled $0.1 million during the three and six months ended June 30, 2022 and $0.1 million and $0.2 million during three and six months ended June 30, 2021, respectively. The Company paid consulting fees to a shareholder of the Company of $41,000 during the three months ended June 30, 2021.

NOTE 13 – EQUITY

As a result of the IPO and reorganization discussed in Note 1- Description of Business, Presentation and Summary of Significant Accounting Policies, the financial statements for the periods prior to the IPO were adjusted to combine the previously separate entities for presentation.

Prior to the IPO, the Company completed a reorganization by which it changed its equity structure to create a single class of LLC Units in LD Holdings. Prior to that transaction, the capital structure consisted of different classes of membership interests held by Continuing LLC Members. The LLC Units were then exchanged on a one-for-one basis for Holdco Units and Class C common stock. The Continuing LLC Members have the right to exchange one Holdco Unit and one share of Class B common stock or Class C common stock, as applicable, together for cash or one share of Class A common stock at the Company’s election, subject to customary conversion rate adjustments for stock splits, stock dividends, and reclassifications. The Company consolidates the financial results of LD Holdings and reports noncontrolling interest related to the interests held by the Continuing LLC Members.

The noncontrolling interest of $0.7 billion and $1.1 billion as of June 30, 2022 and December 31, 2021, respectively, represented the economic interest in LD Holdings held by the Continuing LLC Members. As Continuing LLC Members convert shares, noncontrolling interest is adjusted to proportionately reduce the economic interest in LD Holdings with an offset to


30



additional paid-in-capital on the consolidated statements of equity. The following table summarizes the ownership of LD Holdings as of June 30, 2022.

Holding Member Interests:Holdco UnitsOwnership Percentage
loanDepot, Inc.160,619,71951.35%
Continuing LLC Members152,191,39448.65%
Total312,811,113100.00%

NOTE 14 – EARNINGS (LOSS) PER SHARE

Basic earnings (loss) per share of Class A common stock and Class D common stock is computed by dividing net income (loss) attributable to loanDepot, Inc. by the weighted-average number of shares of Class A common stock and Class D common stock, respectively, outstanding during the period. Diluted earnings (loss) per share of Class A common stock and Class D common stock is computed by dividing net income (loss) attributable to loanDepot, Inc. by the weighted-average number of shares of Class A common stock and Class D common stock respectively, outstanding adjusted to give effect to potentially dilutive securities.
The basic and diluted earnings per share period for the six months ended June 30, 2021 represents the period after February 11, 2021, wherein the Company had outstanding Class A common stock and Class D common stock. There was no Class B common stock outstanding as of June 30, 2022 and 2021. The following table sets forth the calculation of basic and diluted earnings (loss) per share for Class A common stock and Class D common stock:

Three Months EndedSix Months Ended
June 30, 2022June 30, 2022
Class AClass DTotalClass AClass DTotal
Net loss attributable to loanDepot, Inc.
$(37,266)$(63,662)$(100,928)$(45,531)$(90,137)$(135,669)
Weighted average shares - basic56,795,709 97,026,671 153,822,380 49,138,217 97,276,918 146,415,135 
Loss per share - basic
$(0.66)$(0.66)$(0.66)$(0.93)$(0.93)$(0.93)
Diluted loss per share:
Net loss allocated to common stockholders - diluted
$(37,266)$(63,662)$(100,928)$(45,531)$(90,137)$(135,668)
Weighted average shares - diluted56,795,709 97,026,671 153,822,380 49,138,217 97,276,918 146,415,135 
Loss per share - diluted
$(0.66)$(0.66)$(0.66)$(0.93)$(0.93)$(0.93)




31



Three Months EndedSix Months Ended
June 30, 2021June 30, 2021
Class AClass DTotalClass AClass DTotal
Net income attributable to loanDepot, Inc.
$678 $7,883 $8,561 $3,633 $49,803 $53,436 
Weighted average shares - basic10,038,195 116,688,681 126,726,876 8,592,536 117,800,413 126,392,949 
Earnings per share - basic
$0.07 $0.07 $0.07 $0.42 $0.42 $0.42 
Diluted income per share:
Net income allocated to common stockholders - diluted
$678 $7,883 $8,561 $3,633 $49,803 $53,436 
Weighted average shares - diluted10,038,195 116,688,681 126,726,876 8,592,536 117,800,413 126,392,949 
Earnings per share - diluted
$0.07 $0.07 $0.07 $0.42 $0.42 $0.42 

For the three and six months ended June 30, 2022, 165,281,304 and 173,245,208 shares of Class C common stock were evaluated for the assumed exchange of noncontrolling interests and determined to be anti-dilutive, and thus were excluded from the computation of diluted loss per share.

For the three and six months ended June 30, 2022, 14,221,221 and 11,914,870 of Class A RSUs and nonqualified stock options were determined to be anti-dilutive, and thus excluded from the computation of diluted loss per share.

For the three months ended June 30, 2021, 196,741,703 shares of Class C common stock were evaluated for the assumed exchange of noncontrolling interests and determined to be anti-dilutive, and thus were excluded from the computation of diluted earnings per share. For the period from February 11, 2021 to June 30, 2021, 197,366,213 shares of Class C common stock were evaluated for the assumed exchange of noncontrolling interests and determined to be anti-dilutive, and thus were excluded from the computation of diluted earnings per share.

For the three months ended June 30, 2021, 808,090 of RSUs were determined to be anti-dilutive, and thus excluded from the computation of diluted earnings per share. For the period from February 11, 2021 to June 30, 2021, 748,185 of RSUs were determined to be anti-dilutive, and thus excluded from the computation of diluted earnings per share.


NOTE 15– COMMITMENTS AND CONTINGENCIES

Escrow Services

In conducting its operations, the Company, through its wholly-owned subsidiaries, LDSS and ACT, routinely hold customers' assets in escrow pending completion of real estate financing transactions. These amounts are maintained in segregated bank accounts and are offset with the related liabilities resulting in no amounts reported in the accompanying consolidated balance sheets. The balances held for the Company’s customers totaled $14.7 million and $21.1 million at June 30, 2022 and December 31, 2021, respectively.

Legal Proceedings

The Company is a defendant in, or a party to, legal actions and proceedings that arise in the ordinary course of business. In some of these actions and proceedings, claims for monetary damages are asserted against the Company. These matters include actions alleging improper lending practices, improper servicing, quiet title actions, improper foreclosure practices, violations of consumer protection laws, etc. and on account of consumer bankruptcies. In many of these actions, the Company may not be the real party of interest (because the Company is not the servicer of the loan or the holder of the note) but it may appear in the pleadings because it is in the chain of title to property over which there may be a dispute. Such matters may be indemnified and managed by the appropriate party, which is generally the Company’s subservicer. In other cases, such


32



as lien avoidance cases brought in bankruptcy, the Company is insured by title insurance, and the case is turned over to the title insurer who tenders the Company’s defense. In some of these actions and proceedings, claims for monetary damages are asserted against the Company. In view of the inherent difficulty of predicting the outcome of such legal actions and proceedings, the Company generally cannot predict what the eventual outcome of the pending matters will be, what the timing of the ultimate resolution of these matters will be, or what the eventual loss related to each pending matter may be, if any.

The Company seeks to resolve all litigation and regulatory matters in the manner management believes is in the best interest of the Company and contests liability, allegations of wrongdoing, and, where applicable, the amount of damages or scope of any penalties or other relief sought as appropriate in each pending matter. On at least a quarterly basis, the Company assesses its liabilities and contingencies in connection with outstanding legal and regulatory proceedings utilizing the latest information available. Any estimated loss is subject to significant judgment and is based upon currently available information, a variety of assumptions, and known and unknown uncertainties. Where available information indicates that it is probable a liability has been incurred and the Company can reasonably estimate the amount of the loss, an accrued liability is established. The actual costs of resolving these proceedings may be substantially higher or lower than the amounts accrued.

Employment Litigation

On December 24, 2020, the Company received a demand letter from one of the senior members of its operations team alleging, among other things, loan origination noncompliance and various employment related claims, including hostile work environment and gender discrimination, with unspecified damages. The executive has since resigned her position with the Company. The parties participated in pre-litigation mediation in May 2021. The parties did not resolve the matter at mediation and a complaint was filed with the Superior Court of the State of California, County of Orange on September 21, 2021 and an amended complaint was filed on December 21, 2021. In response, on February 2, 2022 the Company filed a demurrer to the complaint with the Superior Court of the State of California, County of Orange, for failing to state facts sufficient to constitute a cause of action while still vigorously denying the claims within the complaint. On March 24, 2022, the plaintiff filed her opposition to loanDepot’s demurrer. On March 29, 2022, the Company filed its reply to Plaintiff’s opposition. A hearing was held on the Company’s demurrer on May 12, 2022, at the Superior Court of the State of California, County of Orange. The court sustained the Company’s demurrer in full. On June 30, 2022, the Company filed its answer and affirmative defenses to the amended complaint. The plaintiff seeks damages in excess of $75 million. The Company believes this lawsuit is without merit and intends to vigorously defend against it.

While the Company’s management does not believe these allegations have merit, defending such allegations could result in substantial costs and a diversion of management’s attention and resources.

The ultimate outcome of the other legal proceedings is uncertain, and the amount of any future potential loss is not considered probable or estimable. The Company will incur defense costs and other expenses in connection with these legal proceedings. If the final resolution of any legal proceedings is unfavorable, it could have a material adverse effect on the Company’s business and financial condition.

Based on the Company’s current understanding of these pending legal actions and proceedings, management does not believe that judgments or settlements arising from pending or threatened legal matters, individually or in the aggregate, will have a material adverse effect on the consolidated financial position, operating results or cash flows of the Company. However, unfavorable resolutions could affect the consolidated financial position, results of operations or cash flows for the years in which they are resolved.

Regulatory Requirements

The Company is subject to various capital requirements by the U.S. Department of Housing and Urban Development (“HUD”); lenders of the warehouse lines of credit; and secondary markets investors. Failure to maintain minimum capital requirements could result in the inability to participate in HUD-assisted mortgage insurance programs, to borrow funds from warehouse line lenders or to sell or service mortgage loans. As of June 30, 2022, the Company was in compliance with its selling and servicing capital requirements.

Commitments to Extend Credit



33



The Company enters into IRLCs with customers who have applied for residential mortgage loans and meet certain credit and underwriting criteria. These commitments expose the Company to market risk if interest rates change and the loan is not economically hedged or committed to an investor. The Company is also exposed to credit loss if the loan is originated and not sold to an investor and the customer does not perform. The collateral upon extension of credit typically consists of a first deed of trust in the mortgagor’s residential property. Commitments to originate loans do not necessarily reflect future cash requirements as some commitments are expected to expire without being drawn upon. Total commitments to originate loans as of June 30, 2022 and December 31, 2021 approximated $7.7 billion and $12.7 billion, respectively. These loan commitments are treated as derivatives and are carried at fair value, refer to Note 6- Derivative Financial Instruments and Hedging Activities for further information on derivatives.

Loan Loss Obligation for Sold Loans

When the Company sells mortgage loans, it makes customary representations and warranties to the purchasers about various characteristics of each loan such as the origination and underwriting guidelines, including but not limited to the validity of the lien securing the loan, property eligibility, borrower credit, income and asset requirements, and compliance with applicable federal, state and local law. The Company establishes a loan repurchase reserve for losses associated with repurchase loan obligations if the Company breached a representation or warranty given to the loan purchaser. Additionally, the Company’s loan loss obligation for sold loans includes an estimate for losses associated with early payoffs and early payment defaults. There have been charge-offs associated with early payoffs, early payment defaults and losses related to representations, warranties, and other provisions for the three and six months ended June 30, 2022 and 2021.

The activity related to the loan loss obligation for sold loans is as follows:
Three Months Ended
June 30,
Six Months Ended
June 30,
2022202120222021
Balance at beginning of period$41,159 $30,052 $29,877 $33,591 
Provision for loan loss obligations82,373 (533)95,619 267 
Charge-offs(37,659)(2,893)(39,623)(7,232)
Balance at end of period$85,873 $26,626 $85,873 $26,626 

Obligation for Sold MSRs

The Company recognizes sales of mortgage servicing rights as sales if title passes, if substantially all risks and rewards of ownership have irrevocably passed to the purchaser, and any protection provisions retained by the Company are minor and can be reasonably estimated.  If a sale is recognized and only minor protection provisions exist, a liability for the estimated obligation associated with those provisions is recorded in accounts payable, accrued expenses and other liabilities on the consolidated balance sheet. The Company establishes a reserve related to the reimbursement of the purchase price for any loans that are prepaid in full within 90 days of the MSR sale transaction. The obligation for sold MSRs was $9.8 million and $0.4 million as of June 30, 2022 and December 31, 2021, respectively

TRA Liability

As part of the IPO and reorganization, the Company entered into a TRA with Parthenon Stockholders and certain Continuing LLC Members, whereby loanDepot, Inc. will be obligated to pay such parties or their permitted assignees, 85% of the amount of cash tax savings, if any, in U.S. federal, state, and local taxes that loanDepot, Inc. realizes, or is deemed to realize as a result of future tax benefits from increases in tax basis. The TRA liability is accounted for as a contingent liability with amounts accrued when deemed probable and estimable. The Company recognized a TRA liability of $48.8 million and $32.9 million as of June 30, 2022 and December 31, 2021, respectively, which represents the Company’s estimate of the aggregate amount that it will pay under the TRA as a result of the offering transaction. The amounts payable under the TRA will vary depending on a number of factors, such as the amount and timing of taxable income attributable to loanDepot, Inc.

NOTE 16 – REGULATORY CAPITAL AND LIQUIDITY REQUIREMENTS


34




The Company, through certain subsidiaries, is required to maintain minimum net worth, liquidity and other financial requirements specified in certain of its selling and servicing agreements, including:

Ginnie Mae single-family issuers. The eligibility requirements include net worth of $2.5 million plus 0.35% of outstanding Ginnie Mae single-family obligations and a liquidity requirement equal to the greater of $1.0 million or 0.10% of outstanding Ginnie Mae single-family securities.

Fannie Mae and Freddie Mac. The eligibility requirements for seller/servicers include tangible net worth of $2.5 million plus 0.25% of the Company’s total single-family servicing portfolio, excluding loans subserviced for others and a liquidity requirement equal to 0.35% of the aggregate UPB serviced for the agencies plus 2.0% of total nonperforming agency servicing UPB in excess of 6%.
HUD. The eligibility requirements include a minimum adjusted net worth of $1.0 million plus 1% of the total volume in excess of $25.0 million of FHA Single Family Mortgages originated, underwritten, serviced, and/or purchased during the prior fiscal year, up to a maximum required adjusted net worth of $2.5 million.
Fannie Mae, Freddie Mac and Ginnie Mae. The Company is also required to hold a ratio of Adjusted/Tangible Net Worth to Total Assets greater than 6%.

To the extent that these requirements are not met, the Company may be subject to a variety of regulatory actions which could have a material adverse impact on our results of operations and financial condition. The most restrictive of the minimum net worth and capital requirements require the Company to maintain a minimum adjusted net worth balance of $120.4 million as of June 30, 2022. The Company was in compliance with the net worth, liquidity and other financial requirements of its selling and servicing requirements as of June 30, 2022.





35



Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion provides an analysis of the Company's financial condition, cash flows and results of operations from management's perspective and should be read in conjunction with our consolidated financial statements and the accompanying notes included under Part I. Item 1 of this report. The results of operations described below are not necessarily indicative of the results to be expected for any future periods. This discussion includes forward-looking information that involves risks and assumptions which could cause actual results to differ materially from management’s expectations. See our cautionary language at the beginning of this report under “Special Note Regarding Forward-Looking Statements” and for a more complete discussion of the factors that could affect our future results refer to Part II. “Item 1A. Risk Factors” and elsewhere in this Form 10-Q and Part I, Item 1A "Risk Factors" in our 2021 Form 10-K. Capitalized terms used but not otherwise defined herein have the meanings set forth in the our Form 10-K.
Overview

loanDepot is a customer-centric and technology-enabled residential mortgage platform. We launched our business in 2010 to provide mortgage loan solutions to consumers who were dissatisfied with the services offered by banks and other traditional market participants. Since our inception, we have significantly expanded our origination platform both in terms of size and capabilities. Our primary sources of revenue are derived from the origination of conventional and government mortgage loans, servicing conventional and government mortgage loans, and providing a growing suite of ancillary services.

The Company's common stock began trading on the New York Stock Exchange on February 11, 2021 under the ticker symbol "LDI." The initial public offering consisted of 3,850,000 shares of Class A common stock, $0.001 par value per share, at an offering price of $14.00 per share, pursuant to a Registration Statement on Form S-1.

A summary of our critical accounting policies and estimates is included in Critical Accounting Policies and Estimates.
Key Factors Influencing Our Results of Operations
Market and Economic Environment
The consumer lending market and the associated loan origination volumes for mortgage loans are influenced by interest rates and economic conditions. While borrower demand for consumer credit has typically remained strong in most economic environments, general market conditions, including the interest rate environment, unemployment rates, home price appreciation and consumer confidence may affect borrower willingness to seek financing and investor desire and ability to invest in loans. For example, a significant interest rate increase or rise in unemployment could cause potential borrowers to defer seeking financing as they wait for interest rates to stabilize or the general economic environment to improve. Additionally, if the economy weakens and actual or expected default rates increase, loan investors may postpone or reduce their investments in loan products.
The volume of mortgage loan originations associated with home purchases is generally affected by broader economic factors as well as the overall strength of the economy, housing prices, and interest rate fluctuations. Increases in interest rates may affect affordability and the ability for potential home buyers to qualify for a mortgage loan. Purchase mortgage loan origination volume can be subject to seasonal trends as home sales typically rise during the spring and summer seasons and decline in the fall and winter seasons. This is somewhat offset by purchase loan originations sourced from our joint ventures which experience their highest level of activity during November and December as home builders focus on completing and selling homes prior to year-end. Seasonality has less of an impact on mortgage loan refinancing volumes, which are primarily driven by fluctuations in mortgage loan interest rates.
Fluctuations in Interest Rates
Our mortgage loan refinancing volumes (and to a lesser degree, our purchase volumes), balance sheets, and results of operations are influenced by changes in interest rates and how we effectively manage the related interest rate risk. As interest rates decline, mortgage loan refinance volumes tend to increase, while an increasing interest rate environment may cause a decrease in refinance volumes and purchase volumes. In addition, the majority of our assets are subject to interest rate risk, including LHFS, which consist of mortgage loans held on our consolidated balance sheets for a short period of time after


36



origination until we are able to sell them, IRLCs, servicing rights and mandatory trades, forward sales contracts, interest rate swap futures and put options that we enter into to manage interest rate risk created by IRLCs and uncommitted LHFS. We refer to such mandatory trades, forward sales contracts, interest rate swap futures and put options collectively as “Hedging Instruments.” As interest rates increase, our LHFS and IRLCs generally decrease in value while our Hedging Instruments utilized to hedge against interest rate risk typically increase in value. Rising interest rates cause our expected mortgage loan servicing revenues to increase due to a decline in mortgage loan prepayments which extends the average life of our servicing portfolio and increases the value of our servicing rights. Conversely, as interest rates decline, our LHFS and IRLCs generally increase in value while our Hedging Instruments decrease in value. In a declining interest rate environment, borrowers tend to refinance their mortgage loans, which increases prepayment speed and causes our expected mortgage loan servicing revenues to decrease, which reduces the average life of our servicing portfolio and decreases the value of our servicing rights. The changes in fair value of our servicing rights are recorded as unrealized gains and losses in changes in fair value of servicing rights, net, in our consolidated statements of operations.

When interest rates rise, rate and term refinancings become less attractive to consumers after a historically long period of low interest rates. However, rising interest rates are also indicative of overall economic growth that may create more opportunities with respect to cash-out refinancings. In addition, these periods of growth (leading to higher consumer confidence) typically should generate more purchase-focused transactions requiring loans. Sustained periods of home price appreciation should result in increasing opportunities for home equity loans.

Current Market Conditions
According to the MBA’s Mortgage Finance Forecast published July 18, 2022, there was approximately $13.0 trillion of residential mortgage debt outstanding in the United States at June 30, 2022 which is forecasted to increase to $13.8 trillion by June 30, 2023. Annual one-to-four family residential mortgage origination volumes are expected to decrease by 44% to $2.2 trillion by December 31, 2023. The primary driver of this decrease is refinance volume, which is expected to decrease by $1.8 trillion, partially offset by a $58.0 billion expected increase in purchase volume. The significant reductions in overall mortgage transaction volumes and higher interest rates have resulted in and are expected to continue to result in a significant decrease in our mortgage production activities, which, as described below, has adversely impacted, and is expected to continue to impact, our results of operations, liquidity and financial condition.
Due to current market conditions, we have implemented the Vision 2025 plan. The plan’s four primary elements are to: 1) Increase focus on purchase transactions while serving increasingly diverse communities across the country, 2) Execute previously announced growth-generating initiatives, 3) Centralize management of loan originations and loan fulfillment to enhance quality and effectiveness, and 4) Right-size our cost structure.

As part of the plan, we have also made the determination to exit the wholesale business. This will allow us to further reduce expenses, consolidate operations, increase margins, and better meet our goals of becoming a purpose driven organization with direct customer engagement throughout the entire lending process.

Key Performance Indicators
We manage and assess the performance of our business by evaluating a variety of metrics. Selected key performance metrics include loan originations and sales and servicing metrics.
Loan Origination and Sales
Loan originations and sales by volume and units are a measure of how successful we are at growing sales of mortgage loan products and a metric used by management in an attempt to isolate how effectively we are performing. We believe that originations and sales are an indicator of our market penetration in mortgage loans and that this provides useful information because it allows investors to better assess the strength of our core business. Loan originations and sales include brokered loan originations not funded by us. We enter into IRLCs to originate loans, at specified interest rates, with customers who have applied for a mortgage and meet certain credit and underwriting criteria. We believe the volume of our IRLCs is another measure of our overall market share.
Gain on sale margin represents the total of (i) gain on origination and sale of loans, net, and (ii) origination income, net, divided by loan origination volume during period. Gain on the origination and sale of loans, net was adjusted to exclude the


37



change in fair value of forward sale contracts, including pair-offs, hedging MSRs, which are now included in the change in fair value of servicing rights, net on the consolidated statements of operations. We determined that this change would more appropriately reflect the hedged item and better align with industry practices. Gain on origination and sale of loans, net and change in fair value of servicing rights, net, in the current and prior periods along with the related disclosures have been adjusted to reflect this reclassification.
Pull through weighted gain on sale margin represents the total of (i) gain on origination and sale of loans, net, and (ii) origination income, net, divided by the pull through weighted rate lock volume. Pull through weighted rate lock volume is the unpaid principal balance of loans subject to interest rate lock commitments, net of a pull-through factor for the loan funding probability.
Servicing Metrics
Servicing metrics include the unpaid principal balance of our servicing portfolio and servicing portfolio units, which represent the number of mortgage loan customers we service. We believe that the net additions to our portfolio and number of units are indicators of the growth of our mortgage loans serviced and our servicing income, but may be offset by sales of servicing rights.
Three Months Ended
June 30,
Six Months Ended
June 30,
(Dollars in thousands)2022202120222021
Financial statement data
Total revenue$308,639 $779,914 $811,949 $2,095,922 
Total expenses 560,657 749,405 1,166,913 1,619,283 
Net (loss) income
(223,822)26,284 (315,141)454,137 
(Loss) earnings per share of Class A and Class D common stock:
Basic$(0.66)$0.07 $(0.93)$0.42 
Diluted$(0.66)$0.07 $(0.93)$0.42 
Non-GAAP financial measures(1)
Adjusted total revenue$273,273 $825,330 $777,877 $2,066,770 
Adjusted net (loss) income
(167,855)57,504 (249,587)377,031 
Adjusted (LBITDA) EBITDA
(191,510)109,264 (265,916)567,361 
Adjusted diluted (loss) earnings per share
N/AN/AN/AN/A
Loan origination and sales
Loan originations by channel:
Retail$10,877,875 $27,881,773 $27,357,265 $61,309,562 
Partner5,117,180 6,612,393 10,188,521 14,663,755 
Total$15,995,055 $34,494,166 $37,545,786 $75,973,317 
Loan originations by purpose:
Purchase$9,500,164 $10,382,964 $17,530,930 $18,299,476 
Refinance6,494,891 24,111,202 20,014,856 57,673,841 
Total$15,995,055 $34,494,166 $37,545,786 $75,973,317 
Loan originations (units)47,311 100,153 112,262 211,553 


38



Three Months Ended
June 30,
Six Months Ended
June 30,
(Dollars in thousands)2022202120222021
Licensed loan officers:
Retail2,587 2,818 2,587 2,818 
Partner320 267 320 267 
Total2,907 3,085 2,907 3,085 
Loans sold:
Servicing retained $10,568,649 $30,981,299 $27,691,365 $68,417,090 
Servicing released7,342,889 3,309,151 13,088,211 5,802,037 
Total$17,911,538 $34,290,450 $40,779,576 $74,219,127 
Loans sold (units)51,862 98,342 120,011 207,029 
Gain on sale margin1.16 %2.28 %1.62 %2.66 %
Gain on sale margin - retail1.03 2.50 1.76 2.91 
Gain on sale margin - partner1.45 1.32 1.26 1.61 
Pull through weighted gain on sale margin1.50 2.64 1.89 3.19 
IRLCs $19,596,763 $42,065,981 $49,588,215 $87,828,642 
IRLCs (units)58,855 130,894 149,875 262,445 
Pull through weighted lock volume$12,412,894 $29,787,081 $32,212,939 $63,249,436 
Servicing metrics
Total servicing portfolio (unpaid principal balance)$155,217,012 $138,767,860 $155,217,012 $138,767,860 
Total servicing portfolio (units)507,231 446,606 507,231 446,606 
60+ days delinquent ($)$1,511,871 $1,976,658 $1,511,871 $1,976,658 
60+ days delinquent (%)0.97 %1.42 %0.97 %1.42 %
Servicing rights at fair value, net(2)
$2,204,593 $1,776,395 $2,204,593 $1,776,395 
Weighted average servicing fee (3)
0.29 %0.30 %0.29 %0.30 %
Multiple(3) (4)
5.1 4.5 5.1 4.5 
(1)Refer to the section titled “Non-GAAP Financial Measures” for a discussion and reconciliation of our Non-GAAP financial measures.
(2)Amount represents the fair value of servicing rights, net of servicing liabilities, which are included in accounts payable, accrued expenses, and other liabilities in the consolidated balance sheets.
(3)Agency only.
(4)Amounts represent the fair value of servicing rights, net, divided by the weighted average annualized servicing fee.

Results of Operations

The following table sets forth our consolidated financial statement data for the three months ended June 30, 2022 compared to the three months ended June 30, 2021.


39



Three Months Ended
June 30,
Change
$
Change
%
(Dollars in thousands)20222021
(Unaudited)
REVENUES:
Net interest income
$22,799 $7,026 $15,773 224.5 %
Gain on origination and sale of loans, net 146,562 692,479 (545,917)(78.8)
Origination income, net 39,108 92,624 (53,516)(57.8)
Servicing fee income 117,326 94,742 22,584 23.8 
Change in fair value of servicing rights, net (33,507)(145,098)111,591 76.9 
Other income 16,351 38,141 (21,790)(57.1)
Total net revenues 308,639 779,914 (471,275)(60.4)
EXPENSES:
Personnel expense 296,569 470,125 (173,556)(36.9)
Marketing and advertising expense 60,837 114,133 (53,296)(46.7)
Direct origination expense 33,996 50,017 (16,021)(32.0)
General and administrative expense 63,927 48,654 15,273 31.4 
Occupancy expense 9,388 9,283 105 1.1 
Depreciation and amortization 11,323 8,686 2,637 30.4 
Servicing expense 10,741 27,241 (16,500)(60.6)
Other interest expense 33,140 21,266 11,874 55.8 
Goodwill impairment40,736 — 40,736 NM
Total expenses 560,657 749,405 (188,748)(25.2)
(Loss) income before income taxes
(252,018)30,509 (282,527)(926.0)
Income tax (benefit) expense
(28,196)4,225 (32,421)(767.4)
Net (loss) income
(223,822)26,284 (250,106)(951.6)
Net (loss) income attributable to noncontrolling interests
(122,894)17,723 (140,617)(793.4)
Net (loss) income attributable to loanDepot, Inc.
$(100,928)$8,561 $(109,489)(1,278.9)

The results for the three months ended June 30, 2022 reflected an increase in mortgage rates which resulted in a decrease in our profit margins. The decrease of $250.1 million, or 951.6% in net income is primarily from a $545.9 million decrease in gain on origination and sale of loans, net, partially offset by a $188.7 million decrease in total expenses. The increased interest rate environment resulted in a decrease in margins and volume of mortgage loan originations and IRLCs from the comparable 2021 period.

Revenues
Net Interest Income. Net interest income is earned on LHFS offset by interest expense on amounts borrowed under warehouse and other lines of credit to finance such loans until sold. The increase in net interest income reflected higher yields on LHFS, partially offset by a $3.0 billion decrease in the average balance of LHFS.

Gain on Origination and Sale of Loans, Net. Gain on origination and sale of loans, net, was comprised of the following components:


40



Three Months Ended
June 30,
Change
$
Change
%
(Dollars in thousands)20222021
(Discount) premium from loan sales
$(437,194)$407,314 $(844,508)(207.3)%
Servicing rights180,455 427,458 (247,003)(57.8)
Fair value gains on IRLC and LHFS
96,224 231,956 (135,732)(58.5)
Fair value gains (losses) from Hedging Instruments
317,683 (346,179)663,862 191.8 
Discount points, rebates and lender paid costs71,767 (28,603)100,370 350.9 
(Provision for) recovery of loan loss obligation for loans sold
(82,373)533 (82,906)(15,554.6)
Total gain on origination and sale of loans, net$146,562 $692,479 $(545,917)(78.8)
•     (Discount) premium from loan sales represent the net premium or discount we receive or pay in excess of the loan principal amount and certain fees charged by investors upon sale of the loans. The decrease in premiums from loan sales was a result of lower volume and margins due to increasing interest rates subsequent to loan origination during the three months ended June 30, 2022 compared to decreasing rates during the three months ended June 30, 2021.
•    Servicing rights represent the fair value of servicing rights from loans sold on a servicing-retained basis. The 57.8% decrease in servicing rights was driven by the 65.9% decrease in volume of loans sold on a servicing-retained basis.
Fair value gains on IRLC and LHFS decreased $135.7 million or 58.5%. The decrease in gains was primarily due to the decrease in volume, partially offset by increasing interest rates during the three months ended June 30, 2022 compared to decreasing rates during the three months ended June 30, 2021.
•     Fair value gains on Hedging Instruments represent the net unrealized gains or losses on mandatory trades, forward sales contracts, interest rate swap futures, and put options hedging IRLCs and LHFS as well as realized gains or losses from pair-off settlements. The increase of $663.9 million reflects changes in interest rates during the period.
Discount points, rebates, and lender paid costs represent discount points collected, rebates paid to borrowers, and lender paid costs for the origination of loans (including broker fee compensation paid to independent wholesale brokers and brokerage fees paid to our joint ventures for referred loans). The increase of $100.4 million or 350.9% was driven by an increase in discount points collected and a decrease in lender paid costs.
Provision for loan loss obligation related to loans sold represents the provision to establish our estimated liability for loan losses that we may experience as a result of a breach of representation or warranty provided to the purchasers or insurers of loans that we have sold. The increase of $82.9 million was driven by increased market rates which have reduced the fair value of loans subject to repurchase that were originated in prior periods at lower interest rates.
Origination Income, Net. Origination income, net, reflects the fees that we earn, net of lender credits we pay, from originating loans. Origination income includes loan origination fees, processing fees, underwriting fees, and other fees collected from the borrower at the time of funding. Lender credits typically include rebates or concessions to borrowers for certain loan origination costs. The $53.5 million or 57.8% decrease in origination income was the result of a 53.6% decrease in loan origination volumes.
Servicing Fee Income. Servicing fee income reflects contractual servicing fees and ancillary and other fees (including late charges) related to the servicing of mortgage loans. The increase of $22.6 million or 23.8% in servicing income was the result of an increase of $20.5 billion in the average UPB of our servicing portfolio due to an increase in servicing-retained loan sales.
Change in Fair Value of Servicing Rights, Net. Change in fair value of servicing rights, net includes (i) fair value gains or losses net of Hedging Instrument gains or losses; (ii) collection/realization of cash flows, which includes principal amortization and prepayments; and (iii) realized gains or losses on the sales of servicing rights. Change in fair value of servicing rights, net


41



was a loss of $33.5 million for the three months ended June 30, 2022, as compared to $145.1 million for the three months ended June 30, 2021; the decrease in loss reflects $80.8 million in fair value gains, net of hedging losses and a $39.4 million decrease in the collection and realization of cash flows from lower prepayments due to the increasing rate environment for the three months ended June 30, 2022.
Other Income. Other income includes our pro rata share of the net earnings from joint ventures and fee income from title, escrow and settlement services for mortgage loan transactions performed by LDSS, and fair value changes in our trading securities. The decrease of $21.8 million or 57.1% was primarily the result of a decrease of $18.4 million in escrow and title fee income due to decreased mortgage loan settlement services and fair value losses of $6.3 million on our trading securities due to the increasing rate environment.
Expenses
Personnel Expense. Personnel expense reflects employee compensation related to salaries, commissions, incentive compensation, benefits, and other employee costs. The $173.6 million or 36.9% decrease was the result of a decrease of $131.8 million in commissions due to the decreases in loan origination volumes and decreases in salaries and benefits expense of $41.7 million as a result of reduced headcount. As of June 30, 2022, we had 8,540 employees compared to 11,572 employees as of June 30, 2021, representing a decrease of 26.2%.
Marketing and Advertising Expense. Marketing and advertising expense primarily reflects online advertising costs, including fees paid to search engines, television, print and radio, distribution partners, master service agreements with brokers, and desk rental agreements with realtors. The $53.3 million or 46.7% decrease in marketing expense was driven by a reduction in national television campaigns and purchased leads.
Servicing Expense. Servicing expense reflects in-house servicing costs as well as amounts that we pay to our sub-servicers to service our mortgage loan servicing portfolio. The $16.5 million or 60.6% decrease in subservicing expense reflects our shift to in-house servicing.
Other Interest Expense. The $11.9 million or 55.8% increase in other interest expense was the result of a $1.0 billion increase in average outstanding debt obligations primarily resulting from a $942.7 million increase in MSR facilities.
Income Tax Expense (Benefit). Benefit for income taxes was $28.2 million for the three months ended June 30, 2022, as compared to expense of $4.2 million for the three months ended June 30, 2021 reflects net losses, partially offset by non-deductible impairment of goodwill and other intangible assets for the three months ended June 30, 2022 compared to net income for the three months ended June 30, 2021.


42




Six Months Ended June 30, 2022 Compared to Six Months Ended June 30, 2021
Six Months Ended
June 30,
Change
$
Change
%
(Dollars in thousands)20222021
(Unaudited)
REVENUES:
Net interest income
$35,874 $8,259 $27,615 334.4 %
Gain on origination and sale of loans, net 509,692 1,826,054 (1,316,362)(72.1)
Origination income, net 98,181 194,223 (96,042)(49.4)
Servicing fee income 228,385 177,309 51,076 28.8 
Change in fair value of servicing rights, net (101,890)(188,733)86,843 46.0 
Other income 41,707 78,810 (37,103)(47.1)
Total net revenues 811,949 2,095,922 (1,283,973)(61.3)
EXPENSES:
Personnel expense 642,563 1,073,861 (431,298)(40.2)
Marketing and advertising expense 162,350 223,759 (61,409)(27.4)
Direct origination expense 87,153 96,993 (9,840)(10.1)
General and administrative expense 113,675 99,972 13,703 13.7 
Occupancy expense 18,784 19,270 (486)(2.5)
Depreciation and amortization 21,867 17,139 4,728 27.6 
Servicing expense32,252 53,851 (21,599)(40.1)
Other interest expense 47,533 34,438 13,095 38.0 
Goodwill impairment40,736 — 40,736 100.0
Total expenses 1,166,913 1,619,283 (452,370)(27.9)
(Loss) income before income taxes
(354,964)476,639 (831,603)(174.5)
Income tax (benefit) expense
(39,823)22,502 (62,325)(277.0)
Net (loss) income
(315,141)454,137 (769,278)(169.4)
Net (loss) income attributable to noncontrolling interests
(179,472)400,701 (580,173)(144.8)
Net (loss) income attributable to loanDepot, Inc.
$(135,669)$53,436 $(189,105)(353.9)

Results for the six months ended June 30, 2022 reflected a sharp increase in mortgage rates which resulted in a decrease to our profit margins. The decrease of $769.3 million, or 169.4% in net income is primarily from a $1.3 billion decrease in gain on origination and sale of loans, net, partially offset by a $452.4 million decrease in total expenses. The increased interest rate environment resulted in a decrease in margins and volume of mortgage loan originations and IRLCs from the comparable 2021 period.

Revenues
Net Interest Income. The increase in net interest income reflected higher yields on LHFS, partially offset by a $1.3 billion decrease in average LHFS.
 
Gain on Origination and Sale of Loans, Net. Gain on origination and sale of loans, net was comprised of the following components:


43



Six Months Ended
June 30,
Change
$
Change
%
(Dollars in thousands)20222021
(Discount) premium from loan sales
$(673,291)$877,887 $(1,551,178)(176.7)%
Servicing rights450,215 957,002 (506,787)(53.0)
Fair value losses on IRLC and LHFS
(297,534)(347,155)49,621 14.3 
Fair value gains from Hedging Instruments
994,087 482,045 512,042 106.2 
Discount points, rebates and lender paid costs131,834 (143,458)275,292 191.9 
Provision for loan loss obligation for loans sold
(95,619)(267)(95,352)(35,712.4)
$509,692 $1,826,054 $(1,316,362)(72.1)

•     Discounts on loan sales of $673.3 million for the six months ended June 30, 2022 reflect lower margins from the sharper increase in interest rates subsequent to loan origination and the resulting decrease in volume;
•    The 53.0% decrease in servicing rights was driven by a decrease in volume of loans sold on a servicing-retained basis for the six months ended June 30, 2022 as compared to the six months ended June 30, 2021;
•    The decrease of $49.6 million or 14.3% in fair value losses on IRLC and LHFS was due to changes in interest rates between periods as well as decreased volumes for the six months ended June 30, 2022 compared to the six months ended June 30, 2021;
•     The increase of $512.0 million in fair value gains from Hedging Instruments reflects higher pair-off gains from the increase in interest rates during the six months ended June 30, 2022;
•    The increase of $275.3 million or 191.9% in discount points, rebates and lender paid costs was driven by an increase in discount points collected and a decrease in lender paid costs.
•    The increase of $95.4 million in provision for loan loss obligations was driven by increased market rates which have reduced the fair value of loans subject to repurchase that were originated in prior periods at lower interest rates.
Origination Income, Net. The decrease in origination income, net, of $96.0 million or 49.4% is consistent with the decrease in loan origination volumes.
Servicing Fee Income. The $51.1 million or 28.8% increase was the result of an increase of $33.7 billion in the average UPB of our servicing portfolio.
Change in Fair Value of Servicing Rights, Net. The decrease in net loss of $86.8 million was driven by an $80.4 million decrease in the collection and realization of cash flows due to lower prepayments from the increasing rate environment.
Other Income. The decrease of $37.1 million or 47.1% was primarily the result of a decrease of $27.1 million in escrow and title fee income due to increased mortgage loan settlement services and $13.9 million in fair value losses on trading securities from rising interest rates.
Expenses
Personnel Expense. The decrease of $431.3 million reflects a $278.4 million decrease in commissions due to the decrease in loan origination volumes and a decrease in salaries and benefits due to the 26.2% decrease in headcount.


44



Marketing and Advertising Expense. The decrease of $61.4 million or 27.4% was driven by fewer television ads from a reduction in national campaigns.
Servicing Expense. The decrease of $21.6 million or 40.1% between periods reflects our shift to in-house servicing.
Other Interest Expense. The $13.1 million or 38.0% increase in other interest expense was the result of an increase in the average balance of our MSR facilities and Senior Notes, partially offset by a $10.5 million gain on extinguishment of debt from the repurchase of $97.5 million of the 2028 Senior Notes during the first quarter of 2022.
Provision for Income Taxes. The benefit for income taxes of $39.8 million for the six months ended June 30, 2022, as compared to expense of $22.5 million for the six months ended June 30, 2021 reflects net losses, partially offset by non-deductible impairment of goodwill and other intangible assets for the six months ended June 30, 2022 compared to net income for the six months ended June 30, 2021.


45



Balance Sheet Highlights
June 30, 2022 Compared to December 31, 2021
The following table sets forth our consolidated balance sheets as of the dates indicated:
(Dollars in thousands)June 30,
2022
December 31,
2021
Change
$
Change
%
(Unaudited)
ASSETS
Cash and cash equivalents $954,930 $419,571 $535,359 127.6 %
Restricted cash 194,645 201,025 (6,380)(3.2)
Accounts receivable, net 91,766 56,183 35,583 63.3 
Loans held for sale, at fair value 4,656,338 8,136,817 (3,480,479)(42.8)
Derivative assets, at fair value 153,607 194,665 (41,058)(21.1)
Servicing rights, at fair value 2,213,700 2,006,712 206,988 10.3 
Trading securities, at fair value105,308 72,874 32,434 44.5 
Property and equipment, net 111,443 104,262 7,181 6.9 
Operating lease right-of-use assets48,443 55,646 (7,203)(12.9)
Prepaid expenses and other assets 140,145 140,315 (170)(0.1)
Loans eligible for repurchase 506,454 363,373 143,081 39.4 
Investments in joint ventures 18,408 18,553 (145)(0.8)
Goodwill and intangible assets, net — 42,317 (42,317)(100.0)
Total assets $9,195,187 $11,812,313 $(2,617,126)(22.2)
LIABILITIES & EQUITY
Warehouse and other lines of credit $4,265,343 $7,457,199 $(3,191,856)(42.8)
Accounts payable, accrued expenses and other liabilities 643,144624,44418,700 3.0 
Derivative liabilities, at fair value 72,75837,79734,961 92.5 
Liability for loans eligible for repurchase506,454363,373143,081 39.4 
Operating lease liability66,48571,932(5,447)(7.6)
Debt obligations, net 2,427,1401,628,208798,93249.1 
Total liabilities 7,981,324 10,182,953 (2,201,629)(21.6)
Total equity1,213,863 1,629,360 (415,497)(25.5)
Total liabilities and equity$9,195,187 $11,812,313 $(2,617,126)(22.2)

Cash and Cash Equivalents. The $535.4 million or 127.6% increase in cash and cash equivalents included $388.0 million in proceeds from the bulk sale of MSRs and increased utilization of MSR facilities, partially offset by the repurchase of $97.5 million of 2028 Senior Notes and $117.1 million of dividends and distributions.
Loans Held for Sale, at Fair Value. Loans held for sale, at fair value, are primarily fixed and variable rate, 15- to 30-year term first-lien loans that are secured by residential property. The $3.5 billion or 42.8% decrease was primarily the result of $40.8 billion in loan sales, offset by $37.5 billion in originations.
Derivative Assets, at Fair Value. The $41.1 million or 21.1% decrease was primarily the result of a $92.5 million decrease in IRLCs assets from the decrease in IRLC volume, partially offset by a $51.4 million increase in Hedging Instruments from increasing interest rates. At June 30, 2022, derivative assets included Hedging Instruments with fair value of $61.7 million compared to $10.3 million at December 31, 2021.


46



Servicing Rights, at Fair Value. The $207.0 million or 10.3% increase included $450.2 million in capitalized servicing rights from the sale of loans on a servicing-retained basis and a $297.8 million increase in estimated fair value due to a decrease in prepayment speed assumptions from increased interest rates, partially offset by a $399.3 million decrease in servicing rights from the sale of $24.7 billion in UPB of servicing rights and $143.5 million of principal amortization and prepayments.
Trading Securities. The $32.4 million or 44.5% increase was due to Mello Mortgage Capital Acceptance securitizations completed in 2022. We retained a five percent economic interest in the credit risk of the assets collateralizing the securitization pursuant to the U.S. credit risk retention rules.
Goodwill and intangible assets, net. The impact of rising interest rates on the mortgage industry and the Company’s recent stock performance triggered an interim evaluation of goodwill and other intangible assets. Based upon the results of these evaluations, a non-cash impairment charge of $42.1 million was recognized to write off the balance of goodwill and other intangible assets. The impairment charge was driven predominantly by stock market valuations and the price of our common stock, which adversely impacted the valuation of our goodwill and other intangible assets as of June 30, 2022. As of June 30, 2022, the entire balance of goodwill and other intangible assets had been written off.
Warehouse and Other Lines of Credit. The decrease of $3.2 billion or 42.8% was the result of loan sales outpacing originations by $3.2 billion during the six months ended June 30, 2022.
Derivative Liabilities, at Fair Value. The increase of $35.0 million or 92.5% reflects a $30.5 million increase in IRLCs and a $4.4 million increase in Hedging Instrument liabilities due to increasing interest rates.
Debt Obligations, net. The increase of $798.9 million or 49.1% included an increase in secured credit facilities of $894.2 million, partially offset by the repurchase of $97.5 million of our 2028 Senior Notes.
Equity. Total equity was $1.2 billion and $1.6 billion as of June 30, 2022 and December 31, 2021, respectively. The decrease was attributed to net loss of $315.1 million, dividends and distributions totaling $89.4 million, decrease to additional paid in capital of $17.7 million related to deferred taxes, and the repurchase of treasury shares, at cost of $0.2 million to net settle and withhold tax on vested RSUs, partially offset by stock-based compensation of $7.0 million.
Liquidity and Capital Resources
Liquidity

Our liquidity reflects our ability to meet our current obligations (including our operating expenses and, when applicable, the retirement of our debt and margin calls relating to our Hedging Instruments, warehouse and other lines of credit, and secured credit facilities, fund new originations and purchases, meet servicing requirements, and make investments as we identify them. We forecast the need to have adequate liquid funds available to operate and grow our business. As of June 30, 2022, unrestricted cash and cash equivalents were $954.9 million and committed and uncommitted available capacity under our warehouse and other lines of credit was $5.5 billion.
We fund substantially all of the mortgage loans we close through borrowings under our warehouse and other lines of credit. Our mortgage origination liquidity could be affected as our lenders reassess their exposure to the mortgage origination industry and either curtail access to uncommitted mortgage warehouse financing capacity or impose higher costs to access such capacity. Our liquidity may be further constrained as there may be less demand by investors to acquire our mortgage loans in the secondary market.
As a servicer, we are required to advance principal and interest to the investor for up to four months on GSE backed mortgages and longer on other government agency backed mortgages on behalf of clients who have entered a forbearance plan. As of June 30, 2022, approximately 0.4%, or $587.8 million UPB, of our servicing portfolio was in active forbearance. While these advance requirements have decreased from the higher levels during 2020, the economic impact of COVID-19 could continue to result in additional advance requirements related to forbearance plans.


47



Sources and Uses of Cash
Our primary sources of liquidity have been as follows: (i) funds obtained from our warehouse and other lines of credit; (ii) proceeds from debt obligations; (iii) proceeds received from the sale and securitization of loans; (iv) proceeds from the sale of servicing rights; (v) loan fees from the origination of loans; (vi) servicing fees; (vii) title and escrow fees from settlement services; (viii) real estate referral fees; and (ix) interest income from LHFS.
Our primary uses of funds for liquidity have included the following: (i) funding mortgage loans; (ii) funding loan origination costs; (iii) payment of warehouse line haircuts required at loan origination; (iv) payment of interest expense on warehouse and other lines of credit ; (v) payment of interest expense under debt obligations; (vi) payment of operating expenses; (vii) repayment of warehouse and other lines of credit; (viii) repayment of debt obligations; (ix) funding of servicing advances; (x) margin calls on warehouse and other lines of credit or Hedging Instruments; (xi) payment of tax distributions to holders of Holdco Units; (xii) payments of cash dividends or distributions subject to the discretion of our board of directors, (xiii) repurchases of loans under representation and warranty breaches; and (xiv) costs relating to servicing and subservicing.
We rely on the secondary mortgage market as a source of long-term capital to support our mortgage lending operations. Approximately 78% of the mortgage loans that we originated during the six months ended June 30, 2022 were sold in the secondary mortgage market to Fannie Mae or Freddie Mac or, in the case of MBS guaranteed by Ginnie Mae, are mortgage loans insured or guaranteed by the FHA or VA. We also sell loans to many private investors.

At this time, we currently believe that our cash on hand, as well as the sources of liquidity described above, will be sufficient to maintain our current operations and fund our loan operations and capital commitments for the next twelve months. However, we will continue to review our liquidity needs in light of current and anticipated mortgage market conditions and we have taken various steps to align our cost structure with current and expected mortgage origination volumes.

 
Warehouse and Other Lines of Credit and Debt Obligations
Warehouse and other lines of credit are discussed in Note 9- Warehouse and Other Lines of Credit and debt obligations are discussed in Note 10- Debt Obligations of the Notes to Consolidated Financial Statements contained in Item 1.
Our lenders require us to comply with various financial covenants including tangible net worth, liquidity, leverage ratios and profitability. As a result of our second quarter losses, we were required to amend certain of our warehouse lines or amend and obtain waivers of profitability related financial covenants in certain of our debt obligations. We expect that we will need to further amend or obtain waivers during fiscal 2022 in order to maintain compliance with such financial covenants. Our lenders are not required to grant any such amendments, extensions or waivers and may determine not to do so. As of June 30, 2022, following certain amendments or waivers, we were in full compliance with all financial covenants. Although these financial covenants limit the amount of indebtedness that we may incur and affect our liquidity through minimum cash reserve requirements, we believe that these covenants currently provide us with sufficient flexibility to operate our business and obtain the financing necessary to achieve that purpose.
We finance most of our loan originations on a short-term basis using our warehouse and other lines of credit. Under these facilities, we agree to transfer certain loans to our counterparties against the transfer of funds by them, with a simultaneous agreement by the counterparties to transfer the loans back to us at the date loans are sold, or on demand by us, against the transfer of funds from us. We do not recognize these transfers as sales for accounting purposes. On average, loans are repurchased within 19 days of funding. Our warehouse facilities are generally short-term borrowings with original maturities between one and two years. Our securitization facilities have two and three year terms. We utilize both committed and uncommitted loan funding facilities and we evaluate our needs under these facilities based on forecasted volume of loan originations and sales.
As of June 30, 2022, we maintained revolving lines of credit with fourteen counterparties providing warehouse and securitization facilities with borrowing capacity totaling $9.9 billion of which $3.1 billion was committed. Our $9.9 billion of capacity as of June 30, 2022 was comprised of $6.1 billion with maturities staggered throughout 2022, $2.3 billion maturing in 2023, and $1.5 billion maturing in 2024. As of June 30, 2022, we had $4.3 billion of borrowings outstanding and $5.5 billion of additional availability under our facilities.
When we draw on our warehouse and securitization facilities we must pledge eligible loan collateral. Our warehouse line providers require us to make a capital investment, or “haircut.” upon financing the loan, which is generally based on product


48



types and the market value of the loans. The haircuts are normally recovered from sales proceeds. As of June 30, 2022, we had $90.8 million in restricted cash posted as additional collateral with our warehouse and securitization facilities.
In addition to our warehouse lines, we fund our balance sheet through our secured and unsecured debt obligations. The availability and cost of funds to us can vary depending on market conditions. From time to time, and subject to any applicable laws or regulations, we may take steps to reduce or repurchase our debt through redemptions, tender offers, cash purchases, prepayments, refinancing, exchange offers, open market or privately-negotiated transactions. The amount of debt, if any, that may be reduced or repurchased will depend on various factors, such as market conditions, trading levels of our debt, our cash positions, our compliance with debt covenants, and other considerations.

Secured debt obligations as of June 30, 2022 totaled $1.4 billion net of $3.2 million of deferred financing costs, as compared to $542.9 million net of $2.7 million of deferred financing costs as of December 31, 2021. Secured debt obligations as of June 30, 2022 included secured credit facilities and Term Notes. Secured credit facilities included MSR facilities, securities financing facilities, and servicing advance facilities. MSR facilities are secured by Ginnie Mae, Fannie Mae, and Freddie Mac MSRs. Securities financing facilities are secured by trading securities which represent our retained interest in the credit risk of the assets collateralizing certain securitization transactions. Servicing advance facilities are secured by servicing advance receivables made pursuant to Fannie Mae, Freddie Mac or Ginnie Mae requirements or other principal and interest or servicing advance reimbursement amounts. The Term Notes are secured by certain participation certificates relating to Ginnie Mae mortgage servicing rights pursuant to the terms of a base indenture.

Unsecured debt obligations as of June 30, 2022 totaled $1.0 billion net of $12.0 million of deferred financing costs, as compared to $1.1 billion, net of $14.7 million of deferred financing costs as of December 31, 2021. Unsecured debt obligations as of June 30, 2022 and December 31, 2021 consisted of our Senior Notes. During the first quarter of 2022, we repurchased $97.5 million of 2028 Senior Notes at an average purchase price of 87.9% of par which resulted in a $10.5 million gain on extinguishment of debt recorded in other interest expense on the consolidated statement of operations.

Dividends and Distributions
During the six months ended June 30, 2022, we paid dividends and distributions of $117.1 million.
On December 13, 2021, we declared a regular cash dividend of $0.08 per share on our Class A common stock and Class D common stock. The board of directors of LD Holdings authorized a simultaneous cash distribution on its units. The dividend was paid on January 18, 2022 to the Company's stockholders of record as of the close of business on January 3, 2022.
On March 14, 2022, we declared a regular cash dividend of $0.08 per share on our Class A common stock and Class D common stock. The board of directors of LD Holdings authorized a simultaneous cash distribution on its units. The dividend was paid on April 18, 2022 to the Company's stockholders of record as of the close of business on April 4, 2022.
Cash dividends are subject to the discretion of our board of directors and our compliance with applicable law, and depend on, among other things, our results of operations, financial condition, level of indebtedness, capital requirements, contractual restrictions, including the satisfaction of our obligations under the TRA, restrictions in our debt agreements, business prospects and other factors that our board of directors may deem relevant.
Our ability to pay dividends depends on our receipt of cash dividends from our operating subsidiaries, which may further restrict our ability to pay dividends as a result of the laws of their jurisdiction of organization or agreements of our subsidiaries, including agreements governing our indebtedness. Future agreements may also limit our ability to pay dividends.
As part of our balance sheet and capital management strategies, we suspended our regular quarterly dividend effective March 31, 2022 and for the foreseeable future.


49



Contractual Obligations and Commitments
Our estimated contractual obligations as of June 30, 2022 are as follows:
 
Payments Due by Period
(Dollars in thousands)TotalLess than 1 Year1-3 years3-5 Years More than
5 Years
Warehouse and other lines of credit$4,265,343 $2,465,343 $1,800,000 $— $— 
Debt obligations (1)
Secured credit facilities1,239,841 814,841 425,000 — — 
Term Notes200,000 — 200,000 — — 
Senior Notes1,002,475 — — 500,000 502,475 
Operating lease obligations (2)
76,948 15,760 41,120 13,262 6,806 
Naming and promotional rights agreements103,048 18,851 43,008 20,189 21,000 
Total contractual obligations$6,887,655 $3,314,795 $2,509,128 $533,451 $530,281 

(1)    Amounts exclude deferred financing costs.
(2)    Represents lease obligations for office space under non-cancelable operation lease agreements.
In addition to the above contractual obligations, we also have interest rate lock commitments and forward sale contracts. Commitments to originate loans do not necessarily reflect future cash requirements as some commitments are expected to expire without being drawn upon and, therefore, those commitments have been excluded from the table above. Refer to Note 6- Derivative Financial Instruments and Hedging Activities of the Notes to Consolidated Financial Statements contained in Item 1 for further discussion on derivatives.
Off-Balance Sheet Arrangements
As of June 30, 2022, we were party to mortgage loan participation purchase and sale agreements, pursuant to which we have access to uncommitted facilities that provide liquidity for recently sold MBS up to the MBS settlement date. These facilities, which we refer to as gestation facilities, are a component of our financing strategy and are off-balance sheet arrangements provided by certain warehouse lenders.
Critical Accounting Policies and Estimates
We prepare our consolidated financial statements in accordance with GAAP, which requires us to make judgments, estimates and assumptions that affect: (i) the reported amounts of our assets and liabilities; (ii) the disclosure of our contingent assets and liabilities at the end of each reporting period; and (iii) the reported amounts of revenues and expenses during each reporting period. We continually evaluate these judgments, estimates and assumptions based on our own historical experience, knowledge and assessment of current business and other conditions and our expectations regarding the future based on available information which together form our basis for making judgments about matters that are not readily apparent from other sources. Since the use of estimates is an integral component of the financial reporting process, our actual results could differ from those estimates. Some of our accounting policies require a higher degree of judgment than others in their application. Our accounting policies are described in Note 1 to the consolidated financial statements included in the Company's 2021 Form 10-K. At December 31, 2021, the most critical of these significant accounting policies were policies related to the fair value of loans held for sale, servicing rights, and derivative financial instruments. As of the date of this report, there have been no significant changes to the Company's critical accounting policies or estimates.
When reading our consolidated financial statements, you should consider our selection of critical accounting policies, the judgment and other uncertainties affecting the application of such policies and the sensitivity of reported results to changes in conditions and assumptions.



50



Reconciliation of Non-GAAP Measures
To provide investors with information in addition to our results as determined by GAAP, we disclose certain non-GAAP measures to assist investors in evaluating our financial results. We believe these non-GAAP measures provide useful information to investors regarding our results of operations because each measure assists both investors and management in analyzing and benchmarking the performance and value of our business. They facilitate company-to-company operating performance comparisons by backing out potential differences caused by variations in hedging strategies, changes in valuations, capital structures (affecting interest expense on non-funding debt), taxation, the age and book depreciation of facilities (affecting relative depreciation expense), the amortization of intangibles, and certain historical cost or benefit items which may vary for different companies for reasons unrelated to operating performance. These non-GAAP measures include our Adjusted Total Revenue, Adjusted Net Income (Loss), Adjusted Diluted Earnings (Loss) Per Share, and Adjusted EBITDA (LBITDA). We exclude from each of these non-GAAP financial measures the change in fair value of MSRs and related hedging gains and losses as they add volatility and are not indicative of the Company’s operating performance or results of operation. We also exclude stock compensation expense, which is a non-cash expense, management fees, IPO expenses, gains or losses on extinguishment of debt, non-cash goodwill impairment, and other impairment charges to intangible assets and operating lease right-of-use assets as management does not consider these costs to be indicative of our performance or results of operations. Adjusted EBITDA (LBITDA) includes interest expense on funding facilities, which are recorded as a component of “net interest income (expense)”, as these expenses are a direct operating expense driven by loan origination volume. By contrast, interest expense on our non-funding debt is a function of our capital structure and is therefore excluded from Adjusted EBITDA (LBITDA). Adjustments for income taxes are made to reflect historical results of operations on the basis that it was taxed as a corporation under the Internal Revenue Code, and therefore subject to U.S. federal, state and local income taxes. These non-GAAP measures have limitations as analytical tools, and should not be considered in isolation or as a substitute for revenue, net income, or any other operating performance measure calculated in accordance with GAAP, and may not be comparable to a similarly titled measure reported by other companies. Some of these limitations are:

Adjusted EBITDA (LBITDA) does not reflect the significant interest expense or the cash requirements necessary to service interest or principal payment on our debt;
although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced or require improvements in the future, and Adjusted Total Revenue, Adjusted Net Income (Loss), and Adjusted EBITDA (LBITDA) do not reflect any cash requirement for such replacements or improvements; and
they are not adjusted for all non-cash income or expense items that are reflected in our statements of cash flows.

Because of these limitations, Adjusted Total Revenue, Adjusted Net Income (Loss), Adjusted Diluted Earnings (Loss) Per Share, and Adjusted EBITDA (LBITDA) are not intended as alternatives to total revenue, net income (loss), net income (loss) attributable to the Company, or Diluted Earnings (Loss) Per Share or as an indicator of our operating performance and should not be considered as measures of discretionary cash available to us to invest in the growth of our business or as measures of cash that will be available to us to meet our obligations. We compensate for these limitations by using Adjusted Total Revenue, Adjusted Net Income (Loss), Adjusted Diluted Earnings (Loss) Per Share, and Adjusted EBITDA (LBITDA) along with other comparative tools, together with U.S. GAAP measurements, to assist in the evaluation of operating performance. See below for a reconciliation of these non-GAAP measures to their most comparable U.S. GAAP measures.

Reconciliation of Total Revenue to Adjusted Total Revenue
(Dollars in thousands)
(Unaudited):
Three Months EndedSix Months Ended
June 30, 2022June 30, 2021June 30, 2022June 30, 2021
Total net revenue$308,639 $779,914 $811,949 $2,095,922 
Change in fair value of servicing rights net, of hedging gains and losses(1)
(35,366)45,416 (34,072)(29,152)
Adjusted total revenue$273,273 $825,330 $777,877 $2,066,770 
(1)Represents the change in the fair value of servicing rights attributable to changes in assumptions, net of hedging gains and losses.



51



Reconciliation of Net Income (Loss) to Adjusted Net Income (Loss)
(Dollars in thousands)
(Unaudited):
Three Months EndedSix Months Ended
June 30, 2022June 30, 2021June 30, 2022June 30, 2021
Net (loss) income attributable to loanDepot, Inc.
$(100,928)$8,561 $(135,669)$53,436 
Net (loss) income from the pro forma conversion of Class C common shares to Class A common shares(1)
(122,894)17,723 (179,472)400,701 
Net (loss) income
(223,822)26,284 (315,141)454,137 
Adjustments to the benefit (provision) for income taxes(2)
31,952 (4,684)46,663 (105,905)
Tax-effected net (loss) income
(191,870)21,600 (268,478)348,232 
Change in fair value of servicing rights, net of hedging gains and losses(3)
(35,366)45,416 (34,072)(29,152)
Stock-based compensation expense and management fees4,712 2,126 7,021 62,202 
IPO expenses— 1,261 — 6,095 
Gain on extinguishment of debt— — (10,528)(10,528)— 
Goodwill impairment40,736 — 40,736 0.0
Other impairment5,963 — 5,963 0.0
Tax effect of adjustments(4)
7,970 (12,899)9,771 (10,346)
Adjusted net (loss) income
$(167,855)$57,504 $(249,587)$377,031 
(1)Reflects net income (loss) to Class A common stock and Class D common stock from the pro forma exchange of Class C common stock.
(2)loanDepot, Inc. is subject to federal, state and local income taxes. Adjustments to income tax (benefit) reflect the effective income tax rates below, and the pro forma assumption that loanDepot, Inc. owns 100% of LD Holdings.
Three Months EndedSix Months Ended
June 30, 2022June 30, 2021June 30, 2022June 30, 2021
Statutory U.S. federal income tax rate21.00 %21.00 %21.00 %21.00 %
State and local income taxes (net of federal benefit)5.00 5.43 5.00 5.43 
Effective income tax rate26.00 %26.43 %26.00 %26.43 %

(3)Represents the change in the fair value of servicing rights attributable to changes in assumptions, net of hedging gains and losses.
(4)Amounts represent the income tax effect of (a) change in fair value of servicing rights, net of hedging gains and losses, (b) stock compensation expense and management fees, (c) IPO expense, and (d) gain on extinguishment of debt at the aforementioned effective income tax rates.


52



Reconciliation of Adjusted Diluted Weighted Average Shares Outstanding to Diluted Weighted Average Shares Outstanding
(Dollars in thousands except per share)
(Unaudited)
Three Months EndedSix Months Ended
June 30, 2022June 30, 2021June 30, 2022June 30, 2021
Net (loss) income attributable to loanDepot, Inc.
$(100,928)$8,561 $(135,669)$53,436 
Adjusted net (loss) income
(167,855)57,504 (249,587)377,031 
Share Data:
Diluted weighted average shares of Class A and Class D common stock outstanding153,822,380 126,726,876 146,415,135 126,392,949 
Assumed pro forma conversion of weighted average Class C shares to Class A common stock (1)
165,281,304 196,741,703 173,245,208 197,366,213 
Adjusted diluted weighted average shares outstanding319,103,684323,468,579319,660,343323,759,162
Diluted (loss) earnings per share
$(0.66)$0.07 $(0.93)$0.42 
Adjusted diluted (loss) earnings per share (2)
N/AN/AN/AN/A
(1)Reflects the assumed pro forma conversion of all outstanding shares of Class C common stock to Class A common stock.
(2)Omitted adjusted diluted (loss) earnings per share measures that included the impact of assumed exchange of shares to the extent the exchange was antidilutive.

Reconciliation of Net Income (Loss) to Adjusted EBITDA (LBITDA)
(Dollars in thousands)
(Unaudited):
Three Months EndedSix Months Ended
June 30, 2022June 30, 2021June 30, 2022June 30, 2021
Net (loss) income
$(223,822)$26,284 $(315,141)$454,137 
Interest expense — non-funding debt(1)
33,140 21,266 47,533 34,438 
Income tax (benefit) expense
(28,196)4,225 (39,823)22,502 
Depreciation and amortization11,323 8,686 21,867 17,139 
Change in fair value of servicing rights, net of hedging gains and
losses(2)
(35,366)45,416 (34,072)(29,152)
Stock-based compensation expense and management fees4,712 2,126 7,021 62,202 
IPO expenses— 1,261 — 6,095 
Goodwill impairment40,736 — 40,736 — 
Other impairment5,963 — 5,963 — 
Adjusted (LBITDA) EBITDA
$(191,510)$109,264 $(265,916)$567,361 
(1)Represents other interest expense, which includes gain on extinguishment of debt and amortization of debt issuance costs, in the Company’s consolidated statement of operations.
(2)Represents the change in the fair value of servicing rights attributable to changes in assumptions, net of hedging gains and losses.

Item 3. Quantitative and Qualitative Disclosures About Market Risk
In the normal course of business, we are exposed to various risks which can affect our business, results and operations. The primary market risks to which we are exposed include interest rate risk, credit risk, prepayment risk and inflation risk.


53



We manage our interest rate risk and the price risk associated with changes in interest rates pursuant to the terms of an Interest Rate Risk Management Policy which (i) quantifies our interest rate risk exposure, (ii) lists the derivatives eligible for use as Hedging Instruments and (iii) establishes risk and liquidity tolerances.
Interest Rate Risk
Our principal market exposure is to interest rate risk as our business is subject to variability in results of operations due to fluctuations in interest rates. We anticipate that interest rates will remain our primary benchmark for market risk for the foreseeable future. Changes in interest rates affect our assets and liabilities measured at fair value, including LHFS, IRLCs, servicing rights and Hedging Instruments. In a declining interest rate environment, we would expect our results of operations to be positively impacted by higher loan origination volumes and loan margins. However, we would expect our results of operations to be negatively impacted by higher actual and projected loan prepayments related to our loan servicing portfolio and a decrease in the value of our servicing rights. As interest rates decline, our LHFS and IRLCs generally increase in value while our Hedging Instruments utilized to hedge against interest rate risk decrease in value. In a rising interest rate environment, we would expect a negative impact on the results of operations of our production activities and a positive impact on the results of operations of our servicing activities (principally through an increase in the fair value of our servicing rights). As interest rates increase, our LHFS and IRLCs generally decrease in value while our Hedging Instruments typically increase in value. The interaction between the results of operations of our various activities is a core component of our overall interest rate risk strategy.
IRLCs represent an agreement to extend credit to a potential customer, whereby the interest rate on the loan is set prior to funding. Our LHFS, which are held in inventory awaiting sale into the secondary market, and our IRLCs, are subject to changes in interest rates from the date of the commitment through the sale of the loan into the secondary market. Accordingly, we are exposed to interest rate risk and related price risk during the period from the date of the lock commitment through (i) the lock commitment cancellation or expiration date, or (ii) the date of sale into the secondary mortgage market. The average term for outstanding interest rate lock commitments at June 30, 2022 was 41 days; and our average holding period of the loan from funding to sale was 25 days during the six months ended June 30, 2022.
We manage the interest rate risk associated with our outstanding IRLCs, LHFS and servicing rights by entering into Hedging Instruments. Management expects these Hedging Instruments will experience changes in fair value opposite to changes in fair value of the IRLCs and LHFS, thereby reducing earnings volatility. We take into account various factors and strategies in determining the portion of IRLCs, LHFS and servicing rights that we want to economically hedge. Our expectation of how many of our IRLCs will ultimately close is a key factor in determining the notional amount of Hedging Instruments used in hedging the position.
 
Credit Risk
We are subject to credit risk in connection with our loan sale transactions. While our contracts vary, we provide representations and warranties to purchasers and insurers of the mortgage loans sold that typically are in place for the life of the loan. In the event of a breach of these representations and warranties, we may be required to repurchase a mortgage loan or indemnify the purchaser, and any subsequent loss on the mortgage loan may be borne by us. The representations and warranties require adherence to applicable origination and underwriting guidelines (including those of Fannie Mae, Freddie Mac and Ginnie Mae), including but not limited to the validity of the lien securing the loan, property eligibility, borrower credit, income and asset requirements and compliance with applicable federal, state and local law.
We record a provision for losses relating to such representations and warranties as part of our loan sale transactions. The level of the liability for losses from representations and warranties is difficult to estimate and requires considerable management judgment. The level of loan repurchase losses is dependent on economic factors, trends in property values, investor repurchase demand strategies and other external conditions that may change over the lives of the underlying loans. We evaluate the adequacy of our liability for losses from representations and warranties based on our loss experience and our assessment of incurred losses relating to loans that we have previously sold and which remain outstanding at the balance sheet date. As our portfolio of loans sold subject to representations and warranties grows and as economic fundamentals change, such adjustments can be material. However, we believe that our current estimates adequately approximate the losses incurred on our sold loans subject to such representations and warranties.


54



Additionally, we are exposed to credit risk associated with our customers from our LHFS as well as credit risks related to our counterparties including our subservicer, Hedging Instrument counterparties and other significant vendors. Our ability to operate profitably is dependent on both our access to capital to finance our assets and our ability to profitably originate, sell and service loans. Our ability to hold loans pending sale and/or securitization depends, in part, on the availability to us of adequate financing lines of credit at suitable interest rates and favorable advance rates.
In general, we manage such risk by selecting only counterparties that we believe to be financially strong, dispersing the risk among multiple counterparties, placing contractual limits on the amount of unsecured credit extended to any single counterparty and entering into netting agreements with the counterparties, as appropriate. During the six months ended June 30, 2022 and 2021, we incurred no losses due to nonperformance by any of our counterparties.
Prepayment Risk
Prepayment risk is affected by interest rates (and their inherent risk) and borrowers’ actions relative to their underlying loans. To the extent that the actual prepayment speed on the loans underlying our servicing rights differs from what we projected when we initially recognized them and when we measured fair value as of the end of each reporting period, the carrying value of our investment in servicing rights will be affected. In general, an increase in prepayment expectations will decrease our estimates of the fair value of the servicing right, thereby reducing expected servicing income. We monitor the servicing portfolio to identify potential refinancings and the impact that would have on associated servicing rights.
Inflation Risk
Almost all of our assets and liabilities are interest rate sensitive in nature. As a result, interest rates and other factors will influence our performance more than inflation. Changes in interest rates do not necessarily correlate with inflation rates or changes in inflation rates. Additionally, our financial statements are prepared in accordance with GAAP and our activities and balance sheets are measured with reference to historical cost and/or fair value without considering inflation.



55



Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our CEO and CFO, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of the end of the period covered by this Form 10-Q. Based on such evaluation, our CEO and CFO have concluded that as of June 30, 2022, our disclosure controls and procedures are designed at a reasonable assurance level and are effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting identified in management’s evaluation pursuant to Rules 13a-15(d) or 15d-15(d) of the Exchange Act during the period covered by this Form 10-Q that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on Effectiveness of Controls and Procedures
In designing and evaluating the disclosure controls and procedures and internal control over financial reporting, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, we and certain of our subsidiaries are involved in various lawsuits in state or federal courts regarding violations of state or federal statutes, regulations or common law related to matters arising out of the ordinary course of business. For a further discussion of our material legal proceedings, see Note 15 - Commitments and Contingencies of the Notes to Consolidated Financial Statements included in “Item 1 Financial Statements.” Additionally, below we have described certain other significant legal proceedings.

Securities Class Action Litigation.
Beginning in September 2021, two putative class action lawsuits were filed in the United States District Court for the Central District of California asserting claims under the U.S. securities laws against the Company, certain of its directors, and certain of its officers regarding certain disclosures made in connection with the Company’s IPO. The two actions were consolidated and the court appointed a lead plaintiff in May 2022. A consolidated amended complaint was filed in June 2022, which, in addition to challenging disclosures made in connection with the IPO, alleges that certain disclosures made after the IPO were false and/or misleading. The Company’s motion to dismiss is due on August 24, 2022. The plaintiffs seek unspecified monetary damages. The Company believes this lawsuit is without merit and intends to vigorously defend against it. The Company does not believe that a loss is probable or that the amount of loss is reasonably estimable in this matter at this time.

Stockholder Derivative Litigation.
Beginning in October 2021, four shareholder derivative complaints were filed in the United States District Court for the Central District of California against certain of the Company’s directors and officers, alleging, among things, that these defendants breached their fiduciary duties by causing the Company to make the disclosures being challenged in the putative securities class action described above and seeking unspecified monetary damages for the Company and that the Company make certain changes to its corporate governance. These derivative actions subsequently were consolidated into a single action (the “California Action”). The California Action is stayed pending resolution of a motion to dismiss in the putative securities class action. Beginning in March 2022, two


56



substantially similar shareholder derivative complaints were filed in the United States District Court for the District of Delaware, and then were consolidated into a single action (the “Delaware Action”). The Delaware Action is stayed pending resolution of a motion to dismiss in the putative securities class action. The Company believes these lawsuits are without merit. The Company does not believe that a loss is probable or that the amount of loss is reasonably estimable in this matter at this time.


Item 1A. Risk Factors

Other than the risk factor set forth below, there have been no material changes in the risk factors discussed under Part I. "Item 1A. Risk Factors" of our 2021 Form 10-K filed with the SEC on March 18, 2022.

Macroeconomic headwinds, including inflation and higher interest rates, have negatively impacted our operations and financial results and may further negatively impact us. While we are implementing initiatives such as our Vision 2025 plan to better position the Company, these initiatives may not effectively mitigate the effects of deterioration in the macroeconomic environment.

Our operations and financial performance are affected by factors including macroeconomic conditions such as inflation fluctuations, interest rates, consumer confidence and demand. We generate a sizeable portion of our revenues from refinance and purchase mortgages. As interest rates have risen, refinancing volumes have decreased as fewer consumers were incentivized to refinance their mortgages. As a result, our revenues have decreased substantially and we experienced net losses for the six months ended June 30, 2022. In addition, investors may seek to have us repurchase additional loans in the current environment, and because repurchased loans are typically resold at a discount to their repurchase price and unpaid principal balance we have experienced increased losses on repurchased loans or loans subject to repurchase originated at interest rates lower than currently prevailing rates. An increase in repurchase volumes of loans originated at lower interest rates could materially adversely affect our business, financial condition and results of operations.

As a result of our second quarter losses, we were required to amend certain of our warehouse lines or amend and obtain waivers of profitability related financial covenants in certain of our debt obligations for the quarter and we expect that we will need to execute additional amendments or obtain additional waivers from certain of our lending counterparties related to our profitability covenants or other similar financial covenants in the future including for the third quarter. There can be no assurance that such amendments or waivers will be received, in which case we would be in default under these agreements, and our lenders could elect to declare outstanding amounts due and payable, terminate their commitments, require the posting of additional collateral and enforce their interests against existing collateral, as well as triggering cross default provisions under other financing facilities which could materially adversely affect our financial condition and results of operations.

In July 2022, we announced our Vision 2025 plan designed to address current and anticipated mortgage market conditions by reducing staffing levels to approximately 6,500 by year-end 2022 and implementing business process optimization and other cost saving measures. We may not realize, in full or in part, the anticipated benefits, savings and improvements in our operations from our restructuring efforts due to unforeseen difficulties, delays or unexpected costs. If we are unable to realize the expected operational efficiencies and cost savings through headcount reduction, attrition, business process optimization, reduced marketing and third-party spending, and real estate consolidation, our operating results, financial condition, cash flows and competitive position may be materially adversely affected. We also cannot guarantee that we will not have to undertake additional staffing reductions or strategic reorganization activities in the future.

Furthermore, planned staffing reductions could create an additional risk of claims being made on behalf of affected employees. Any alleged violation of applicable wage laws or other labor-or employment-related laws could result in complaints by current or former employees, adverse media coverage, investigations and damages or penalties which could have a materially adverse effect on our reputation, business, operating results and prospects. In addition, responding to any such proceeding may result in a significant diversion of management’s attention and resources, significant defense costs and other professional fees.

Finally, we may be exposed to unanticipated consequences of our staffing reductions, including attrition beyond the planned reductions, increased difficulties in our day-to-day operations, including as a result of a loss of continuity, loss of accumulated knowledge and/or efficiency, reduced employee morale and reduced ability to attract


57



and retain qualified personnel. Employees who were not affected by our planned staffing reductions may seek alternate employment, which may force us to rely on third-party contract support creating unplanned additional expense or harm our productivity.


Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Shares of the Company's Class B common stock or Class C common stock may each be converted, together with a corresponding Holding Unit, as applicable, at any time and from time to time at the option of the holder of such share of Class B common stock or Class C common stock, as applicable, for one fully paid and non-assessable share of Class A common stock. Each share of the Company’s Class D common stock may be converted into one fully paid and non-assessable share of Class A common stock at any time at the option of the holder of such share of Class D common stock. There is no cash or other consideration paid by the holder converting such shares and, accordingly, there is no cash or other consideration received by the Company. The shares of Class A common stock issued by the Company in such conversions are exempt from registration pursuant to Section 3(a)(9) of the Securities Act.

On April 1, 2022, we issued to stockholders 1,259,307 shares of Class A common stock upon the conversion of the same number of shares of our Class C common stock and corresponding Holding Units held by such stockholders.

On May 2, 2022, we issued to stockholders 17,726,451 shares of Class A common stock upon the conversion of the same number of shares of our Class C common stock and corresponding Holding Units held by such stockholders.

In May 2022, 20,174 shares were purchased from employees to pay for taxes related to restricted stock vesting under the terms of an employee share-based compensation plan.
On June 1, 2022, we issued to stockholders 667,899 shares of Class A common stock upon the conversion of the same number of shares of our Class C common stock and corresponding Holding Units held by such stockholders.

In June 2022, 11,921 shares were purchased from employees to pay for taxes related to restricted stock vesting under the terms of an employee share-based compensation plan.

On July 1, 2022, we issued to stockholders 455,797 shares of Class A common stock upon the conversion of the same number of shares of our Class C common stock and corresponding Holding Units held by such stockholders.

In July 2022, 25,177 shares were purchased from employees to pay for taxes related to restricted stock vesting under the terms of an employee share-based compensation plan.


Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

Not applicable.

Item 6. Exhibits



58



The following documents are filed as a part of this report:
Exhibit No.Description
3.1
3.2
10.1*
10.2
10.3*
10.4*
10.5*
10.6
10.7
10.8*+
10.9*
10.10*
10.11*
10.12*+
10.13*
31.1*
31.2*
32.1*
32.2*
101.0XBRL Document
101.INSXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCHXBRL Taxonomy Extension Schema Document.
101.CALXBRL Taxonomy Extension Calculation Linkbase Document.
101.DEFXBRL Taxonomy Extension Definition Linkbase Document.
101.LABXBRL Taxonomy Extension Label Linkbase Document.
101.PREXBRL Taxonomy Extension Presentation Linkbase Document.


59



Exhibit No.Description
104.0Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
* Filed herewith
+ Confidential information has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed pursuant to Item 601(b)(10) of Regulation S-K. Certain schedules, exhibits and similar attachments have been omitted pursuant to Item 601(a)(5) of Regulation S-K or constitutes a clearly unwarranted invasion of personal privacy pursuant to Item 601(a)(6) of Regulation S-K. A copy of any omitted schedule or exhibit will be furnished supplementally to the staff of the Securities and Exchange Commission upon request.



60



SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

LOANDEPOT, INC.
  
  
Dated: August 10, 2022
By:/s/ Frank Martell
Name:Frank Martell
Title:President and Chief Executive Officer
Dated: August 10, 2022
By:/s/ Patrick Flanagan
Name:Patrick Flanagan
Title:Chief Financial Officer




61

Exhibit 10.1
LOANDEPOT, INC.
2021 OMNIBUS INCENTIVE PLAN
(as amended by the First Amendment)
ARTICLE I
PURPOSE
The purpose of this loanDepot, Inc. 2021 Omnibus Incentive Plan is to enhance the profitability and value of the Company for the benefit of its stockholders by enabling the Company to offer Eligible Individuals cash and stock-based incentives in order to attract, retain and reward such individuals and strengthen the mutuality of interests between such individuals and the Company’s stockholders. The Plan is effective as of the date set forth in Article XVI.
ARTICLE II
DEFINITIONS
For purposes of the Plan, the following terms shall have the following meanings:
2.1    “Affiliate” means each of the following: (a) any Subsidiary; (b) any Parent; (c) any corporation, trade or business (including, without limitation, a partnership or limited liability company) which is directly or indirectly controlled 50% or more (whether by ownership of stock, assets or an equivalent ownership interest or voting interest) by the Company or one of its Affiliates; (d) any trade or business (including, without limitation, a partnership or limited liability company) which directly or indirectly controls 50% or more (whether by ownership of stock, assets or an equivalent ownership interest or voting interest) of the Company; and (e) any other entity in which the Company or any of its Affiliates has a material equity interest and which is designated as an “Affiliate” by resolution of the Committee; provided that, unless otherwise determined by the Committee, the Common Stock subject to any Award constitutes “service recipient stock” for purposes of Section 409A of the Code or otherwise does not subject the Award to Section 409A of the Code.
2.2    “Award” means any award under the Plan of any Stock Option, Stock Appreciation Right, Restricted Stock Award, Performance Award, Other Stock-Based Award, Other Cash-Based Award or LTIP Units. All Awards shall be granted by, confirmed by, and subject to the terms of, a written agreement executed by the Company and the Participant.
2.3    “Award Agreement” means the written or electronic agreement setting forth the terms and conditions applicable to an Award.
2.4    “Board” means the Board of Directors of the Company.
2.5    “Cause” means, unless otherwise determined by the Committee in the applicable Award Agreement, with respect to a Participant’s Termination of Employment or Termination of Consultancy, the following: (a) in the case where there is no employment agreement, consulting agreement, change in control agreement or similar agreement in effect between the Company or an Affiliate and the Participant at the time of the grant of the Award (or where there is such an agreement but it does not define “cause” (or words of like import)), termination due to a Participant’s insubordination, dishonesty, fraud, incompetence, moral turpitude, willful misconduct, failure to adhere to written policies of the Company or any Affiliate, refusal to perform the Participant’s duties or responsibilities for any reason other than


Exhibit 10.1
illness or incapacity or materially unsatisfactory performance of the Participant’s duties for the Company or an Affiliate or indictment for, or conviction of (including a guilty plea or plea of nolo contendere), a felony or misdemeanor involving moral turpitude, as determined by the Committee in its good faith discretion; or (b) in the case where there is an employment agreement, consulting agreement, change in control agreement or similar agreement in effect between the Company or an Affiliate and the Participant at the time of the grant of the Award that defines “cause” (or words of like import), “cause” as defined under such agreement; provided, however, that with regard to any agreement under which the definition of “cause” only applies on occurrence of a change in control, such definition of “cause” shall not apply until a change in control actually takes place and then only with regard to a termination thereafter. With respect to a Participant’s Termination of Directorship, “cause” means an act or failure to act that constitutes cause for removal of a director under applicable Delaware law.
2.6    “Change in Control” has the meaning set forth in Section 12.2.
2.7    “Change in Control Price” has the meaning set forth in Section 12.1.
2.8    “Code” means the Internal Revenue Code of 1986, as amended. Any reference to any section of the Code shall also be a reference to any successor provision and any regulation of U.S. Department of Treasury promulgated thereunder (the “Treasury Regulation”).
2.9    “Committee” means any committee of the Board duly authorized by the Board to administer the Plan. If no committee is duly authorized by the Board to administer the Plan, the term “Committee” shall be deemed to refer to the Board for all purposes under the Plan.
2.10    “Common Stock” means the Class A common stock, $0.001 par value per share, of the Company.
2.11    “Company” means loanDepot, Inc., a Delaware corporation, and its successors by operation of law.
2.12    “Consultant” means any Person who is an advisor or consultant to the Company or its Affiliates.
2.13    “Disability” means, unless otherwise determined by the Committee in the applicable Award Agreement, with respect to a Participant’s Termination, a permanent and total disability as defined in Section 22(e)(3) of the Code. A Disability shall only be deemed to occur at the time of the determination by the Committee of the Disability. Notwithstanding the foregoing, for Awards that are subject to Section 409A of the Code, Disability shall mean that a Participant is disabled under Section 409A(a)(2)(C)(i) or (ii) of the Code.
2.14    “Effective Date” means the effective date of the Plan as defined in Article XVI.
2.15    “Eligible Employees” means each employee of the Company or an Affiliate.
2.16    “Eligible Individual” means an Eligible Employee, Non-Employee Director or Consultant who is designated by the Committee in its discretion as eligible to receive Awards subject to the conditions set forth herein.
2.17    “Exchange Act” means the Securities Exchange Act of 1934, as amended. Reference to a specific section of the Exchange Act or regulation thereunder shall include such section or regulation, any valid regulation or interpretation promulgated under such section, and any comparable provision of any future legislation or regulation amending, supplementing or superseding such section or regulation.


Exhibit 10.1
2.18    “Fair Market Value” means, for purposes of the Plan, unless otherwise required by any applicable provision of the Code or any regulations issued thereunder, as of any date and except as provided below, closing sales price reported for the Common Stock on the applicable date: (a) as reported on the principal national securities exchange in the United States on which it is then traded or (b) if the Common Stock is not traded, listed or otherwise reported or quoted, the Committee shall determine in good faith the Fair Market Value in whatever manner it considers appropriate taking into account the requirements of Section 409A of the Code. For purposes of the grant of any Award, the applicable date shall be the trading day immediately prior to the date on which the Award is granted. For purposes of the exercise of any Award, the applicable date shall be the date a notice of exercise is received by the Committee or, if not a day on which the applicable market is open, the next day that it is open.
2.19    “Family Member” means “family member” as defined in Section A.1.(a)(5) of the general instructions of Form S-8.
2.20    “Holdings” means LD Holdings Group, LLC.
2.21    “Incentive Stock Option” means any Stock Option awarded to an Eligible Employee of the Company, its Subsidiaries and its Parents (if any) under the Plan intended to be and designated as an “Incentive Stock Option” within the meaning of Section 422 of the Code.
2.22    “Incumbent Director” has the meaning set forth in Section 12.2(c)
2.23    “LLC Agreement” means the Fourth Amended and Restated Limited Liability Company Agreement of LD Holdings Group, LLC, as may be amended and/or restated from time to time.
2.24    “Lead Underwriter” has the meaning set forth in Section 15.19.
2.25    “Limited Stock Appreciation Right” has the meaning set forth in Section 7.5.
2.26    “Lock-Up Period” has the meaning set forth in Section 15.19.
2.27    “LTIP Units” shall mean common units in Holdings issued under the LLC Agreement.
2.28    “Non-Employee Director” means a director or a member of the Board of the Company or any Affiliate who is not an active employee of the Company or any Affiliate.
2.29    “Non-Qualified Stock Option” means any Stock Option awarded under the Plan that is not an Incentive Stock Option.
2.30    “Non-Tandem Stock Appreciation Right” shall mean the right to receive an amount in cash and/or stock equal to the difference between (x) the Fair Market Value of a share of Common Stock on the date such right is exercised, and (y) the aggregate exercise price of such right, otherwise than on surrender of a Stock Option.
2.31    “Other Cash-Based Award” means an Award granted pursuant to Section 11.3 of the Plan and payable in cash at such time or times and subject to such terms and conditions as determined by the Committee in its sole discretion.
2.32    “Other Stock-Based Award” means an Award under Article XI of the Plan that is valued in whole or in part by reference to, or is payable in or otherwise based on, Common Stock, including, without limitation, an Award valued by reference to an Affiliate.


Exhibit 10.1
2.33    “Parent” means any parent corporation of the Company within the meaning of Section 424(e) of the Code.
2.34    “Participant” means an Eligible Individual to whom an Award has been granted pursuant to the Plan.
2.35    “Performance Award” means an Award granted to a Participant pursuant to Article IX hereof contingent upon achieving certain Performance Goals.
2.36    “Performance Goals” means goals established by the Committee as contingencies for Awards to vest and/or become exercisable or distributable based on one or more performance goals established by the Committee in its sole discretion.
2.37    “Performance Period” means the designated period during which the Performance Goals must be satisfied with respect to the Award to which the Performance Goals relate.
2.38    “Person” means an individual, a partnership, a corporation, a limited liability company, an association, a joint stock company, a trust, a joint venture, an unincorporated organization and a government or any branch, department, agency, political subdivision or official thereof.
2.39    “Plan” means this loanDepot, Inc. 2021 Omnibus Incentive Plan, as amended from time to time.
2.40    “Proceeding” has the meaning set forth in Section 15.8.
2.41    “Reference Stock Option” has the meaning set forth in Section 7.1.
2.42    “Registration Date” means the date on which the Company sells its Common Stock in a bona fide, firm commitment underwriting pursuant to a registration statement under the Securities Act.
2.43    “Reorganization” has the meaning set forth in Section 4.2(b)(ii).
2.44    “Restricted Stock” means an Award of shares of Common Stock under the Plan that is subject to restrictions under Article VIII.
2.45    “Restriction Period” has the meaning set forth in Section 8.3(a) with respect to Restricted Stock.
2.46    “Rule 16b-3” means Rule 16b-3 under Section 16(b) of the Exchange Act as then in effect or any successor provision.
2.47     “Section 409A of the Code” means the nonqualified deferred compensation rules under Section 409A of the Code and any applicable Treasury Regulations and other official guidance thereunder.
2.48    “Securities Act” means the Securities Act of 1933, as amended and all rules and regulations promulgated thereunder. Reference to a specific section of the Securities Act or regulation thereunder shall include such section or regulation, any valid regulation or interpretation promulgated under such section, and any comparable provision of any future legislation or regulation amending, supplementing or superseding such section or regulation.
2.49    “Stock Appreciation Right” shall mean the right pursuant to an Award granted under Article VII.


Exhibit 10.1
2.50    “Stock Option” or “Option” means any option to purchase shares of Common Stock granted to Eligible Individuals granted pursuant to Article VI.
2.51    “Subsidiary” means any subsidiary corporation of the Company within the meaning of Section 424(f) of the Code.
2.52    “Substitute Award” shall mean an Award granted under the Plan in connection with a corporate transaction, such as a merger, combination, consolidation or acquisition of property or stock, in any case, upon the assumption of, or in substitution for, outstanding equity awards previously granted by a company or other entity; provided, however, that in no event shall the term “Substitute Award” be construed to refer to an award made in connection with the cancellation and repricing of an Stock Option or Stock Appreciation Right.
2.53    “Tandem Stock Appreciation Right” shall mean the right to surrender to the Company all (or a portion) of a Stock Option in exchange for an amount in cash and/or stock equal to the difference between (a) the Fair Market Value on the date such Stock Option (or such portion thereof) is surrendered, of the Common Stock covered by such Stock Option (or such portion thereof), and (b) the aggregate exercise price of such Stock Option (or such portion thereof).
2.54    “Ten Percent Stockholder” means a Person owning stock possessing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company, its Subsidiaries or its Parent.
2.55    “Termination” means a Termination of Consultancy, Termination of Directorship or Termination of Employment, as applicable.
2.56    “Termination of Consultancy” means: (a) that the Consultant is no longer acting as a consultant to the Company or an Affiliate; or (b) when an entity which is retaining a Participant as a Consultant ceases to be an Affiliate unless the Participant otherwise is, or thereupon becomes, a Consultant to the Company or another Affiliate at the time the entity ceases to be an Affiliate. In the event that a Consultant becomes an Eligible Employee or a Non-Employee Director upon the termination of such Consultant’s consultancy, unless otherwise determined by the Committee, in its sole discretion, no Termination of Consultancy shall be deemed to occur until such time as such Consultant is no longer a Consultant, an Eligible Employee or a Non-Employee Director. Notwithstanding the foregoing, the Committee may otherwise define Termination of Consultancy in the Award Agreement or, if no rights of a Participant are reduced, may otherwise define Termination of Consultancy thereafter, provided that any such change to the definition of the term “Termination of Consultancy” does not subject the applicable Award to Section 409A of the Code.
2.57    “Termination of Directorship” means that the Non-Employee Director has ceased to be a director of the Company; except that if a Non-Employee Director becomes an Eligible Employee or a Consultant upon the termination of such Non-Employee Director’s directorship, such Non-Employee Director’s ceasing to be a director of the Company shall not be treated as a Termination of Directorship unless and until the Participant has a Termination of Employment or Termination of Consultancy, as the case may be.
2.58    “Termination of Employment” means: (a) a termination of employment (for reasons other than a military or personal leave of absence granted by the Company) of a Participant from the Company and its Affiliates; or (b) when an entity which is employing a Participant ceases to be an Affiliate, unless the Participant otherwise is, or thereupon becomes, employed by the Company or another Affiliate at the


Exhibit 10.1
time the entity ceases to be an Affiliate. In the event that an Eligible Employee becomes a Consultant or a Non-Employee Director upon the termination of such Eligible Employee’s employment, unless otherwise determined by the Committee, in its sole discretion, no Termination of Employment shall be deemed to occur until such time as such Eligible Employee is no longer an Eligible Employee, a Consultant or a Non-Employee Director. Notwithstanding the foregoing, the Committee may otherwise define Termination of Employment in the Award Agreement or, if no rights of a Participant are reduced, may otherwise define Termination of Employment thereafter, provided that any such change to the definition of the term “Termination of Employment” does not subject the applicable Award to Section 409A of the Code.
2.59    “Transfer” means: (a) when used as a noun, any direct or indirect transfer, sale, assignment, pledge, hypothecation, encumbrance or other disposition (including the issuance of equity in any entity), whether for value or no value and whether voluntary or involuntary (including by operation of law), and (b) when used as a verb, to directly or indirectly transfer, sell, assign, pledge, encumber, charge, hypothecate or otherwise dispose of (including the issuance of equity in any entity) whether for value or for no value and whether voluntarily or involuntarily (including by operation of law). “Transferred” and “Transferable” shall have a correlative meaning.
ARTICLE III ADMINISTRATION
3.1    The Committee. The Plan shall be administered and interpreted by the Committee. To the extent required by applicable law, rule or regulation, it is intended that each member of the Committee shall qualify as (a) a “non-employee director” under Rule 16b-3, and (b) an “independent director” under the rules of any securities exchange or automated quotation system on which shares of Common Stock are listed, quoted or traded. If it is later determined that one or more members of the Committee do not so qualify, actions taken by the Committee prior to such determination shall be valid despite such failure to qualify.
3.2    Grants of Awards. The Committee shall have full authority to grant, pursuant to the terms of the Plan, to Eligible Individuals: (i) Stock Options, (ii) Stock Appreciation Rights, (iii) Restricted Stock Awards, (iv) Performance Awards; (v) Other Stock-Based Awards; (vi) Other Cash-Based Awards; and (v) LTIP Units. In particular, the Committee shall have the authority:
(a)    to select the Eligible Individuals to whom Awards may from time to time be granted hereunder;
(b)    to determine whether and to what extent Awards, or any combination thereof, are to be granted hereunder to one or more Eligible Individuals;
(c)    to determine the number of shares of Common Stock to be covered by each Award granted hereunder;
(d)    to determine the terms and conditions, not inconsistent with the terms of the Plan, of any Award granted hereunder (including, but not limited to, the exercise or purchase price (if any), any restriction or limitation, any vesting schedule or acceleration thereof, or any forfeiture restrictions or waiver thereof, regarding any Award and the shares of Common Stock relating thereto, based on such factors, if any, as the Committee shall determine, in its sole discretion);
(e)    to determine the amount of cash to be covered by each Award granted hereunder;


Exhibit 10.1
(f)    to determine whether, to what extent and under what circumstances grants of Options and other Awards under the Plan are to operate on a tandem basis and/or in conjunction with or apart from other awards made by the Company outside of the Plan;
(g)    to determine whether and under what circumstances a Stock Option may be settled in cash, Common Stock and/or Restricted Stock under Section 6.4(d);
(h)    to determine whether a Stock Option is an Incentive Stock Option or Non-Qualified Stock Option;
(i)    to determine whether to require a Participant, as a condition of the granting of any Award, to not sell or otherwise dispose of shares acquired pursuant to the exercise of an Award for a period of time as determined by the Committee, in its sole discretion, following the date of the acquisition of such Award;
(j)    to modify, extend or renew an Award, subject to Article XIII and Section 6.4(l), provided, however, that such action does not subject the Award to Section 409A of the Code without the consent of the Participant; and
(k)    solely to the extent permitted by applicable law, to determine whether, to what extent and under what circumstances to provide loans (which may be on a recourse basis and shall bear interest at the rate the Committee shall provide) to Participants in order to exercise Options under the Plan.
3.3    Guidelines. Subject to Article XIII hereof, the Committee shall have the authority to adopt, alter and repeal such administrative rules, guidelines and practices governing the Plan and perform all acts, including the delegation of its responsibilities (to the extent permitted by applicable law and applicable stock exchange rules), as it shall, from time to time, deem advisable; to construe and interpret the terms and provisions of the Plan and any Award issued under the Plan (and any agreements relating thereto); and to otherwise supervise the administration of the Plan. The Committee may correct any defect, supply any omission or reconcile any inconsistency in the Plan or in any agreement relating thereto in the manner and to the extent it shall deem necessary to effectuate the purpose and intent of the Plan. The Committee may adopt special guidelines and provisions for Persons who are residing in or employed in, or subject to, the taxes of, any domestic or foreign jurisdictions to comply with applicable tax and securities laws of such domestic or foreign jurisdictions. Notwithstanding the foregoing, no action of the Committee under this Section 3.3 shall impair the rights of any Participant without the Participant’s consent. To the extent applicable, the Plan is intended to comply with the applicable requirements of Rule 16b-3, and the Plan shall be limited, construed and interpreted in a manner so as to comply therewith.
3.4    Decisions Final. Any decision, interpretation or other action made or taken in good faith by or at the direction of the Company, the Board or the Committee (or any of its members) arising out of or in connection with the Plan shall be within the absolute discretion of all and each of them, as the case may be, and shall be final, binding and conclusive on the Company and all employees and Participants and their respective heirs, executors, administrators, successors and assigns.
3.5    Procedures. If the Committee is appointed, the Board shall designate one of the members of the Committee as chairman and the Committee shall hold meetings, subject to the By-Laws of the Company, at such times and places as it shall deem advisable, including, without limitation, by telephone conference or by written consent to the extent permitted by applicable law. A majority of the Committee members shall constitute a quorum. All determinations of the Committee shall be made by a majority of


Exhibit 10.1
its members. Any decision or determination reduced to writing and signed by all of the Committee members in accordance with the By-Laws of the Company, shall be fully effective as if it had been made by a vote at a meeting duly called and held. The Committee shall keep minutes of its meetings and shall make such rules and regulations for the conduct of its business as it shall deem advisable.
3.6    Designation of Consultants/Liability.
(a)    The Committee may designate employees of the Company and professional advisors to assist the Committee in the administration of the Plan and (to the extent permitted by applicable law and applicable exchange rules) may grant authority to officers to grant Awards and/or execute agreements or other documents on behalf of the Committee. In the event of any designation of authority hereunder, subject to applicable law, applicable stock exchange rules and any limitations imposed by the Committee in connection with such designation, such designee or designees shall have the power and authority to take such actions, exercise such powers and make such determinations that are otherwise specifically designated to the Committee hereunder.
(b)    The Committee may employ such legal counsel, consultants and agents as it may deem desirable for the administration of the Plan and may rely upon any opinion received from any such counsel or consultant and any computation received from any such consultant or agent. Expenses incurred by the Committee or the Board in the engagement of any such counsel, consultant or agent shall be paid by the Company. The Committee, its members and any Person designated pursuant to sub-section (a) above shall not be liable for any action or determination made in good faith with respect to the Plan. To the maximum extent permitted by applicable law, no officer of the Company or member or former member of the Committee or of the Board shall be liable for any action or determination made in good faith with respect to the Plan or any Award granted under it.
3.7    Indemnification. To the maximum extent permitted by applicable law and the Certificate of Incorporation and By-Laws of the Company and to the extent not covered by insurance directly insuring such Person, each officer or employee of the Company or any Affiliate and member or former member of the Committee or the Board shall be indemnified and held harmless by the Company against any cost or expense (including reasonable fees of counsel reasonably acceptable to the Committee) or liability (including any sum paid in settlement of a claim with the approval of the Committee), and advanced amounts necessary to pay the foregoing at the earliest time and to the fullest extent permitted, arising out of any act or omission to act in connection with the administration of the Plan, except to the extent arising out of such officer’s, employee’s, member’s or former member’s own fraud or bad faith. Such indemnification shall be in addition to any right of indemnification the employees, officers, directors or members or former officers, directors or members may have under applicable law or under the Certificate of Incorporation or By-Laws of the Company or any Affiliate. Notwithstanding anything else herein, this indemnification will not apply to the actions or determinations made by an individual with regard to Awards granted to such individual under the Plan.
ARTICLE IV
SHARE LIMITATION
4.1    Shares.


Exhibit 10.1
(a)    The aggregate number of shares of Common Stock with respect to which Awards may be granted under the Plan shall initially be equal to 27,147,880 shares (subject to any increase or decrease pursuant to Section 4.2), which amount shall be increased on the first day of each fiscal year during the term of the Plan commencing with the 2023 fiscal year by (i) 2% of the total number of shares of Common Stock outstanding on the last day of the immediately preceding fiscal year, or (ii) a lesser amount determined by the Board. The shares of Common Stock with respect to which awards may be granted under the Plan may be either authorized and unissued Common Stock or Common Stock held in or acquired for the treasury of the Company or both. The maximum number of shares of Common Stock with respect to which Incentive Stock Options may be granted under the Plan shall be 27,147,880 shares. With respect to Stock Appreciation Rights and Options settled in Common Stock, upon settlement, only the number of shares of Common Stock delivered to a Participant shall count against the aggregate and individual share limitations set forth under Sections 4.1(b) and 4.1(b). If any Option, Stock Appreciation Right or Other Stock-Based Awards granted under the Plan expires, terminates or is canceled for any reason without having been exercised in full, the number of shares of Common Stock underlying any unexercised Award shall again be available for the purpose of Awards under the Plan. If any shares of Restricted Stock, Performance Awards or Other Stock-Based Awards denominated in shares of Common Stock awarded under the Plan to a Participant are forfeited for any reason, the number of forfeited shares of Restricted Stock, Performance Awards or Other Stock-Based Awards denominated in shares of Common Stock shall again be available for purposes of Awards under the Plan. If any shares of Common Stock are withheld to satisfy tax withholding obligations on an Award issued under the Plan, the number of shares of Common Stock withheld shall again be available for purposes of Awards under the Plan. If a Tandem Stock Appreciation Right or a Limited Stock Appreciation Right is granted in tandem with an Option, such grant shall only apply once against the maximum number of shares of Common Stock which may be issued under the Plan. Any Award under the Plan settled in cash shall not be counted against the foregoing maximum share limitations..
(b)    The aggregate grant date fair value (computed as of the date of grant in accordance with applicable financial accounting rules) of all Awards granted under the Plan to any individual Non-Employee Director in any fiscal year of the Company (excluding any stock dividends payable in respect of outstanding Awards), when combined with other compensation received for such year in connection with service as a director, shall not exceed $600,000 increased to $1,000,000 in the fiscal year of his or her initial service as a Non-Employee Director.
(c)    In connection with an entity’s merger or consolidation with the Company or the Company’s acquisition of an entity’s property or stock, the Committee may grant Substitute Awards. Substitute awards may be granted on such terms as the Committee deems appropriate, notwithstanding limitations on Awards in the Plan. Substitute Awards shall not reduce the shares of Common Stock authorized for grant under the Plan, except as may be required by reason of Section 422 of the Code. Additionally, in the event that a company acquired by the Company or any Subsidiary or with which the Company or any Subsidiary combines has shares available under a pre-existing plan approved by its stockholders and not adopted in contemplation of such acquisition or combination, the shares available for grant pursuant to the terms of such pre-existing plan (as adjusted, to the extent appropriate, using the exchange ratio or other adjustment or valuation ratio or formula used in such acquisition or combination to determine the consideration payable to the holders of common stock of the


Exhibit 10.1
entities party to such acquisition or combination) may be used for Awards under the Plan and shall not reduce the shares of Common Stock authorized for grant under the Plan; provided that Awards using such available shares of Common Stock shall not be made after the date awards or grants could have been made under the terms of the pre-existing plan, absent the acquisition or combination, and shall only be made to individuals who were not employed by or providing services to the Company or its Subsidiaries immediately prior to such acquisition or combination.
4.2    Changes.
(a)    The existence of the Plan and the Awards granted hereunder shall not affect in any way the right or power of the Board, the Committee or the stockholders of the Company to make or authorize (i) any adjustment, recapitalization, reorganization or other change in the Company’s capital structure or its business, (ii) any merger or consolidation of the Company or any Affiliate, (iii) any issuance of bonds, debentures, preferred or prior preference stock ahead of or affecting the Common Stock, (iv) the dissolution or liquidation of the Company or any Affiliate, (v) any sale or transfer of all or part of the assets or business of the Company or any Affiliate or (vi) any other corporate act or proceeding.
(b)    Subject to the provisions of Section 12.1:
(i)    If the Company at any time subdivides (by any split, recapitalization or otherwise) the outstanding Common Stock into a greater number of shares of Common Stock, or combines (by reverse split, combination or otherwise) its outstanding Common Stock into a lesser number of shares of Common Stock, then the respective exercise prices for outstanding Awards that provide for a Participant elected exercise and the number of shares of Common Stock covered by outstanding Awards shall be appropriately adjusted by the Committee (as the Committee determines in its sole discretion) to prevent dilution or enlargement of the rights granted to, or available for, Participants under the Plan.
(ii)    Excepting transactions covered by Section 4.2(b)(i), if the Company effects any merger, consolidation, statutory exchange, spin-off, reorganization, sale or transfer of all or substantially all the Company’s assets or business, or other corporate transaction or event in such a manner that the Company’s outstanding shares of Common Stock are converted into the right to receive (or the holders of Common Stock are entitled to receive in exchange therefor), either immediately or upon liquidation of the Company, securities or other property of the Company or other entity (each, a “Reorganization”), then, subject to the provisions of Section 12.1, (A) the aggregate number or kind of securities that thereafter may be issued under the Plan, (B) the number or kind of securities or other property (including cash) to be issued pursuant to Awards granted under the Plan (including as a result of the assumption of the Plan and the obligations hereunder by a successor entity, as applicable), or (C) the purchase price thereof, shall be appropriately adjusted by the Committee (as the Committee determines in its sole discretion) to prevent dilution or enlargement of the rights granted to, or available for, Participants under the Plan.
(iii)    If there shall occur any change in the capital structure of the Company other than those covered by Section 4.2(b)(i) or 4.2(b)(ii), including by reason of any extraordinary


Exhibit 10.1
dividend (whether cash or equity), any conversion, any adjustment, any issuance of any class of securities convertible or exercisable into, or exercisable for, any class of equity securities of the Company, then the Committee shall appropriately adjust any Award and/or make such other adjustments to the Plan to prevent dilution or enlargement of the rights granted to, or available for, Participants under the Plan, as the Committee determines in its sole discretion.
(iv)    Any such adjustment determined by the Committee pursuant to this Section 4.2(b) shall be final, binding and conclusive on the Company and all Participants and their respective heirs, executors, administrators, successors and permitted assigns. Any adjustment to, or assumption or substitution of, an Award under this Section 4.2(b) shall be intended to comply with the requirements of Section 409A of the Code and Treasury Regulation §1.424-1 (and any amendments thereto), to the extent applicable. Except as expressly provided in this Section 4.2 or in the applicable Award Agreement, a Participant shall have no additional rights under the Plan by reason of any transaction or event described in this Section 4.2.
(v)    Fractional shares of Common Stock resulting from any adjustment in Awards pursuant to Section 4.2(a) or this Section 4.2(b) shall be aggregated until, and eliminated at, the time of exercise or payment by rounding-down for fractions less than one-half and rounding-up for fractions equal to or greater than one-half, provided, that, any shares of Common Stock underlying Stock Options or Stock Appreciation Rights shall be rounded down. No cash settlements shall be required with respect to fractional shares eliminated by rounding. Notice of any adjustment shall be given by the Committee to each Participant whose Award has been adjusted and such adjustment (whether or not such notice is given) shall be effective and binding for all purposes of the Plan.
4.3    Minimum Purchase Price. Notwithstanding any provision of the Plan to the contrary, if authorized but previously unissued shares of Common Stock are issued under the Plan, such shares shall not be issued for a consideration that is less than as permitted under applicable law.
ARTICLE V
ELIGIBILITY AND GRANTING OF AWARDS
5.1    General Eligibility. All current and prospective Eligible Individuals are eligible to be granted Awards. Eligibility for the grant of Awards and actual participation in the Plan shall be determined by the Committee in its sole discretion.
5.2    Incentive Stock Options. Notwithstanding the foregoing, only Eligible Employees of the Company, its Subsidiaries and its Parent (if any) are eligible to be granted Incentive Stock Options under the Plan. Eligibility for the grant of an Incentive Stock Option and actual participation in the Plan shall be determined by the Committee in its sole discretion.
5.3    General Requirement. The vesting and exercise of Awards granted to a prospective Eligible Individual are conditioned upon such individual actually becoming an Eligible Employee, Consultant or Non-Employee Director, respectively.
5.4    Award Agreement. Each Award shall be evidenced by an Award Agreement that sets forth the terms, conditions and limitations for such Award as determined by the Committee in its sole discretion (consistent with the requirements of the Plan and any applicable Program). Award Agreements


Exhibit 10.1
evidencing Incentive Stock Options shall contain such terms and conditions as may be necessary to meet the applicable provisions of Section 422 of the Code.
5.5    Limitations Applicable to Section 16 Persons. Notwithstanding any other provision of the Plan, the Plan, and any Award granted or awarded to any individual who is then subject to Section 16 of the Exchange Act, shall be subject to any additional limitations set forth in any applicable exemptive rule under Section 16 of the Exchange Act (including Rule 16b 3 of the Exchange Act and any amendments thereto) that are requirements for the application of such exemptive rule. To the extent permitted by applicable law, the Plan and Awards granted or awarded hereunder shall be deemed amended to the extent necessary to conform to such applicable exemptive rule.
5.6    Foreign Holders. Notwithstanding any provision of the Plan or applicable Program to the contrary, in order to comply with the laws in countries other than the United States in which the Company and its Subsidiaries operate or have Eligible Employees, Non-Employee Directors or Consultants, or in order to comply with the requirements of any foreign securities exchange or other applicable law, the Committee, in its sole discretion, shall have the power and authority to: (a) determine which Subsidiaries shall be covered by the Plan; (b) determine which Eligible Individuals outside the United States are eligible to participate in the Plan; (c) modify the terms and conditions of any Award granted to Eligible Individuals outside the United States to comply with applicable law (including, without limitation, applicable foreign laws or listing requirements of any foreign securities exchange); (d) establish subplans and modify exercise procedures and other terms and procedures, to the extent such actions may be necessary or advisable; provided, however, that no such subplans and/or modifications shall increase the share limitation contained in Section 4.1; and (e) take any action, before or after an Award is made, that it deems advisable to obtain approval or comply with any necessary local governmental regulatory exemptions or approvals or listing requirements of any foreign securities exchange.
ARTICLE VI
STOCK OPTIONS
6.1    Options. Stock Options may be granted alone or in addition to other Awards granted under the Plan. Each Stock Option granted under the Plan shall be of one of two types: (a) an Incentive Stock Option or (b) a Non-Qualified Stock Option.
6.2    Grants. The Committee shall have the authority to grant to any Eligible Employee one or more Incentive Stock Options, Non-Qualified Stock Options, or both types of Stock Options. The Committee shall have the authority to grant any Consultant or Non-Employee Director one or more Non-Qualified Stock Options. To the extent that any Stock Option does not qualify as an Incentive Stock Option (whether because of its provisions or the time or manner of its exercise or otherwise), such Stock Option or the portion thereof which does not so qualify shall constitute a separate Non-Qualified Stock Option.
6.3    Incentive Stock Options. Notwithstanding anything in the Plan to the contrary, no term of the Plan relating to Incentive Stock Options shall be interpreted, amended or altered, nor shall any discretion or authority granted under the Plan be so exercised, so as to disqualify the Plan under Section 422 of the Code, or, without the consent of the Participants affected, to disqualify any Incentive Stock Option under such Section 422.


Exhibit 10.1
6.4    Terms of Options. Options granted under the Plan shall be subject to the following terms and conditions and shall be in such form and contain such additional terms and conditions, not inconsistent with the terms of the Plan, as the Committee shall deem desirable:
(a)    Exercise Price. The exercise price per share of Common Stock subject to a Stock Option shall be determined by the Committee at the time of grant, provided that the per share exercise price of a Stock Option shall not be less than 100% (or, in the case of an Incentive Stock Option granted to a Ten Percent Stockholder, 110%) of the Fair Market Value of the Common Stock at the time of grant.
(b)    Stock Option Term. The term of each Stock Option shall be fixed by the Committee, provided that no Stock Option shall be exercisable more than 10 years after the date the Option is granted; and provided further that the term of an Incentive Stock Option granted to a Ten Percent Stockholder shall not exceed five years.
(c)    Exercisability. Unless otherwise provided by the Committee in accordance with the provisions of this Section 6.4, Stock Options granted under the Plan shall be exercisable at such time or times and subject to such terms and conditions as shall be determined by the Committee at the time of grant. If the Committee provides, in its discretion, that any Stock Option is exercisable subject to certain limitations (including, without limitation, that such Stock Option is exercisable only in installments or within certain time periods), the Committee may waive such limitations on the exercisability at any time at or after the time of grant in whole or in part (including, without limitation, waiver of the installment exercise provisions or acceleration of the time at which such Stock Option may be exercised), based on such factors, if any, as the Committee shall determine, in its sole discretion.
(d)    Method of Exercise. Subject to whatever installment exercise and waiting period provisions apply under Section 6.4(c), to the extent vested, Stock Options may be exercised in whole or in part at any time during the Option term, by giving written notice of exercise to the Company specifying the number of shares of Common Stock to be purchased. Such notice shall be accompanied by payment in full of the purchase price as follows: (i) in cash or by check, bank draft or money order payable to the order of the Company; (ii) solely to the extent permitted by applicable law, if the Common Stock is traded on a national securities exchange, and the Committee authorizes, through a procedure whereby the Participant delivers irrevocable instructions to a broker reasonably acceptable to the Committee to deliver promptly to the Company an amount equal to the purchase price; or (iii) on such other terms and conditions as may be acceptable to the Committee (including, without limitation, having the Company withhold shares of Common Stock issuable upon exercise of the Stock Option, or by payment in full or in part in the form of Common Stock owned by the Participant, based on the Fair Market Value of the Common Stock on the payment date as determined by the Committee). No shares of Common Stock shall be issued until payment therefor, as provided herein, has been made or provided for.
(e)    Non-Transferability of Options. No Stock Option shall be Transferable by the Participant other than by will or by the laws of descent and distribution, and all Stock Options shall be exercisable, during the Participant’s lifetime, only by the Participant. Notwithstanding the foregoing, the Committee may determine, in its sole discretion, at the time of grant or thereafter that a Non-Qualified Stock Option that is otherwise not Transferable pursuant to this Section is Transferable to a Family Member in whole or in part and in such


Exhibit 10.1
circumstances, and under such conditions, as specified by the Committee. A Non-Qualified Stock Option that is Transferred to a Family Member pursuant to the preceding sentence (i) may not be subsequently Transferred other than by will or by the laws of descent and distribution and (ii) remains subject to the terms of the Plan and the applicable Award Agreement. Any shares of Common Stock acquired upon the exercise of a Non-Qualified Stock Option by a permissible transferee of a Non-Qualified Stock Option or a permissible transferee pursuant to a Transfer after the exercise of the Non-Qualified Stock Option shall be subject to the terms of the Plan and the applicable Award Agreement.
(f)    Termination by Death or Disability. Unless otherwise determined by the Committee at the time of grant, or if no rights of the Participant are reduced, thereafter, if a Participant’s Termination is by reason of death or Disability, all Stock Options that are held by such Participant that are vested and exercisable at the time of the Participant’s Termination may be exercised by the Participant (or in the case of the Participant’s death, by the legal representative of the Participant’s estate) at any time within a period of one (1) year from the date of such Termination, but in no event beyond the expiration of the stated term of such Stock Options; provided, however, that, in the event of a Participant’s Termination by reason of Disability, if the Participant dies within such exercise period, all unexercised Stock Options held by such Participant shall thereafter be exercisable, to the extent to which they were exercisable at the time of death, for a period of one (1) year from the date of such death, but in no event beyond the expiration of the stated term of such Stock Options.
(g)    Involuntary Termination Without Cause. Unless otherwise determined by the Committee at the time of grant, or if no rights of the Participant are reduced, thereafter, if a Participant’s Termination is by involuntary termination by the Company without Cause, all Stock Options that are held by such Participant that are vested and exercisable at the time of the Participant’s Termination may be exercised by the Participant at any time within a period of ninety (90) days from the date of such Termination, but in no event beyond the expiration of the stated term of such Stock Options.
(h)    Voluntary Resignation. Unless otherwise determined by the Committee at the time of grant, or if no rights of the Participant are reduced, thereafter, if a Participant’s Termination is voluntary (other than a voluntary termination described in Section 6.4(i)(y) hereof), all Stock Options that are held by such Participant that are vested and exercisable at the time of the Participant’s Termination may be exercised by the Participant at any time within a period of thirty (30) days from the date of such Termination, but in no event beyond the expiration of the stated term of such Stock Options.
(i)    Termination for Cause. Unless otherwise determined by the Committee at the time of grant, or if no rights of the Participant are reduced, thereafter, if a Participant’s Termination (x) is for Cause or (y) is a voluntary Termination (as provided in Section 6.4(h)) after the occurrence of an event that would be grounds for a Termination for Cause, all Stock Options, whether vested or not vested, that are held by such Participant shall thereupon terminate and expire as of the date of such Termination.
(j)    Unvested Stock Options. Unless otherwise determined by the Committee at the time of grant, or if no rights of the Participant are reduced, thereafter, Stock Options that are not vested as of the date of a Participant’s Termination for any reason shall terminate and expire as of the date of such Termination.


Exhibit 10.1
(k)    Incentive Stock Option Limitations. To the extent that the aggregate Fair Market Value (determined as of the time of grant) of the Common Stock with respect to which Incentive Stock Options are exercisable for the first time by an Eligible Employee during any calendar year under the Plan and/or any other stock option plan of the Company, any Subsidiary or any Parent exceeds $100,000, such Options shall be treated as Non-Qualified Stock Options. In addition, if an Eligible Employee does not remain employed by the Company, any Subsidiary or any Parent at all times from the time an Incentive Stock Option is granted until three months prior to the date of exercise thereof (or such other period as required by applicable law), such Stock Option shall be treated as a Non-Qualified Stock Option. Should any provision of the Plan not be necessary in order for the Stock Options to qualify as Incentive Stock Options, or should any additional provisions be required, the Committee may amend the Plan accordingly, without the necessity of obtaining the approval of the stockholders of the Company.
(l)    Form, Modification, Extension and Renewal of Stock Options. Subject to the terms and conditions and within the limitations of the Plan, Stock Options shall be evidenced by such form of agreement or grant as is approved by the Committee, and the Committee may (i) modify, extend or renew outstanding Stock Options granted under the Plan (provided that the rights of a Participant are not reduced without such Participant’s consent and provided further that such action does not subject the Stock Options to Section 409A of the Code without the consent of the Participant), and (ii) accept the surrender of outstanding Stock Options (to the extent not theretofore exercised) and authorize the granting of new Stock Options in substitution therefor (to the extent not theretofore exercised). Notwithstanding the foregoing, an outstanding Option may not be modified to reduce the exercise price thereof nor may a new Option at a lower price be substituted for a surrendered Option (other than adjustments or substitutions in accordance with Section 4.2), unless such action is approved by the stockholders of the Company.
(m)    Deferred Delivery of Common Stock. The Committee may in its discretion permit Participants to defer delivery of Common Stock acquired pursuant to a Participant’s exercise of an Option in accordance with the terms and conditions established by the Committee in the applicable Award Agreement, which shall be intended to comply with the requirements of Section 409A of the Code.
(n)    Early Exercise. The Committee may provide that a Stock Option include a provision whereby the Participant may elect at any time before the Participant’s Termination to exercise the Stock Option as to any part or all of the shares of Common Stock subject to the Stock Option prior to the full vesting of the Stock Option and such shares shall be subject to the provisions of Article VIII and be treated as Restricted Stock. Unvested shares of Common Stock so purchased may be subject to a repurchase option in favor of the Company or to any other restriction the Committee determines to be appropriate.
(o)    Other Terms and Conditions. The Committee may include a provision in an Award Agreement providing for the automatic exercise of a Non-Qualified Stock Option on a cashless basis on the last day of the term of such Option if the Participant has failed to exercise the Non-Qualified Stock Option as of such date, with respect to which the Fair Market Value of the shares of Common Stock underlying the Non-Qualified Stock Option exceeds the exercise price of such Non-Qualified Stock Option on the date of expiration of such Option, subject to Section 15.4. Stock Options may contain such other provisions, which


Exhibit 10.1
shall not be inconsistent with any of the terms of the Plan, as the Committee shall deem appropriate.
ARTICLE VII
STOCK APPRECIATION RIGHTS
7.1    Tandem Stock Appreciation Rights. Stock Appreciation Rights may be granted in conjunction with all or part of any Stock Option (a “Reference Stock Option”) granted under the Plan (“Tandem Stock Appreciation Rights”). In the case of a Non-Qualified Stock Option, such rights may be granted either at or after the time of the grant of such Reference Stock Option. In the case of an Incentive Stock Option, such rights may be granted only at the time of the grant of such Reference Stock Option.
7.2    Terms and Conditions of Tandem Stock Appreciation Rights. Tandem Stock Appreciation Rights granted hereunder shall be subject to such terms and conditions, not inconsistent with the provisions of the Plan, as shall be determined from time to time by the Committee, and the following:
(a)    Exercise Price. The exercise price per share of Common Stock subject to a Tandem Stock Appreciation Right shall be determined by the Committee at the time of grant, provided that the per share exercise price of a Tandem Stock Appreciation Right shall not be less than 100% of the Fair Market Value of the Common Stock at the time of grant.
(b)    Term. A Tandem Stock Appreciation Right or applicable portion thereof granted with respect to a Reference Stock Option shall terminate and no longer be exercisable upon the termination or exercise of the Reference Stock Option, except that, unless otherwise determined by the Committee, in its sole discretion, at the time of grant, a Tandem Stock Appreciation Right granted with respect to less than the full number of shares covered by the Reference Stock Option shall not be reduced until, and then only to the extent that the exercise or termination of the Reference Stock Option causes, the number of shares covered by the Tandem Stock Appreciation Right to exceed the number of shares remaining available and unexercised under the Reference Stock Option.
(c)    Exercisability. Tandem Stock Appreciation Rights shall be exercisable only at such time or times and to the extent that the Reference Stock Options to which they relate shall be exercisable in accordance with the provisions of Article VI, and shall be subject to the provisions of Section 6.4(c).
(d)    Method of Exercise. A Tandem Stock Appreciation Right may be exercised by the Participant by surrendering the applicable portion of the Reference Stock Option. Upon such exercise and surrender, the Participant shall be entitled to receive an amount determined in the manner prescribed in this Section 7.2. Stock Options which have been so surrendered, in whole or in part, shall no longer be exercisable to the extent that the related Tandem Stock Appreciation Rights have been exercised.
(e)    Payment. Upon the exercise of a Tandem Stock Appreciation Right, a Participant shall be entitled to receive up to, but no more than, an amount in cash and/or Common Stock (as chosen by the Committee in its sole discretion) equal in value to the excess of the Fair Market Value of one share of Common Stock over the Option exercise price per share specified in the Reference Stock Option agreement multiplied by the number of shares of Common Stock in respect of which the Tandem Stock Appreciation Right shall have been exercised, with the Committee having the right to determine the form of payment.


Exhibit 10.1
(f)    Deemed Exercise of Reference Stock Option. Upon the exercise of a Tandem Stock Appreciation Right, the Reference Stock Option or part thereof to which such Stock Appreciation Right is related shall be deemed to have been exercised for the purpose of the limitation set forth in Article IV of the Plan on the number of shares of Common Stock to be issued under the Plan.
(g)    Non-Transferability. Tandem Stock Appreciation Rights shall be Transferable only when and to the extent that the underlying Stock Option would be Transferable under Section 6.4(e) of the Plan.
7.3    Non-Tandem Stock Appreciation Rights. Non-Tandem Stock Appreciation Rights may also be granted without reference to any Stock Options granted under the Plan.
7.4    Terms and Conditions of Non-Tandem Stock Appreciation Rights. Non-Tandem Stock Appreciation Rights granted hereunder shall be subject to such terms and conditions, not inconsistent with the provisions of the Plan, as shall be determined from time to time by the Committee, and the following:
(a)    Exercise Price. The exercise price per share of Common Stock subject to a Non-Tandem Stock Appreciation Right shall be determined by the Committee at the time of grant, provided that the per share exercise price of a Non-Tandem Stock Appreciation Right shall not be less than 100% of the Fair Market Value of the Common Stock at the time of grant.
(b)    Term. The term of each Non-Tandem Stock Appreciation Right shall be fixed by the Committee, but shall not be greater than 10 years after the date the right is granted.
(c)    Exercisability. Unless otherwise provided by the Committee in accordance with the provisions of this Section 7.4, Non-Tandem Stock Appreciation Rights granted under the Plan shall be exercisable at such time or times and subject to such terms and conditions as shall be determined by the Committee at the time of grant. If the Committee provides, in its discretion, that any such right is exercisable subject to certain limitations (including, without limitation, that it is exercisable only in installments or within certain time periods), the Committee may waive such limitations on the exercisability at any time at or after grant in whole or in part (including, without limitation, waiver of the installment exercise provisions or acceleration of the time at which such right may be exercised), based on such factors, if any, as the Committee shall determine, in its sole discretion.
(d)    Method of Exercise. Subject to whatever installment exercise and waiting period provisions apply under Section 7.4(c), Non-Tandem Stock Appreciation Rights may be exercised in whole or in part at any time in accordance with the applicable Award Agreement, by giving written notice of exercise to the Company specifying the number of Non-Tandem Stock Appreciation Rights to be exercised.
(e)    Payment. Upon the exercise of a Non-Tandem Stock Appreciation Right a Participant shall be entitled to receive, for each right exercised, up to, but no more than, an amount in cash and/or Common Stock (as chosen by the Committee in its sole discretion) equal in value to the excess of the Fair Market Value of one share of Common Stock on the date that the right is exercised over the Fair Market Value of one share of Common Stock on the date that the right was awarded to the Participant.
(f)    Termination. Unless otherwise determined by the Committee at grant or, if no rights of the Participant are reduced, thereafter, subject to the provisions of the applicable Award


Exhibit 10.1
Agreement and the Plan, upon a Participant’s Termination for any reason, Non-Tandem Stock Appreciation Rights will remain exercisable following a Participant’s Termination on the same basis as Stock Options would be exercisable following a Participant’s Termination in accordance with the provisions of Sections 6.4(f) through 6.4(j).
(g)    Non-Transferability. No Non-Tandem Stock Appreciation Rights shall be Transferable by the Participant other than by will or by the laws of descent and distribution, and all such rights shall be exercisable, during the Participant’s lifetime, only by the Participant.
7.5    Limited Stock Appreciation Rights. The Committee may, in its sole discretion, grant Tandem Stock Appreciation Rights and Non-Tandem Stock Appreciation Rights either as a general Stock Appreciation Right or as a Limited Stock Appreciation Right. A “Limited Stock Appreciation Right” is a Stock Appreciation Right that may be exercised only upon the occurrence of a Change in Control or such other event as the Committee may, in its sole discretion, designate at the time of grant or thereafter. Upon the exercise of Limited Stock Appreciation Rights, except as otherwise provided in an Award Agreement, the Participant shall receive in cash and/or Common Stock, as determined by the Committee, an amount equal to the amount (i) set forth in Section 7.2(e) with respect to Tandem Stock Appreciation Rights, or (ii) set forth in Section 7.4(e) with respect to Non-Tandem Stock Appreciation Rights.
7.6    Other Terms and Conditions. The Committee may include a provision in an Award Agreement providing for the automatic exercise of a Stock Appreciation Right on a cashless basis on the last day of the term of such Stock Appreciation Right if the Participant has failed to exercise the Stock Appreciation Right as of such date, with respect to which the Fair Market Value of the shares of Common Stock underlying the Stock Appreciation Right exceeds the exercise price of such Stock Appreciation Right on the date of expiration of such Stock Appreciation Right, subject to Section 15.4. Stock Appreciation Rights may contain such other provisions, which shall not be inconsistent with any of the terms of the Plan, as the Committee shall deem appropriate.
ARTICLE VIII
RESTRICTED STOCK
8.1    Awards of Restricted Stock. Shares of Restricted Stock may be issued either alone or in addition to other Awards granted under the Plan. The Committee shall determine the Eligible Individuals, to whom, and the time or times at which, grants of Restricted Stock shall be made, the number of shares to be awarded, the price (if any) to be paid by the Participant (subject to Section 8.2), the time or times within which such Awards may be subject to forfeiture, the vesting schedule and rights to acceleration thereof, and all other terms and conditions of the Awards.
The Committee may condition the grant or vesting of Restricted Stock upon the attainment of specified performance targets (including, the Performance Goals) or such other factor as the Committee may determine in its sole discretion.
8.2    Awards and Certificates. Eligible Individuals selected to receive Restricted Stock shall not have any right with respect to such Award, unless and until such Participant has delivered a fully executed copy of the agreement evidencing the Award to the Company, to the extent required by the Committee, and has otherwise complied with the applicable terms and conditions of such Award. Further, such Award shall be subject to the following conditions:
(a)    Purchase Price. The purchase price of Restricted Stock shall be fixed by the Committee. Subject to Section 4.2, the purchase price for shares of Restricted Stock may be zero to the


Exhibit 10.1
extent permitted by applicable law, and, to the extent not so permitted, such purchase price may not be less than par value.
(b)    Acceptance. Awards of Restricted Stock must be accepted within a period of 60 days (or such shorter period as the Committee may specify at grant) after the grant date, by executing a Restricted Stock agreement and by paying whatever price (if any) the Committee has designated thereunder.
(c)    Legend. Each Participant receiving Restricted Stock shall be issued a stock certificate in respect of such shares of Restricted Stock, unless the Committee elects to use another system, such as book entries by the transfer agent, as evidencing ownership of shares of Restricted Stock. Such certificate shall be registered in the name of such Participant, and shall, in addition to such legends required by applicable securities laws, bear an appropriate legend referring to the terms, conditions, and restrictions applicable to such Award, substantially in the following form:
“The anticipation, alienation, attachment, sale, transfer, assignment, pledge, encumbrance or charge of the shares of stock represented hereby are subject to the terms and conditions (including forfeiture) of the loanDepot, Inc. (the “Company”) 2021 Omnibus Incentive Plan (the “Plan”) and an Agreement entered into between the registered owner and the Company dated _____________. Copies of such Plan and Agreement are on file at the principal office of the Company.”
(d)    Custody. If stock certificates are issued in respect of shares of Restricted Stock, the Committee may require that any stock certificates evidencing such shares be held in custody by the Company until the restrictions thereon shall have lapsed, and that, as a condition of any grant of Restricted Stock, the Participant shall have delivered a duly signed stock power or other instruments of assignment (including a power of attorney), each endorsed in blank with a guarantee of signature if deemed necessary or appropriate by the Company, which would permit transfer to the Company of all or a portion of the shares subject to the Restricted Stock Award in the event that such Award is forfeited in whole or part.
8.3    Restrictions and Conditions. The shares of Restricted Stock awarded pursuant to the Plan shall be subject to the following restrictions and conditions:
(a)    Restriction Period.
(i)    The Participant shall not be permitted to Transfer shares of Restricted Stock awarded under the Plan during the period or periods set by the Committee (the “Restriction Period”) commencing on the date of such Award, as set forth in the Restricted Stock Award Agreement and such agreement shall set forth a vesting schedule and any event that would accelerate vesting of the shares of Restricted Stock. Within these limits, based on service, attainment of Performance Goals pursuant to Section 8.3(a)(ii) and/or such other factors or criteria as the Committee may determine in its sole discretion, the Committee may condition the grant or provide for the lapse of such restrictions in installments in whole or in part, or may accelerate the vesting of all or any part of any Restricted Stock Award and/or waive the deferral limitations for all or any part of any Restricted Stock Award.


Exhibit 10.1
(ii)    If the grant of shares of Restricted Stock or the lapse of restrictions is based on the attainment of Performance Goals, the Committee shall establish the objective Performance Goals and the applicable vesting percentage of the Restricted Stock applicable to each Participant or class of Participants in writing prior to the beginning of the applicable fiscal year or at such later date as otherwise determined by the Committee and while the outcome of the Performance Goals are substantially uncertain. Such Performance Goals may incorporate provisions for disregarding (or adjusting for) changes in accounting methods, corporate transactions (including, without limitation, dispositions and acquisitions) and other similar type events or circumstances.
(b)    Rights as a Stockholder. Except as provided in Section 8.3(a) and this Section 8.3(b) or as otherwise determined by the Committee in an Award Agreement, the Participant shall have, with respect to the shares of Restricted Stock, all of the rights of a holder of shares of Common Stock of the Company, including, without limitation, the right to receive dividends, the right to vote such shares and, subject to and conditioned upon the full vesting of shares of Restricted Stock, the right to tender such shares; provided, however, that unless otherwise determined by the Committee, payment of dividends shall be deferred until, and conditioned upon, the expiration of the applicable Restriction Period.
(c)    Termination. Unless otherwise determined by the Committee at grant or, if no rights of the Participant are reduced, thereafter, subject to the applicable provisions of the Award Agreement and the Plan, upon a Participant’s Termination for any reason during the relevant Restriction Period, all Restricted Stock still subject to restriction will be forfeited in accordance with the terms and conditions established by the Committee at grant or thereafter.
(d)    Lapse of Restrictions. If and when the Restriction Period expires without a prior forfeiture of the Restricted Stock, the certificates for such shares shall be delivered to the Participant. All legends shall be removed from said certificates at the time of delivery to the Participant, except as otherwise required by applicable law or other limitations imposed by the Committee.
ARTICLE IX
PERFORMANCE AWARDS
9.1    Performance Awards. The Committee may grant a Performance Award to a Participant payable upon the attainment of specific Performance Goals. If the Performance Award is payable in shares of Common Stock, such shares shall be transferable to the Participant only upon attainment of the relevant Performance Goal in accordance with Article VIII. If the Performance Award is payable in cash, it may be paid upon the attainment of the relevant Performance Goals either in cash or in shares of Restricted Stock (based on the then current Fair Market Value of such shares), as determined by the Committee, in its sole and absolute discretion.
9.2    Terms and Conditions. Performance Awards awarded pursuant to this Article IX shall be subject to the following terms and conditions:
(a)    Earning of Performance Award. At the expiration of the applicable Performance Period, the Committee shall determine the extent to which the Performance Goals are achieved and the percentage of each Performance Award that has been earned.


Exhibit 10.1
(b)    Non-Transferability. Subject to the applicable provisions of the Award Agreement and the Plan, Performance Awards may not be Transferred during the Performance Period.
(c)    Dividends. Unless otherwise determined by the Committee at the time of grant, amounts equal to dividends declared during the Performance Period with respect to the number of shares of Common Stock covered by a Performance Award will not be paid to the Participant.
(d)    Payment. Following the Committee’s determination in accordance with Section 9.2(a), the Company shall settle Performance Awards, in such form (including, without limitation, in shares of Common Stock or in cash) as determined by the Committee, in an amount equal to such Participant’s earned Performance Awards.
(e)    Termination. Subject to the applicable provisions of the Award Agreement and the Plan, upon a Participant’s Termination for any reason during the Performance Period for a given Performance Award, the Performance Award in question will vest or be forfeited in accordance with the terms and conditions established by the Committee at grant.
(f)    Accelerated Vesting. Based on service, performance and/or such other factors or criteria, if any, as the Committee may determine, the Committee may, at or after grant, accelerate the vesting of all or any part of any Performance Award.
ARTICLE X
LTIP UNIT AWARDS
10.1    LTIP Unit Awards. Subject to the provisions of the LLC Agreement, the Committee is authorized to grant to Eligible Individuals Awards in the form of, and causing Holdings to issue, LTIP Units, having the rights, voting powers, restrictions, limitations as to distributions, qualifications, redemption and conversion terms, vesting terms and other terms and conditions set forth herein and in the LLC Agreement. To the extent that such LTIP Units are convertible or exchangeable into Common Stock, each LTIP Unit awarded will be equivalent to an award of one share of Common Stock for purposes of reducing the number of shares of Common Stock available under the Plan on a one-for-one basis pursuant to Section 4.1.
ARTICLE XI
OTHER STOCK-BASED AND CASH-BASED AWARDS
11.1    Other Stock-Based Awards. The Committee is authorized to grant to Eligible Individuals Other Stock-Based Awards that are payable in, valued in whole or in part by reference to, or otherwise based on or related to shares of Common Stock, including but not limited to, shares of Common Stock awarded purely as a bonus and not subject to restrictions or conditions, shares of Common Stock in payment of the amounts due under an incentive or performance plan sponsored or maintained by the Company or an Affiliate, stock equivalent units, restricted stock units, and Awards valued by reference to book value of shares of Common Stock. Other Stock-Based Awards may be granted either alone or in addition to or in tandem with other Awards granted under the Plan.
Subject to the provisions of the Plan, the Committee shall have authority to determine the Eligible Individuals, to whom, and the time or times at which, such Awards shall be made, the number of shares of Common Stock to be awarded pursuant to such Awards, and all other conditions of the Awards. The Committee may also provide for the grant of Common Stock under such Awards upon the completion of a specified Performance Period.


Exhibit 10.1
The Committee may condition the grant or vesting of Other Stock-Based Awards upon the attainment of specified Performance Goals as the Committee may determine, in its sole discretion;
11.2    Terms and Conditions. Other Stock-Based Awards made pursuant to this Article XI shall be subject to the following terms and conditions:
(a)    Non-Transferability. Subject to the applicable provisions of the Award Agreement and the Plan, shares of Common Stock subject to Awards made under this Article XI may not be Transferred prior to the date on which the shares are issued, or, if later, the date on which any applicable restriction, performance or deferral period lapses.
(b)    Dividends. Unless otherwise determined by the Committee at the time of Award, subject to the provisions of the Award Agreement and the Plan, the recipient of an Award under this Article XI shall not be entitled to receive, currently or on a deferred basis, dividends or dividend equivalents in respect of the number of shares of Common Stock covered by the Award.
(c)    Vesting. Any Award under this Article XI and any Common Stock covered by any such Award shall vest or be forfeited to the extent so provided in the Award Agreement, as determined by the Committee, in its sole discretion.
(d)    Price. Common Stock issued on a bonus basis under this Article XI may be issued for no cash consideration. Common Stock purchased pursuant to a purchase right awarded under this Article XI shall be priced, as determined by the Committee in its sole discretion.
11.3    Other Cash-Based Awards. The Committee may from time to time grant Other Cash-Based Awards to Eligible Individuals in such amounts, on such terms and conditions, and for such consideration, including no consideration or such minimum consideration as may be required by applicable law, as it shall determine in its sole discretion. Other Cash-Based Awards may be granted subject to the satisfaction of vesting conditions or may be awarded purely as a bonus and not subject to restrictions or conditions, and if subject to vesting conditions, the Committee may accelerate the vesting of such Awards at any time in its sole discretion. The grant of an Other Cash-Based Award shall not require a segregation of any of the Company’s assets for satisfaction of the Company’s payment obligation thereunder.
ARTICLE XII
CHANGE IN CONTROL PROVISIONS
12.1    Benefits. In the event of a Change in Control of the Company (as defined below), and except as otherwise provided by the Committee in an Award Agreement, a Participant’s unvested Award shall not vest automatically and a Participant’s Award shall be treated in accordance with one or more of the following methods as determined by the Committee:
(a)    Awards, whether or not then vested, shall be continued, assumed, or have new rights substituted therefor, as determined by the Committee in a manner consistent with the requirements of Section 409A of the Code, and restrictions to which shares of Restricted Stock or any other Award granted prior to the Change in Control are subject shall not lapse upon a Change in Control and the Restricted Stock or other Award shall, where appropriate in the sole discretion of the Committee, receive the same distribution as other Common Stock on such terms as determined by the Committee; provided that the Committee may decide to


Exhibit 10.1
award additional Restricted Stock or other Awards in lieu of any cash distribution. Notwithstanding anything to the contrary herein, for purposes of Incentive Stock Options, any assumed or substituted Stock Option shall comply with the requirements of Treasury Regulation Section 1.424-1 (and any amendment thereto).
(b)    The Committee, in its sole discretion, may provide for the purchase of any Awards by the Company or an Affiliate for an amount of cash equal to the excess (if any) of the Change in Control Price (as defined below) of the shares of Common Stock covered by such Awards, over the aggregate exercise price of such Awards. For purposes hereof, “Change in Control Price” shall mean the highest price per share of Common Stock paid in any transaction related to a Change in Control of the Company.
(c)    The Committee may, in its sole discretion, terminate all outstanding and unexercised Stock Options, Stock Appreciation Rights, or any Other Stock-Based Award that provides for a Participant elected exercise, effective as of the date of the Change in Control, by delivering notice of termination to each Participant at least twenty (20) days prior to the date of consummation of the Change in Control, in which case during the period from the date on which such notice of termination is delivered to the consummation of the Change in Control, each such Participant shall have the right to exercise in full all of such Participant’s Awards that are then outstanding (without regard to any limitations on exercisability otherwise contained in the Award Agreements), but any such exercise shall be contingent on the occurrence of the Change in Control, and, provided that, if the Change in Control does not take place within a specified period after giving such notice for any reason whatsoever, the notice and exercise pursuant thereto shall be null and void.
(d)    Notwithstanding any other provision herein to the contrary, the Committee may, in its sole discretion, provide for accelerated vesting or lapse of restrictions, of an Award at any time.
12.2    Change in Control. Unless otherwise determined by the Committee in the applicable Award Agreement or other written agreement with a Participant approved by the Committee, a “Change in Control” shall be deemed to occur if:
(a)     any “person,” as such term is used in Sections 13(d) and 14(d) of the Exchange Act (other than the Company, any trustee or other fiduciary holding securities under any employee benefit plan of the Company, PCP Managers, L.P., a Delaware limited partnership, or Anthony Hsieh or any of their respective affiliates, or any company owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of the Company’s then outstanding voting securities), becoming the beneficial owner (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing 50% or more of the combined voting power of the Company’s then outstanding voting securities other than pursuant to a transaction that would not be a Change in Control pursuant to Section 12.2(b) below;
(b)    a merger or consolidation of the Company or a Subsidiary with any other entity, other than (i) a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than 50% of the combined voting power of the voting securities of the Company or such surviving entity or its ultimate parent company outstanding immediately after such merger or


Exhibit 10.1
consolidation in substantially the same proportions as prior to such merger or consolidation, or (ii) a merger or consolidation effected to implement a recapitalization of the Company (or similar transaction) in which no Person (other than those covered by the exceptions in Section 0 acquires more than 50% of the combined voting power of the Company’s then outstanding securities;
(c)    at any time, Incumbent Directors cease to constitute a majority of the Board. For this purpose, “Incumbent Director” means each member of the Board on the Effective Date and each person whose election or nomination for election to the Board is approved by a majority of the Incumbent Directors; provided that any person elected or nominated for election as the result of an actual or threatened proxy contest will not be considered to be an Incumbent Director. Notwithstanding the foregoing, for purposes of the Plan, the occurrence of the Registration Date or any change in the composition of the Board within one year following the Registration Date shall not be considered a Change in Control; or
(d)    a complete liquidation or dissolution of the Company or the consummation of a sale or disposition by the Company of all or substantially all of the Company’s assets (in one or a series of related transactions)(which for this purpose shall mean total assets which represent at least 70% or more of the total fair market value of the assets of the Company and its Subsidiaries on a consolidated basis) other than the sale or disposition of all or substantially all of the assets (in one or a series of related transactions)(which for this purpose shall mean total assets which represent at least 70% or more of the total fair market value of the assets of the Company and its Subsidiaries on a consolidated basis to a Person or Persons who beneficially own, directly or indirectly, 50% or more of the combined voting power of the outstanding voting securities of the Company at the time of the sale.
Notwithstanding the foregoing, with respect to any Award that is characterized as “nonqualified deferred compensation” within the meaning of Section 409A of the Code, an event shall not be considered to be a Change in Control under the Plan for purposes of payment of such Award unless such event is also a “change in ownership,” a “change in effective control” or a “change in the ownership of a substantial portion of the assets” of the Company within the meaning of Section 409A of the Code.
12.3    Initial Public Offering not a Change in Control. Notwithstanding the foregoing, for purposes of the Plan, the occurrence of the Registration Date or any change in the composition of the Board within one year following the Registration Date shall not be considered a Change in Control.
ARTICLE XIII
TERMINATION OR AMENDMENT OF PLAN
Notwithstanding any other provision of the Plan, the Board may at any time, and from time to time, amend, in whole or in part, any or all of the provisions of the Plan (including any amendment deemed necessary to ensure that the Company may comply with any regulatory requirement referred to in Article XV or Section 409A of the Code), or suspend or terminate it entirely, retroactively or otherwise; provided, however, that, unless otherwise required by law or specifically provided herein, the rights of a Participant with respect to Awards granted prior to such amendment, suspension or termination, may not be impaired without the consent of such Participant and, provided further, that without the approval of the holders of the Company’s Common Stock entitled to vote in accordance with applicable law, no amendment may be made that would (i) increase the aggregate number of shares of Common Stock that may be issued under the Plan (except by operation of Section 4.2); (ii) increase the maximum individual


Exhibit 10.1
Participant limitations for a fiscal year under Section 4.1(b) (except by operation of Section 4.2); (iii) change the classification of individuals eligible to receive Awards under the Plan; (iv) decrease the minimum option price of any Stock Option or Stock Appreciation Right; (v) extend the maximum option period under Section 6.4; (vii) award any Stock Option or Stock Appreciation Right in replacement of a canceled Stock Option or Stock Appreciation Right with a higher exercise price than the replacement award; or (viii) require stockholder approval in order for the Plan to continue to comply with the applicable provisions of Section 422 of the Code. In no event may the Plan be amended without the approval of the stockholders of the Company in accordance with the applicable laws of the State of Delaware to increase the aggregate number of shares of Common Stock that may be issued under the Plan, decrease the minimum exercise price of any Award, or to make any other amendment that would require stockholder approval under Financial Industry Regulatory Authority (FINRA) rules and regulations or the rules of any exchange or system on which the Company’s securities are listed or traded at the request of the Company. Notwithstanding anything herein to the contrary, the Board may amend the Plan or any Award Agreement at any time without a Participant’s consent to comply with applicable law including Section 409A of the Code. The Committee may amend the terms of any Award theretofore granted, prospectively or retroactively, but, subject to Article IV or as otherwise specifically provided herein, no such amendment or other action by the Committee shall impair the rights of any holder without the holder’s consent.
ARTICLE XIV
UNFUNDED STATUS OF PLAN
The Plan is intended to constitute an “unfunded” plan for incentive and deferred compensation. With respect to any payment as to which a Participant has a fixed and vested interest but which are not yet made to a Participant by the Company, nothing contained herein shall give any such Participant any right that is greater than those of a general unsecured creditor of the Company.
ARTICLE XV
GENERAL PROVISIONS
15.1    Legend. The Committee may require each Person receiving shares of Common Stock pursuant to a Stock Option or other Award under the Plan to represent to and agree with the Company in writing that the Participant is acquiring the shares without a view to distribution thereof. In addition to any legend required by the Plan, the certificates for such shares may include any legend that the Committee deems appropriate to reflect any restrictions on Transfer. All certificates for shares of Common Stock delivered under the Plan shall be subject to such stop transfer orders and other restrictions as the Committee may deem advisable under the rules, regulations and other requirements of the Securities and Exchange Commission, any stock exchange upon which the Common Stock is then listed or any national securities exchange system upon whose system the Common Stock is then quoted, any applicable federal or state securities law, and any applicable corporate law, and the Committee may cause a legend or legends to be put on any such certificates to make appropriate reference to such restrictions.
15.2    Other Plans. Nothing contained in the Plan shall prevent the Board from adopting other or additional compensation arrangements, subject to stockholder approval if such approval is required, and such arrangements may be either generally applicable or applicable only in specific cases.
15.3    No Right to Employment/Directorship/Consultancy. Neither the Plan nor the grant of any Option or other Award hereunder shall give any Participant or other employee, Consultant or Non-


Exhibit 10.1
Employee Director any right with respect to continuance of employment, consultancy or directorship by the Company or any Affiliate, nor shall there be a limitation in any way on the right of the Company or any Affiliate by which an employee is employed or a Consultant or Non-Employee Director is retained to terminate such employment, consultancy or directorship at any time.
15.4    Withholding of Taxes. The Company, or an Affiliate, as applicable, shall have the right to deduct from any payment to be made pursuant to the Plan, or to otherwise require, prior to the issuance or delivery of shares of Common Stock or the payment of any cash hereunder, payment by the Participant of, any federal, state or local taxes required by law to be withheld. Upon the vesting of Restricted Stock (or other Award that is taxable upon vesting), or upon making an election under Section 83(b) of the Code, a Participant shall pay all required withholding to the Company. Any minimum statutorily required withholding obligation with regard to any Participant may be satisfied, subject to the consent of the Committee, by reducing the number of shares of Common Stock otherwise deliverable or by delivering shares of Common Stock already owned. Furthermore, at the discretion of the Committee, any additional tax obligations of a Participant with respect to an Award may be satisfied by further reducing the number of shares of Common Stock, otherwise deliverable with respect to such Award, to the extent that such reductions do not result in any adverse accounting implications to the Company, as determined by the Committee. Any fraction of a share of Common Stock required to satisfy any such tax obligations shall be disregarded and the amount due shall be paid instead in cash by the Participant.
15.5    No Assignment of Benefits. No Award or other benefit payable under the Plan shall, except as otherwise specifically provided by law or permitted by the Committee, be Transferable in any manner, and any attempt to Transfer any such benefit shall be void, and any such benefit shall not in any manner be liable for or subject to the debts, contracts, liabilities, engagements or torts of any Person who shall be entitled to such benefit, nor shall it be subject to attachment or legal process for or against such Person.
15.6    Listing and Other Conditions.
(a)    Unless otherwise determined by the Committee, as long as the Common Stock is listed on a national securities exchange or system sponsored by a national securities association, the issuance of shares of Common Stock pursuant to an Award shall be conditioned upon such shares being listed on such exchange or system. The Company shall have no obligation to issue such shares unless and until such shares are so listed, and the right to exercise any Option or other Award with respect to such shares shall be suspended until such listing has been effected.
(b)    If at any time counsel to the Company shall be of the opinion that any sale or delivery of shares of Common Stock pursuant to an Option or other Award is or may in the circumstances be unlawful or result in the imposition of excise taxes on the Company under the statutes, rules or regulations of any applicable jurisdiction, the Company shall have no obligation to make such sale or delivery, or to make any application or to effect or to maintain any qualification or registration under the Securities Act or otherwise, with respect to shares of Common Stock or Awards, and the right to exercise any Option or other Award shall be suspended until, in the opinion of said counsel, such sale or delivery shall be lawful or will not result in the imposition of excise taxes on the Company.
(c)    Upon termination of any period of suspension under this Section 15.6, any Award affected by such suspension which shall not then have expired or terminated shall be reinstated as to all


Exhibit 10.1
shares available before such suspension and as to shares which would otherwise have become available during the period of such suspension, but no such suspension shall extend the term of any Award.
(d)    A Participant shall be required to supply the Company with certificates, representations and information that the Company requests and otherwise cooperate with the Company in obtaining any listing, registration, qualification, exemption, consent or approval the Company deems necessary or appropriate.
15.7    Governing Law. The Plan and actions taken in connection herewith shall be governed and construed in accordance with the laws of the State of Delaware (regardless of the law that might otherwise govern under applicable Delaware principles of conflict of laws).
15.8    Jurisdiction; Waiver of Jury Trial. Any suit, action or proceeding with respect to the Plan or any Award Agreement, or any judgment entered by any court of competent jurisdiction in respect of any thereof, shall be resolved only in the courts of the State of Delaware or the United States District Court for the District of Delaware and the appellate courts having jurisdiction of appeals in such courts. In that context, and without limiting the generality of the foregoing, the Company and each Participant shall irrevocably and unconditionally (a) submit in any proceeding relating to the Plan or any Award Agreement, or for the recognition and enforcement of any judgment in respect thereof (a “Proceeding”), to the exclusive jurisdiction of the courts of the State of Delaware, the court of the United States of America for the District of Delaware, and appellate courts having jurisdiction of appeals from any of the foregoing, and agree that all claims in respect of any such Proceeding shall be heard and determined in such Delaware State court or, to the extent permitted by law, in such federal court, (b) consent that any such Proceeding may and shall be brought in such courts and waives any objection that the Company and each Participant may now or thereafter have to the venue or jurisdiction of any such Proceeding in any such court or that such Proceeding was brought in an inconvenient court and agree not to plead or claim the same, (c) waive all right to trial by jury in any Proceeding (whether based on contract, tort or otherwise) arising out of or relating to the Plan or any Award Agreement, (d) agree that service of process in any such Proceeding may be effected by mailing a copy of such process by registered or certified mail (or any substantially similar form of mail), postage prepaid, to such party, in the case of a Participant, at the Participant’s address shown in the books and records of the Company or, in the case of the Company, at the Company’s principal offices, attention General Counsel, and (e) agree that nothing in the Plan shall affect the right to effect service of process in any other manner permitted by the laws of the State of Delaware.
15.9    Construction. Wherever any words are used in the Plan in the masculine gender they shall be construed as though they were also used in the feminine gender in all cases where they would so apply, and wherever words are used herein in the singular form they shall be construed as though they were also used in the plural form in all cases where they would so apply.
15.10    Other Benefits. No Award granted or paid out under the Plan shall be deemed compensation for purposes of computing benefits under any retirement plan of the Company or its Affiliates nor affect any benefit under any other benefit plan now or subsequently in effect under which the availability or amount of benefits is related to the level of compensation.
15.11    Costs. The Company shall bear all expenses associated with administering the Plan, including expenses of issuing Common Stock pursuant to Awards hereunder.


Exhibit 10.1
15.12    No Right to Same Benefits. The provisions of Awards need not be the same with respect to each Participant, and such Awards to individual Participants need not be the same in subsequent years.
15.13    Death/Disability. The Committee may in its discretion require the transferee of a Participant to supply it with written notice of the Participant’s death or Disability and to supply it with a copy of the will (in the case of the Participant’s death) or such other evidence as the Committee deems necessary to establish the validity of the transfer of an Award. The Committee may also require that the agreement of the transferee to be bound by all of the terms and conditions of the Plan.
15.14    Section 16(b) of the Exchange Act. All elections and transactions under the Plan by Persons subject to Section 16 of the Exchange Act involving shares of Common Stock are intended to comply with any applicable exemptive condition under Rule 16b-3. The Committee may establish and adopt written administrative guidelines, designed to facilitate compliance with Section 16(b) of the Exchange Act, as it may deem necessary or proper for the administration and operation of the Plan and the transaction of business thereunder.
15.15    Section 409A of the Code. The Plan is intended to comply with the applicable requirements of Section 409A of the Code and shall be limited, construed and interpreted in accordance with such intent. To the extent that any Award is subject to Section 409A of the Code, it shall be paid in a manner that will comply with Section 409A of the Code, including proposed, temporary or final regulations or any other guidance issued by the Secretary of the Treasury and the Internal Revenue Service with respect thereto. Notwithstanding anything herein to the contrary, any provision in the Plan that is inconsistent with Section 409A of the Code shall be deemed to be amended to comply with Section 409A of the Code and to the extent such provision cannot be amended to comply therewith, such provision shall be null and void. The Company shall have no liability to a Participant, or any other party, if an Award that is intended to be exempt from, or compliant with, Section 409A of the Code is not so exempt or compliant or for any action taken by the Committee or the Company and, in the event that any amount or benefit under the Plan becomes subject to penalties under Section 409A of the Code, responsibility for payment of such penalties shall rest solely with the affected Participants and not with the Company. Notwithstanding any contrary provision in the Plan or Award Agreement, any payment(s) of “nonqualified deferred compensation” (within the meaning of Section 409A of the Code) that are otherwise required to be made under the Plan to a “specified employee” (as defined under Section 409A of the Code) as a result of such employee’s separation from service (other than a payment that is not subject to Section 409A of the Code) shall be delayed for the first six (6) months following such separation from service (or, if earlier, the date of death of the specified employee) and shall instead be paid (in a manner set forth in the Award Agreement) upon expiration of such delay period.
15.16    Successor and Assigns. The Plan shall be binding on all successors and permitted assigns of a Participant, including, without limitation, the estate of such Participant and the executor, administrator or trustee of such estate.
15.17    Severability of Provisions. If any provision of the Plan shall be held invalid or unenforceable, such invalidity or unenforceability shall not affect any other provisions hereof, and the Plan shall be construed and enforced as if such provisions had not been included.
15.18    Payments to Minors, Etc. Any benefit payable to or for the benefit of a minor, an incompetent Person or other Person incapable of receipt thereof shall be deemed paid when paid to such Person’s guardian or to the party providing or reasonably appearing to provide for the care of such


Exhibit 10.1
Person, and such payment shall fully discharge the Committee, the Board, the Company, its Affiliates and their employees, agents and representatives with respect thereto.
15.19    Lock-Up Agreement. As a condition to the grant of an Award, if requested by the Company and the lead underwriter of any public offering of the Common Stock (the “Lead Underwriter”), a Participant shall irrevocably agree not to sell, contract to sell, grant any option to purchase, transfer the economic risk of ownership in, make any short sale of, pledge or otherwise transfer or dispose of, any interest in any Common Stock or any securities convertible into, derivative of, or exchangeable or exercisable for, or any other rights to purchase or acquire Common Stock (except Common Stock included in such public offering or acquired on the public market after such offering) during such period of time following the effective date of a registration statement of the Company filed under the Securities Act that the Lead Underwriter shall specify (the “Lock-Up Period”). The Participant shall further agree to sign such documents as may be requested by the Lead Underwriter to effect the foregoing and agree that the Company may impose stop-transfer instructions with respect to Common Stock acquired pursuant to an Award until the end of such Lock-Up Period.
15.20    Headings and Captions. The headings and captions herein are provided for reference and convenience only, shall not be considered part of the Plan, and shall not be employed in the construction of the Plan.
15.21    Company Recoupment of Awards. A Participant’s rights with respect to any Award hereunder shall in all events be subject to (i) any right that the Company may have under any Company recoupment policy or other agreement or arrangement with a Participant, or (ii) any right or obligation that the Company may have to the extent required by applicable law or as required by an stock exchange or quotation system in which the Common Stock is listed or quoted including by not limited to but not limited to Section 304 of the Sarbanes-Oxley Act of 2002 and Section 10D of the Exchange Act, and any other applicable rules and regulations promulgated thereunder from time to time by the U.S. Securities and Exchange Commission.
ARTICLE XVI
EFFECTIVE DATE OF PLAN
The Plan shall become effective on the date that is two days immediately prior to the Registration Date subject to the approval of the Plan by the stockholders of the Company in accordance with the requirements of the laws of the State of Delaware.
ARTICLE XVII
TERM OF PLAN
No Award shall be granted pursuant to the Plan on or after the tenth anniversary of the earlier of the date that the Plan is adopted or the date of stockholder approval, but Awards granted prior to such tenth anniversary may extend beyond that date.
ARTICLE XVIII
NAME OF PLAN
The Plan shall be known as the “loanDepot 2021 Omnibus Incentive Plan.”

Exhibit 10.3
RESTRICTED STOCK UNIT AWARD AGREEMENT
PURSUANT TO THE
LOANDEPOT, INC. 2022 INDUCEMENT PLAN

* * * * *

Participant:

Grant Date:

Number of Restricted Stock Units Granted:

* * * * *

THIS RESTRICTED STOCK UNIT AWARD AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between loanDepot, Inc., a corporation organized in the State of Delaware (the “Company”), and the Participant specified above, pursuant to the loanDepot, Inc. 2022 Inducement Plan, as in effect and as amended from time to time (the “Plan”), which is administered by the Compensation Committee of the Board of Directors of the Company (the “Committee”); and

WHEREAS, it has been determined under the Plan that it would be in the best interests of the Company to grant the Restricted Stock Units (“RSUs”) provided herein to the Participant.

NOW, THEREFORE, in consideration of the mutual covenants and promises hereinafter set forth and for other good and valuable consideration, the parties hereto hereby mutually covenant and agree as follows:

1.Incorporation By Reference; Plan Document Receipt. This Agreement is subject in all respects to the terms and provisions of the Plan (including, without limitation, any amendments thereto adopted at any time and from time to time, unless such amendments are expressly intended not to apply to the Award provided hereunder), all of which terms and provisions are made a part of and incorporated in this Agreement as if they were each expressly set forth herein. Any capitalized term not defined in this Agreement shall have the same meaning as is ascribed thereto in the Plan. The Participant hereby acknowledges receipt of a true copy of the Plan and that the Participant has read the Plan carefully and fully understands its content.

2.Grant of Restricted Stock Unit Award. The Company hereby grants to the Participant, as of the Grant Date specified above, the number of RSUs specified above. Except as otherwise provided by the Plan, the Participant agrees and understands that nothing contained in this Agreement provides, or is intended to provide, the Participant with any protection against potential future dilution of the Participant’s interest in the Company for any reason, and no adjustments shall be made for dividends in cash or other property, distributions or other rights in respect of the shares of Common Stock underlying the RSUs, except as otherwise specifically provided for in the Plan or this Agreement.
- 1 -

Exhibit 10.3
3.Vesting.
(a)Subject to the provisions of Sections 3(b) and 3(c) hereof, and subject to the provisions of the Participant’s executive employment agreement with the Company (the “Executive Employment Agreement”), the RSUs subject to this Award shall become vested as follows, provided that the Participant has not incurred a Termination prior to the applicable vesting date.
Vesting DateNumber of RSUs
There shall be no proportionate or partial vesting in the periods prior to each vesting date and all vesting shall occur only on the appropriate vesting date, subject to the Participant’s continued service with the Company or any of its Subsidiaries on each applicable vesting date (except as otherwise set forth in Section 3(b) or 3(c) hereof or in the Executive Employment Agreement).
(b)Committee Discretion to Accelerate Vesting. Notwithstanding the foregoing, the Committee may, in its sole discretion, provide for accelerated vesting of the RSUs at any time and for any reason.
(c)Forfeiture. Subject to the Committee’s discretion to accelerate vesting hereunder and the terms of Participant’s Executive Employment Agreement, all unvested RSUs shall be immediately forfeited upon the Participant’s Termination for any reason (other than, for the avoidance of doubt, (i) a Termination by reason of death or Disability or (ii) a Covered Termination that occurs during the CIC Protection Period (as each term is defined in the Executive Employment Agreement), which Terminations in each case are covered by the terms of the Executive Employment Agreement).

4.Delivery of Shares.

(a)General. Subject to the provisions of Sections 4(b) and 8 hereof, within thirty (30) days following the vesting of the RSUs, the Participant shall receive the number of shares of Common Stock that correspond to the number of RSUs that have become vested on the applicable vesting date.

(b)Blackout Periods. If the Participant is subject to any Company “blackout” policy or other trading restriction imposed by the Company on the date such distribution would otherwise be made pursuant to Section 3(a) hereof, such distribution shall be instead made on the earlier of (i) the date that the Participant is not subject to any such policy or restriction and (ii) the later of (A) the end of the calendar year in which such distribution would otherwise have been made and (B) a date that is immediately prior to the expiration of two and one-half months following the date such distribution would otherwise have been made hereunder.

5.Dividends; Rights as Stockholder. Cash dividends on shares of Common Stock issuable hereunder shall be credited to a dividend book entry account on behalf of the Participant with respect to each RSU granted to the Participant, provided that such cash dividends shall not be deemed to be reinvested in shares of Common Stock and shall be held uninvested and without interest and paid in cash at the same time that the shares of Common Stock (or cash payments, if applicable) underlying the RSUs are delivered to the Participant in accordance with the provisions hereof. Stock dividends on shares of Common Stock shall be credited to a dividend book entry
- 2 -

Exhibit 10.3
account on behalf of the Participant with respect to each RSU granted to the Participant, provided, that such stock dividends shall be paid in shares of Common Stock at the same time that the shares of Common Stock underlying the RSUs are delivered to the Participant in accordance with the provisions hereof. Except as otherwise provided herein, the Participant shall have no rights as a stockholder with respect to any shares of Common Stock covered by any RSU unless and until the Participant has become the holder of record of such shares.

6.Non-Transferability. No portion of the RSUs may be sold, assigned, transferred, encumbered, hypothecated or pledged by the Participant, other than to the Company as a result of forfeiture of the RSUs as provided herein, unless and until payment is made in respect of vested RSUs in accordance with the provisions hereof and the Participant has become the holder of record of the vested shares of Common Stock issuable hereunder.

7.Governing Law. All questions concerning the construction, validity and interpretation of this Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, without regard to the choice of law principles thereof.

8.Withholding of Tax. The Company shall have the power and the right to deduct or withhold, or require the Participant to remit to the Company, an amount sufficient to satisfy any federal, state, local and foreign taxes of any kind (including, but not limited to, the Participant’s FICA and SDI obligations) which the Company, in its sole discretion, deems necessary to be withheld or remitted to comply with the Code and/or any other applicable law, rule or regulation with respect to the RSUs and, if the Participant fails to do so, the Company may otherwise refuse to issue or transfer any shares of Common Stock otherwise required to be issued pursuant to this Agreement. Any minimum statutorily required withholding obligation with regard to the Participant or any additional tax obligation with regard to the Participant that does not result in any adverse accounting implications to the Company may, with the consent of the Independent Compensation Committee (not to be unreasonably withheld), be satisfied by reducing the amount of cash or shares of Common Stock otherwise deliverable to the Participant hereunder.

9.Legend. The Company may at any time place legends referencing any applicable federal, state or foreign securities law restrictions on all certificates representing shares of Common Stock issued pursuant to this Agreement. The Participant shall, at the request of the Company, promptly present to the Company any and all certificates representing shares of Common Stock acquired pursuant to this Agreement in the possession of the Participant in order to carry out the provisions of this Section 9.

10.Securities Representations. This Agreement is being entered into by the Company in reliance upon the following express representations and warranties of the Participant. The Participant hereby acknowledges, represents and warrants that:

(a)The Participant has been advised that the Participant may be an “affiliate” within the meaning of Rule 144 under the Securities Act and in this connection the Company is relying in part on the Participant’s representations set forth in this Section 10.

(b)If the Participant is deemed an affiliate within the meaning of Rule 144 of the Securities Act, then the shares of Common Stock issuable hereunder must be held indefinitely unless an exemption from any applicable resale restrictions is available or the Company files an additional registration statement (or a “re-offer prospectus”) with regard to such shares of Common Stock and the Company is under no obligation to register such shares of Common Stock (or to file a “re- offer prospectus”).

(c)If the Participant is deemed an affiliate within the meaning of Rule 144 of the Securities Act, then the Participant understands that (i) the exemption from registration under Rule 144 will not be available unless (A) a public trading market then exists for the Common Stock of
- 3 -

Exhibit 10.3
the Company, (B) adequate information concerning the Company is then available to the public, and (C) other terms and conditions of Rule 144 or any exemption therefrom are complied with, and (ii) any sale of the shares of Common Stock issuable hereunder may be made only in limited amounts in accordance with the terms and conditions of Rule 144 or any exemption therefrom.

11.Entire Agreement; Amendment. This Agreement, together with the Plan and the Executive Employment Agreement, contains the entire agreement between the parties hereto with respect to the subject matter contained herein, and supersedes all prior agreements or prior understandings, whether written or oral, between the parties relating to such subject matter. The Committee shall have the right, in its sole discretion, to modify or amend this Agreement from time to time in accordance with and as provided in the Plan. This Agreement may also be modified or amended by a writing signed by both the Company and the Participant. The Company shall give written notice to the Participant of any such modification or amendment of this Agreement as soon as practicable after the adoption thereof. In the event of any conflict between the terms of the Plan and this Agreement or the Executive Employment Agreement, as applicable, the terms of this Agreement or the Executive Employment Agreement, as applicable, will govern.

12.Notices. Any notice hereunder by the Participant shall be given to the Company in writing and such notice shall be deemed duly given only upon receipt thereof by the General Counsel of the Company. Any notice hereunder by the Company shall be given to the Participant in writing and such notice shall be deemed duly given only upon receipt thereof at such address as the Participant may have on file with the Company.

13.No Right to Employment. Any questions as to whether and when there has been a Termination and the cause of such Termination shall be determined in the sole discretion of the Committee. Nothing in this Agreement shall interfere with or limit in any way the right of the Company, its Subsidiaries or its Affiliates to terminate the Participant’s employment or service at any time, for any reason and with or without Cause.

14.Transfer of Personal Data. The Participant authorizes, agrees and unambiguously consents to the transmission by the Company (or any Subsidiary) of any personal data information related to the RSUs awarded under this Agreement for legitimate business purposes (including, without limitation, the administration of the Plan). This authorization and consent is freely given by the Participant.

15.Compliance with Laws. The grant of RSUs and the issuance of shares of Common Stock hereunder shall be subject to, and shall comply with, any applicable requirements of any foreign and U.S. federal and state securities laws, rules and regulations (including, without limitation, the provisions of the Securities Act, the Exchange Act and in each case any respective rules and regulations promulgated thereunder) and any other law, rule regulation or exchange requirement applicable thereto. The Company shall not be obligated to issue the RSUs or any shares of Common Stock pursuant to this Agreement if any such issuance would violate any such requirements. As a condition to the settlement of the RSUs, the Company may require the Participant to satisfy any qualifications that may be necessary or appropriate to evidence compliance with any applicable law or regulation.

16.Section 409A. Notwithstanding anything herein or in the Plan to the contrary, the RSUs are intended to be exempt from the applicable requirements of Section 409A of the Code and shall be limited, construed and interpreted in accordance with such intent.

17.Binding Agreement; Assignment. This Agreement shall inure to the benefit of, be binding upon, and be enforceable by the Company and its successors and assigns. The Participant shall not assign (except in accordance with Section 6 hereof) all or any part of this Agreement without the prior written consent of the Company.

- 4 -

Exhibit 10.3
18.Headings. The titles and headings of the various sections of this Agreement have been inserted for convenience of reference only and shall not be deemed to be a part of this Agreement.

19.Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original, but all of which shall constitute one and the same instrument.

20.Electronic Signatures. The parties acknowledge and agree that this Agreement may be executed by electronic signature, which shall be considered as an original signature for all purposes and shall have the same force and effect as an original signature. Without limitation, “electronic signature” shall include faxed versions of an original signature or electronically scanned and transmitted versions (e.g., via pdf) of an original signature.

21.Further Assurances. Each party hereto shall do and perform (or shall cause to be done and performed) all such further acts and shall execute and deliver all such other agreements, certificates, instruments and documents as either party hereto reasonably may request in order to carry out the intent and accomplish the purposes of this Agreement and the Plan and the consummation of the transactions contemplated hereunder.

22.Severability. The invalidity or unenforceability of any provisions of this Agreement in any jurisdiction shall not affect the validity, legality or enforceability of the remainder of this Agreement in such jurisdiction or the validity, legality or enforceability of any provision of this Agreement in any other jurisdiction, it being intended that all rights and obligations of the parties hereunder shall be enforceable to the fullest extent permitted by law.

23.Acquired Rights. The Participant acknowledges and agrees that: (a) the Company may terminate or amend the Plan at any time; (b) the Award of RSUs made under this Agreement is completely independent of any other award or grant and is made at the sole discretion of the Company; (c) no past grants or awards (including, without limitation, the RSUs awarded hereunder) give the Participant any right to any grants or awards in the future whatsoever; and (d) any benefits granted under this Agreement are not part of the Participant’s ordinary salary, and shall not be considered as part of such salary in the event of severance, redundancy or resignation.

* * * * *
- 5 -

Exhibit 10.3
IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first written above.

LOANDEPOT, INC.

By:     Name:
Title:

PARTICIPANT


image_0.jpg
    [Name]




Exhibit 10.4
PERFORMANCE AWARD AGREEMENT
PURSUANT TO THE
LOANDEPOT, INC. 2022 INDUCEMENT PLAN

* * * * *

Participant:

Grant Date:

Target Number of Performance Share Units to be Granted:

* * * * *

THIS PERFORMANCE AWARD AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between loanDepot, Inc., a corporation organized in the State of Delaware (the “Company”), and the Participant specified above, pursuant to the loanDepot, Inc. 2022 Inducement Plan, as in effect and as amended from time to time (the “Plan”), which is administered by the Compensation Committee of the Board of Directors of the Company (the “Committee”); and

WHEREAS, it has been determined under the Plan that it would be in the best interests of the Company to grant the Performance Share Units (“PSUs”) as provided herein to the Participant (“Performance Award”).

NOW, THEREFORE, in consideration of the mutual covenants and promises hereinafter set forth and for other good and valuable consideration, the parties hereto hereby mutually covenant and agree as follows:

1.Incorporation By Reference; Plan Document Receipt. This Agreement is subject in all respects to the terms and provisions of the Plan (including, without limitation, any amendments thereto adopted at any time and from time to time, unless such amendments are expressly intended not to apply to the Award provided hereunder), all of which terms and provisions are made a part of and incorporated in this Agreement as if they were each expressly set forth herein. Any capitalized term not defined in this Agreement shall have the same meaning as is ascribed thereto in the Plan. The Participant hereby acknowledges receipt of a true copy of the Plan and that the Participant has read the Plan carefully and fully understands its content.

2.Grant of Performance Award. The Company hereby grants to the Participant, as of the Grant Date specified above, the number of PSUs specified above subject to the performance targets described in Section 3(a) hereof measurable during the period commencing on the Grant Date and expiring on the _____ anniversary thereof (“Performance Period”). Except as otherwise provided by the Plan, the Participant agrees and understands that nothing contained in this Agreement provides, or is intended to provide, the Participant with any protection against potential future dilution of the Participant’s interest in the Company for any reason, and no adjustments shall be made for dividends in cash or other property, distributions or other rights in respect of the shares of Common Stock underlying the PSUs, except as otherwise specifically provided for in the Plan or this Agreement.
3.Performance Targets and Vesting.
(a)[vesting provisions to be inserted]
(b)Committee Discretion to Accelerate Vesting. Notwithstanding the foregoing, the Committee may, in its sole discretion, provide for accelerated vesting of the PSUs at any time and for any reason.
- 1 -
1



Exhibit 10.4
(c)Forfeiture. Subject to the Committee’s discretion to accelerate vesting hereunder and the terms of the Executive Employment Agreement, all unvested PSUs shall be immediately forfeited upon the Participant’s Termination for any reason (other than, for the avoidance of doubt, (i) a Termination by reason of death or Disability or (ii) a Covered Termination, regardless of whether or not it occurs during the CIC Protection Period (as each term is defined in the Executive Employment Agreement), which Terminations in each case are covered by the terms of the Executive Employment Agreement).

4.Delivery of Shares.

(a)General. Subject to the provisions of Sections 4(b) and 8 hereof, within thirty (30) days of the Vesting Date with respect to Earned PSUs, the Participant shall receive the number of shares of Common Stock that correspond to the number of Vested PSUs.

(b)Blackout Periods. If the Participant is subject to any Company “blackout” policy or other trading restriction imposed by the Company on the date such distribution would otherwise be made pursuant to Section 3(a) hereof, such distribution shall be instead made on the earlier of (i) the date that the Participant is not subject to any such policy or restriction and (ii) the later of (A) the end of the calendar year in which such distribution would otherwise have been made and (B) a date that is immediately prior to the expiration of two and one-half months following the date such distribution would otherwise have been made hereunder.

5.Dividends; Rights as Stockholder. Cash dividends on shares of Common Stock issuable hereunder shall be credited to a dividend book entry account on behalf of the Participant with respect to each PSU granted to the Participant, provided that such cash dividends shall not be deemed to be reinvested in shares of Common Stock and shall be held uninvested and without interest and paid in cash at the same time that the shares of Common Stock (or cash payments, if applicable) underlying the PSUs are delivered to the Participant in accordance with the provisions hereof. Stock dividends on shares of Common Stock shall be credited to a dividend book entry account on behalf of the Participant with respect to each PSU granted to the Participant, provided, that such stock dividends shall be paid in shares of Common Stock at the same time that the shares of Common Stock underlying the PSUs are delivered to the Participant in accordance with the provisions hereof. Except as otherwise provided herein, the Participant shall have no rights as a stockholder with respect to any shares of Common Stock covered by any PSU unless and until the Participant has become the holder of record of such shares

6.Non-Transferability. No portion of the PSUs may be sold, assigned, transferred, encumbered, hypothecated or pledged by the Participant, other than to the Company as a result of forfeiture of the PSUs as provided herein, unless and until payment is made in respect of Vested PSUs in accordance with the provisions hereof and the Participant has become the holder of record of the vested shares of Common Stock issuable hereunder.

7.Governing Law. All questions concerning the construction, validity and interpretation of this Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, without regard to the choice of law principles thereof.

8.Withholding of Tax. The Company shall have the power and the right to deduct or withhold, or require the Participant to remit to the Company, an amount sufficient to satisfy any federal, state, local and foreign taxes of any kind (including, but not limited to, the Participant’s FICA and SDI obligations) which the Company, in its sole discretion, deems necessary to be withheld or remitted to comply with the Code and/or any other applicable law, rule or regulation with respect to the PSUs and, if the Participant fails to do so, the Company may otherwise refuse to issue or transfer any shares of Common Stock otherwise required to be issued pursuant to this Agreement. Any minimum statutorily required withholding obligation with regard to the Participant or any additional tax obligation with regard to the Participant that does not result in any adverse accounting implications to the Company may, with the consent of the Independent
- 2 -
1



Exhibit 10.4
Compensation Committee (not to be unreasonably withheld), be satisfied by reducing the amount of cash or shares of Common Stock otherwise deliverable to the Participant hereunder.

9.Legend. The Company may at any time place legends referencing any applicable federal, state or foreign securities law restrictions on all certificates representing shares of Common Stock issued pursuant to this Agreement. The Participant shall, at the request of the Company, promptly present to the Company any and all certificates representing shares of Common Stock acquired pursuant to this Agreement in the possession of the Participant in order to carry out the provisions of this Section 9.

10.Securities Representations. This Agreement is being entered into by the Company in reliance upon the following express representations and warranties of the Participant. The Participant hereby acknowledges, represents and warrants that:

(a)The Participant has been advised that the Participant may be an “affiliate” within the meaning of Rule 144 under the Securities Act and in this connection the Company is relying in part on the Participant’s representations set forth in this Section 10.

(b)If the Participant is deemed an affiliate within the meaning of Rule 144 of the Securities Act, then the shares of Common Stock issuable hereunder must be held indefinitely unless an exemption from any applicable resale restrictions is available or the Company files an additional registration statement (or a “re-offer prospectus”) with regard to such shares of Common Stock and the Company is under no obligation to register such shares of Common Stock (or to file a “re- offer prospectus”).

(c)If the Participant is deemed an affiliate within the meaning of Rule 144 of the Securities Act, then the Participant understands that (i) the exemption from registration under Rule 144 will not be available unless (A) a public trading market then exists for the Common Stock of the Company, (B) adequate information concerning the Company is then available to the public, and (C) other terms and conditions of Rule 144 or any exemption therefrom are complied with, and (ii) any sale of the shares of Common Stock issuable hereunder may be made only in limited amounts in accordance with the terms and conditions of Rule 144 or any exemption therefrom.


11.Entire Agreement; Amendment. This Agreement, together with the Plan and the Executive Employment Agreement, contains the entire agreement between the parties hereto with respect to the subject matter contained herein, and supersedes all prior agreements or prior understandings, whether written or oral, between the parties relating to such subject matter. The Committee shall have the right, in its sole discretion, to modify or amend this Agreement from time to time in accordance with and as provided in the Plan. This Agreement may also be modified or amended by a writing signed by both the Company and the Participant. The Company shall give written notice to the Participant of any such modification or amendment of this Agreement as soon as practicable after the adoption thereof. In the event of any conflict between the terms of the Plan and this Agreement or the Executive Employment Agreement, as applicable, the terms of this Agreement or the Executive Employment Agreement, as applicable, will govern.

12.Notices. Any notice hereunder by the Participant shall be given to the Company in writing and such notice shall be deemed duly given only upon receipt thereof by the General Counsel of the Company. Any notice hereunder by the Company shall be given to the Participant in writing and such notice shall be deemed duly given only upon receipt thereof at such address as the Participant may have on file with the Company.

13.No Right to Employment. Any questions as to whether and when there has been a Termination and the cause of such Termination shall be determined in the sole discretion of the Committee. Nothing in this Agreement shall interfere with or limit in any way the right of the
- 3 -
1



Exhibit 10.4
Company, its Subsidiaries or its Affiliates to terminate the Participant’s employment or service at any time, for any reason and with or without Cause.

14.Transfer of Personal Data. The Participant authorizes, agrees and unambiguously consents to the transmission by the Company (or any Subsidiary) of any personal data information related to the PSUs awarded under this Agreement for legitimate business purposes (including, without limitation, the administration of the Plan). This authorization and consent is freely given by the Participant.

15.Compliance with Laws. The grant of PSUs and the issuance of shares of Common Stock hereunder shall be subject to, and shall comply with, any applicable requirements of any foreign and U.S. federal and state securities laws, rules and regulations (including, without limitation, the provisions of the Securities Act, the Exchange Act and in each case any respective rules and regulations promulgated thereunder) and any other law, rule regulation or exchange requirement applicable thereto. The Company shall not be obligated to issue the PSUs or any shares of Common Stock pursuant to this Agreement if any such issuance would violate any such requirements. As a condition to the settlement of the PSUs, the Company may require the Participant to satisfy any qualifications that may be necessary or appropriate to evidence compliance with any applicable law or regulation.

16.Section 409A. Notwithstanding anything herein or in the Plan to the contrary, the PSUs are intended to be exempt from the applicable requirements of Section 409A of the Code and shall be limited, construed and interpreted in accordance with such intent.

17.Binding Agreement; Assignment. This Agreement shall inure to the benefit of, be binding upon, and be enforceable by the Company and its successors and assigns. The Participant shall not assign (except in accordance with Section 6 hereof) all or any part of this Agreement without the prior written consent of the Company.

18.Headings. The titles and headings of the various sections of this Agreement have been inserted for convenience of reference only and shall not be deemed to be a part of this Agreement.

19.Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original, but all of which shall constitute one and the same instrument.

20.Electronic Signatures. The parties acknowledge and agree that this Agreement may be executed by electronic signature, which shall be considered as an original signature for all purposes and shall have the same force and effect as an original signature. Without limitation, “electronic signature” shall include faxed versions of an original signature or electronically scanned and transmitted versions (e.g., via pdf) of an original signature.

21.Further Assurances. Each party hereto shall do and perform (or shall cause to be done and performed) all such further acts and shall execute and deliver all such other agreements, certificates, instruments and documents as either party hereto reasonably may request in order to carry out the intent and accomplish the purposes of this Agreement and the Plan and the consummation of the transactions contemplated hereunder.

22.Severability. The invalidity or unenforceability of any provisions of this Agreement in any jurisdiction shall not affect the validity, legality or enforceability of the remainder of this Agreement in such jurisdiction or the validity, legality or enforceability of any provision of this Agreement in any other jurisdiction, it being intended that all rights and obligations of the parties hereunder shall be enforceable to the fullest extent permitted by law.

- 4 -
1



Exhibit 10.4
23.Acquired Rights. The Participant acknowledges and agrees that: (a) the Company may terminate or amend the Plan at any time; (b) the Award of PSUs made under this Agreement is completely independent of any other award or grant and is made at the sole discretion of the Company; (c) no past grants or awards (including, without limitation, the PSUs awarded hereunder) give the Participant any right to any grants or awards in the future whatsoever; and (d) any benefits granted under this Agreement are not part of the Participant’s ordinary salary, and shall not be considered as part of such salary in the event of severance, redundancy or resignation.

* * * * *
- 5 -
1



Exhibit 10.4
IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first written above.

LOANDEPOT, INC.

By:     Name:
Title:

PARTICIPANT


image_0.jpg
    [name]    

[
Exhibit 10.5

NONQUALIFIED STOCK OPTION AGREEMENT
PURSUANT TO THE
LOANDEPOT, INC. 2022 INDUCEMENT PLAN
* * * * *
Participant:
Grant Date:
Per Share Exercise Price: $
Number of Shares of Common Stock subject to this Option:
* * * * *
This Non-Qualified Stock Option Award Agreement (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between loanDepot, Inc., a corporation organized in the State of Delaware (the “Company”), and the Participant specified above, pursuant to the loanDepot, Inc. 2022 Inducement Plan, as in effect and as amended from time to time (the “Plan”), which is administered by the Committee; and
Whereas, it has been determined under the Plan that it would be in the best interests of the Company to grant the Non-Qualified Stock Option provided for herein to the Participant.
Now, Therefore, in consideration of the mutual covenants and promises hereinafter set forth and for other good and valuable consideration, the parties hereto hereby mutually covenant and agree as follows:
1.Incorporation By Reference; Plan Document Receipt. This Agreement is subject in all respects to the terms and provisions of the Plan (including, without limitation, any amendments thereto adopted at any time and from time to time unless such amendments are expressly intended not to apply to the Award provided hereunder), all of which terms and provisions are made a part of and incorporated in this Agreement as if they were each expressly set forth herein. Any capitalized term not defined in this Agreement shall have the same meaning as is ascribed thereto in the Plan. The Participant hereby acknowledges receipt of a true copy of the Plan and that the Participant has read the Plan carefully and fully understands its content. In the event of any conflict between the terms of this Agreement and the terms of the Plan, the terms of the Agreement shall control. No part of the Option granted hereby is intended to qualify as an “incentive stock option” under Section 422 of the Code.
2.Grant of Option. The Company hereby grants to the Participant, as of the Grant Date specified above, a Non-Qualified Stock Option (this “Option”) to acquire from the Company at the Per Share Exercise Price specified above, the aggregate number of shares of Common Stock specified above (the “Option Shares”). Except as otherwise provided by the Plan, the Participant agrees and understands that nothing contained in this Agreement provides, or is intended to provide, the Participant with any protection against potential future dilution of the Participant’s interest in the Company for any reason. The Participant shall have no rights as a stockholder with respect to any shares of Common Stock covered by the Option unless and until the Participant has become the holder of record of such shares, and no adjustments shall be made for dividends in cash or other property, distributions or other rights in respect of any such shares, except as otherwise specifically provided for in the Plan or this Agreement.
3.Vesting and Exercise.
(a)Vesting. Subject to the provisions of Sections 3(b) and 3(c) hereof, and subject to the terms of the Participant’s executive employment agreement with the Company (the “Executive Employment Agreement”), the Option shall vest and become exercisable as follows, provided that the Participant has not incurred a Termination prior to the applicable vesting date:
1



Vesting DateNumber of Shares

There shall be no proportionate or partial vesting in the periods prior to each vesting date and all vesting shall occur only on the appropriate vesting date, subject to the Participant’s continued service with the Company or any of its Subsidiaries on each applicable vesting date (except as otherwise set forth in Section 3(b) hereof or in the Executive Employment Agreement). Upon expiration of the Option, the Option shall be cancelled and no longer exercisable.
(b)Committee Discretion to Accelerate Vesting. Notwithstanding the foregoing, the Committee may, in its sole discretion, provide for accelerated vesting of the Option at any time and for any reason.
(c)Expiration. Unless earlier terminated in accordance with the terms and provisions of the Plan and/or this Agreement, all portions of the Option (whether vested or not vested) shall expire and shall no longer be exercisable after the expiration of ten (10) years from the Grant Date.
4.Termination. Subject to the terms of the Plan and this Agreement, and subject to the terms of the Executive Employment Agreement, the Option, to the extent vested at the time of the Participant’s Termination, shall remain exercisable as follows:
(d)Termination due to Death or Disability. In the event of the Participant’s Termination by reason of death or Disability, the vested portion of the Option shall remain exercisable until the earlier of (i) one (1) year from the date of such Termination, and (ii) the expiration of the stated term of the Option pursuant to Section 3(d) hereof; provided, however, that in the case of a Termination due to Disability, if the Participant dies within such one (1) year exercise period, any unexercised Option held by the Participant shall thereafter be exercisable by the legal representative of the Participant’s estate, to the extent to which it was exercisable at the time of death, for a period of one (1) year from the date of death, but in no event beyond the expiration of the stated term of the Option pursuant to Section 3(d) hereof.
(e)Involuntary Termination Without Cause or Voluntary Resignation for Good Reason. In the event of the Participant’s involuntary Termination by the Company without Cause or the Participant’s voluntary Termination for Good Reason (as defined in the Executive Employment Agreement), the vested portion of the Option shall remain exercisable until the earlier of (i) one year from the date of such Termination, and (ii) the expiration of the stated term of the Option pursuant to Section 3(d) hereof.
(f)Voluntary Resignation Without Good reason. In the event of the Participant’s voluntary Termination (other than a voluntary Termination described in Sections 4(b) and 4(d) hereof), the vested portion of the Option shall remain exercisable until the earlier of (i) ninety (90) days from the date of such Termination, and (ii) the expiration of the stated term of the Option pursuant to Section 3(d) hereof.
(g)Termination for Cause. In the event of the Participant’s Termination for Cause or in the event of the Participant’s voluntary Termination (as provided in Section 4(c) hereof) after an event that would be grounds for a Termination for Cause, the Participant’s entire Option (whether or not vested) shall terminate and expire upon such Termination.
(h)Treatment of Unvested Options upon Termination. Any portion of the Option that is not vested as of the date of the Participant’s Termination for any reason shall terminate and expire as of the date of such Termination, subject to the terms of the Executive Employment Agreement (other than, for the avoidance of doubt, (i) a Termination by reason of death or Disability or (ii) a Covered Termination that occurs during the CIC Protection Period (as each term is defined in the Executive Employment Agreement), which Terminations in each case are covered by the terms of the Executive Employment Agreement).
5.Method of Exercise and Payment. Subject to Section 8 hereof, to the extent that the Option has become vested and exercisable with respect to a number of shares of Common Stock as provided herein, the Option may thereafter be exercised by the Participant, in whole or in part, at any time
2



or from time to time prior to the expiration of the Option as provided herein and in accordance with Sections 6.3(c) and 6.3(d) of the Plan, including, without limitation, by the filing of any written form of exercise notice as may be required by the Committee and payment in full of the Per Share Exercise Price specified above multiplied by the number of shares of Common Stock underlying the portion of the Option exercised.
6.Non-Transferability. The Option, and any rights and interests with respect thereto, issued under this Agreement and the Plan shall not be sold, exchanged, transferred, assigned or otherwise disposed of in any way by the Participant (or any beneficiary of the Participant), other than by testamentary disposition by the Participant or the laws of descent and distribution. Notwithstanding the foregoing, the Committee may, in its sole discretion, permit the Option to be Transferred to a Family Member for no value, provided that such Transfer shall only be valid upon execution of a written instrument in form and substance acceptable to the Committee in its sole discretion evidencing such Transfer and the transferee’s acceptance thereof signed by the Participant and the transferee, and provided, further, that the Option may not be subsequently Transferred other than by will or by the laws of descent and distribution or to another Family Member (as permitted by the Committee in its sole discretion) in accordance with the terms of the Plan and this Agreement, and shall remain subject to the terms of the Plan and this Agreement. Any attempt to sell, exchange, transfer, assign, pledge, encumber or otherwise dispose of or hypothecate in any way the Option, or the levy of any execution, attachment or similar legal process upon the Option, contrary to the terms and provisions of this Agreement and/or the Plan shall be null and void and without legal force or effect.
7.Governing Law. All questions concerning the construction, validity and interpretation of this Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, without regard to the choice of law principles thereof.
8.Withholding of Tax. The Company, or an Affiliate, as applicable, shall have the power and the right to deduct or withhold, or require the Participant to remit to the Company, or an Affiliate, as applicable, an amount sufficient to satisfy any federal, state, local and foreign taxes of any kind (including, but not limited to, the Participant’s FICA and SDI obligations) which the Company, in its sole discretion, deems necessary to be withheld or remitted to comply with the Code and/or any other applicable law, rule or regulation with respect to the Option and, if the Participant fails to do so, the Company may otherwise refuse to issue or transfer any shares of Common Stock otherwise required to be issued pursuant to this Agreement. Any minimum statutorily required withholding obligation with regard to the Participant or any additional tax obligation with regard to the Participant that does not result in any adverse accounting implications to the Company may, with the consent of the Independent Compensation Committee (not to be unreasonably withheld), be satisfied by reducing the amount of cash or shares of Common Stock otherwise deliverable upon exercise of the Option.
9.Entire Agreement; Amendment. This Agreement, together with the Plan and the Executive Employment Agreement, contains the entire agreement between the parties hereto with respect to the subject matter contained herein, and supersedes all prior agreements or prior understandings, whether written or oral, between the parties relating to such subject matter. The Committee shall have the right, in its sole discretion, to modify or amend this Agreement from time to time in accordance with and as provided in the Plan. This Agreement may also be modified or amended by a writing signed by both the Company and the Participant. The Company shall give written notice to the Participant of any such modification or amendment of this Agreement as soon as practicable after the adoption thereof.
10.Notices. Any notice hereunder by the Participant shall be given to the Company in writing and such notice shall be deemed duly given only upon receipt thereof by the General Counsel of the Company. Any notice hereunder by the Company shall be given to the Participant in writing and such notice shall be deemed duly given only upon receipt thereof at such address as the Participant may have on file with the Company.
11.No Right to Employment. Any questions as to whether and when there has been a Termination and the cause of such Termination shall be determined in the sole discretion of the Committee. Nothing in this Agreement shall interfere with or limit in any way the right of the Company, its Subsidiaries or its Affiliates to terminate the Participant’s employment or service at any time, for any reason and with or without Cause.
12.Transfer of Personal Data. The Participant authorizes, agrees and unambiguously consents to the transmission by the Company (or any Subsidiary) of any personal data information related
3



to the Option awarded under this Agreement for legitimate business purposes (including, without limitation, the administration of the Plan). This authorization and consent is freely given by the Participant.
13.Compliance with Laws. The issuance of the Option (and the Option Shares upon exercise of the Option) pursuant to this Agreement shall be subject to, and shall comply with, any applicable requirements of any foreign and U.S. federal and state securities laws, rules and regulations (including, without limitation, the provisions of the Securities Act, the Exchange Act and in each case any respective rules and regulations promulgated thereunder) and any other law or regulation applicable thereto. The Company shall not be obligated to issue the Option or any of the Option Shares pursuant to this Agreement if any such issuance would violate any such requirements.
14.Section 409A. Notwithstanding anything herein or in the Plan to the contrary, the Option is intended to be exempt from the applicable requirements of Section 409A of the Code and shall be limited, construed and interpreted in accordance with such intent.
15.Binding Agreement; Assignment. This Agreement shall inure to the benefit of, be binding upon, and be enforceable by the Company and its successors and assigns. The Participant shall not assign (except in accordance with Section 6 hereof) any part of this Agreement without the prior express written consent of the Company.
16.Headings. The titles and headings of the various sections of this Agreement have been inserted for convenience of reference only and shall not be deemed to be a part of this Agreement.
17.Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original, but all of which shall constitute one and the same instrument.
18.Further Assurances. Each party hereto shall do and perform (or shall cause to be done and performed) all such further acts and shall execute and deliver all such other agreements, certificates, instruments and documents as either party hereto reasonably may request in order to carry out the intent and accomplish the purposes of this Agreement and the Plan and the consummation of the transactions contemplated thereunder.
19.Severability. The invalidity or unenforceability of any provisions of this Agreement in any jurisdiction shall not affect the validity, legality or enforceability of the remainder of this Agreement in such jurisdiction or the validity, legality or enforceability of any provision of this Agreement in any other jurisdiction, it being intended that all rights and obligations of the parties hereunder shall be enforceable to the fullest extent permitted by law.
20.Acquired Rights. The Participant acknowledges and agrees that: (a) the Company may terminate or amend the Plan at any time; (b) the award of the Option made under this Agreement is completely independent of any other award or grant and is made at the sole discretion of the Company; (c) no past grants or awards (including, without limitation, the Option awarded hereunder) give the Participant any right to any grants or awards in the future whatsoever; and (d) any benefits granted under this Agreement are not part of the Participant’s ordinary salary, and shall not be considered as part of such salary in the event of severance, redundancy or resignation.
[Remainder of Page Intentionally Left Blank]
4



In Witness Whereof, the parties hereto have executed this Agreement as of the date first written above.
LOANDEPOT, INC.
By:    
Name:
Title:
PARTICIPANT
Name:    

5
Exhibit 10.8
EXECUTION VERSION

Certain confidential information contained in this document, marked by “[***]”, has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed
TIAA BANK
301 W. Bay Street
Jacksonville, FL 32202
loanDepot.com, LLC
26642 Towne Centre Drive
Foothill Ranch, California 92610
Attention: Patrick Flanagan
Re:    Second Amendment to Amended and Restated Master Repurchase Agreement and Amended and Restated Pricing Letter (“Second Amendment”)
This Second Amendment is made June 30, 2022, (the “Amendment Effective Date”), to that certain Amended and Restated Master Repurchase Agreement, dated November 15, 2021, as amended (the “Repurchase Agreement”) and the Amended and Restated Pricing Letter, dated November 15, 2021, as amended (the “Pricing Letter”), in each case by and among LoanDepot.com LLC, as the seller (the “Seller”), TIAA, FSB, formerly known as EverBank (“TIAA Bank”), as administrative agent (in such capacity, the “Administrative Agent”) for the Buyers and as a buyer, and Signature Bank (“Signature Bank”), as a buyer (together with TIAA Bank, the “Buyers”). The Repurchase Agreement and the Pricing Letter are sometimes hereinafter collectively referred to as the “Agreement.
WHEREAS, Seller requested that Buyers amend the Agreement as provided herein; and
WHEREAS, Seller and Buyers have agreed to so amend the Agreement.
NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree to amend the Agreement as follows:
SECTION 1.Definitions. The following terms shall have the meanings set forth below.
203K Loans” shall mean first lien Mortgage Loans that meet all the requirements for mortgage insurance issued by the Federal Housing Authority under the Section 203(k) Rehabilitation Insured Mortgage Program.
Adjusted Indebtedness” shall mean, [***]
Adjusted Net Income” shall mean [***].
Adjusted Tangible Net Worth” shall mean, [***]
Aged Jumbo Mortgage Loan” shall mean a Jumbo Mortgage Loan (Standard Limit) subject to a Transaction hereunder for [***].
Aged Mortgage Loan” shall mean a Mortgage Loan, other than a Jumbo Mortgage Loan, a Low FICO Government Loan, a 203K Loan or a Manufactured Housing Mortgage Loan, subject to a Transaction hereunder for [***].
Aged State Agency Program Loan” shall mean a State Agency Program Loan subject to a Transaction hereunder for [***].



Aging Limit” shall mean (a) [***] days following the Purchase Date for Mortgage Loans other than Aged Mortgage Loans and Jumbo Mortgage Loans (Standard Limit), and (b) [***] days following the Purchase Date for Aged Mortgage Loans and Jumbo Mortgage Loans (Standard Limit).
Annual Financial Statement Date” shall mean December 31, 2020.
Approved Mortgage Product” shall mean the following mortgage products approved by the Buyers for Transactions under the Agreement: Conforming Mortgage Loans, Eligible Government Mortgage Loans, Jumbo Mortgage Loans, Low FICO Government Loans, State Agency Program Loans, Manufactured Housing Mortgage Loans, 203K Loans, Wet Mortgage Loans and Aged Mortgage Loans. In no event shall an Ineligible Product be an Approved Mortgage Product.
Buyer’s Facility Sum” shall mean $500,000,000 with respect to TIAA Bank and $400,000,000 with respect to Signature Bank.
Cash Equivalents” shall mean [***].
Change in Control” shall mean:
(a)any event or series of events by which any “person” or “group” (as such terms are used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended), but excluding any employee benefit plan of such person or its Subsidiaries, and any person or entity acting in its capacity as trustee, agent or other fiduciary or administrator of any such plan, other than the Permitted Holders becomes the “beneficial owner” (as defined in Rules 13d-3 and 13d-5 under the Securities Exchange Act of 1934, as amended) of the equity securities of loanDepot, Inc., a Delaware corporation, entitled to vote for members of the board of directors or equivalent governing body of Seller on a fully-diluted basis; or
(b)[reserved]; or
(c)the sale, transfer, or other disposition of all or substantially all of Seller’s assets (excluding any such action taken in connection with any securitization transaction); or
(d)the consummation of a merger or consolidation of Seller with or into another entity or any other corporate reorganization (in one transaction or in a series of transactions) if more than 50% of the combined voting power of the continuing or surviving entity’s Capital Stock outstanding immediately after such merger, consolidation or such other reorganization is owned by persons who were not owners of Seller immediately prior to such merger, consolidation or other reorganization.; or
(e)Anthony Hsieh shall no longer be both (i) employed by Seller, and (ii) involved in the day to day operations of Seller.
Concentration Category” shall mean, with respect to Mortgage Loans, each category set forth under the heading “Concentration Category” in the table included in the definition of “Concentration Limit.”
Concentration Limit” shall mean, as of any date of determination, with respect to the Eligible Mortgage Loans included in any Concentration Category, the applicable
-2-


amount that the aggregate Purchase Price for such Eligible Mortgage Loans may not at any time exceed, as set forth in the below table.
Concentration CategoryConcentration Limit (percentages based on Maximum Purchase Amount)
Wet Mortgage Loans
[***]
Jumbo Mortgage Loans[***]
Jumbo Mortgage Loans
(Specialty)
[***]
Delegated Jumbo Mortgage Loans[***]
Low FICO Government Loans[***]
203K Loan[***]
State Agency Program Loans[***]
Manufactured Housing Mortgage
   Loans
[***]
Aged Mortgage Loans[***]

Conforming Mortgage Loan” shall mean a Mortgage Loan (other than a 203K Loan, a State Agency Program Loan, or a Manufactured Housing Mortgage Loan) that conforms to the requirements of an Agency for securitization or cash purchase, and which has a FICO score of [***].
Delegated Jumbo Mortgage Loans” shall mean Jumbo Mortgage Loans (Standard Limit) that are not subject to a takeout commitment from an investor.
Due Diligence Cap” shall mean [***].
Eligible Government Mortgage Loan” shall mean a Government Mortgage Loan (other than a Manufactured Housing Mortgage Loan) which has a FICO score of [***].
ERISA Liability Threshold” shall mean [***].
Fidelity Insurance Requirement” shall mean (a) [***] for fidelity coverage, with a maximum deductible of [***], and (b) [***] for errors and omissions coverage, with a maximum deductible of [***].
Financial Reporting Party” shall mean Seller.
FMV Adjustments” shall mean [***].
Ineligible Product” shall mean any mortgage product that is not an Approved Mortgage Product.
Jumbo Mortgage Loan” is a collective reference to Jumbo Mortgage Loans (Specialty), Jumbo Mortgage Loans (Standard Limit) and Delegated Jumbo Mortgage Loans.
-3-


Jumbo Mortgage Loans (High DTI)” shall mean a Mortgage Loan (i) with a principal balance of not more than [***] (ii) that except with respect to (x) the original principal balance thereof and (y) the Debt-to-Income Ratio, conforms to the requirements for securitization or cash purchase by an Agency, (iii) that has a FICO score of [***], (iv) with a Loan-to-Value Ratio [***], (v) has a Debt-to-Income Ratio [***], (vi) is fully amortizing, and (vii) that is subject to a Takeout Commitment from a Takeout Investor.
Jumbo Mortgage Loans (High LTV)” shall mean a Mortgage Loan (i) with a principal balance of not more than [***] (ii) that except with respect to (x) the original principal balance thereof and (y) the Debt-to-Income Ratio, conforms to the requirements for securitization or cash purchase by an Agency, (iii) that has a FICO score of [***], (iv) with a Loan-to-Value Ratio [***], (v) has a Debt-to-Income Ratio [***], (vi) is fully amortizing and (vii) that is subject to a Takeout Commitment from a Takeout Investor.
Jumbo Mortgage Loans (IO)” shall mean a Mortgage Loan (i) with a principal balance of not more than [***] (ii) does not amortize, (iii) that except with respect to (x) the original principal balance thereof and (y) the failure to amortize, conforms to the requirements for securitization or cash purchase by an Agency, (iv) that satisfies Administrative Agent’s underwriting guidelines for jumbo mortgage loans, (v) that has a FICO score of [***], (vi) with a Loan-to-Value Ratio of [***], and (vii) that is subject to a Takeout Commitment from a Takeout Investor.
Jumbo Mortgage Loans (40 Year IO)” shall mean a Mortgage Loan (i) with a principal balance of not more than [***] (ii) does not amortize, (iii) that except with respect to (x) the original principal balance thereof and (y) the failure to amortize, conforms to the requirements for securitization or cash purchase by an Agency, (iv) that satisfies Administrative Agent’s underwriting guidelines for jumbo mortgage loans, (v) that has a FICO score of [***], (vi) with a Loan-to-Value Ratio of [***], (vii) has a term [***], and (viii) that is subject to a Takeout Commitment from a Takeout Investor.
Jumbo Mortgage Loans (Modified DTI)” shall mean a Mortgage Loan, (i) with a principal balance of not more than [***] (ii) that except with respect to the original principal balance thereof and the calculation of DTI, conforms to the requirements for securitization or cash purchase by an Agency, (iii) that satisfies Administrative Agent’s underwriting guidelines for jumbo mortgage loans, (iv) that has a FICO score of [***], (v) with a Loan-to-Value Ratio of [***], (vi) a Modified DTI [***], and (vii) that is subject to a Takeout Commitment from a Takeout Investor.
Jumbo Mortgage Loans (Modified High DTI)” shall mean a Mortgage Loan, (i) with a principal balance of not more than [***] (ii) that except with respect to the original principal balance thereof and the calculation of DTI, conforms to the requirements for securitization or cash purchase by an Agency, (iii) that satisfies Administrative Agent’s underwriting guidelines for jumbo mortgage loans, (iv) that has a FICO score of [***], (v) with a Loan-to-Value Ratio of [***], (vi) a Modified DTI [***], and (vii) that is subject to a Takeout Commitment from an approved Takeout Investor.
Jumbo Mortgage Loans (Specialty)” is a collective reference to Jumbo Mortgage Loans (High DTI), Jumbo Mortgage Loans (IO), Jumbo Mortgage Loans (40 Year IO), Jumbo Mortgage Loans (High LTV), Jumbo Mortgage Loans (Modified DTI) and Jumbo Mortgage Loans (Modified High DTI).
Jumbo Mortgage Loan (Standard Limit)” shall mean a Mortgage Loan, (i) with a principal balance of not more than [***] (ii) that except with respect to the original principal balance thereof, conforms to the requirements for securitization or cash
-4-


purchase by an Agency, (iii) that satisfies Administrative Agent’s underwriting guidelines for jumbo mortgage loans, (iv) that has a FICO score of [***], (v) with a (x) Loan-to-Value Ratio of [***] for single unit properties, and (y) [***] for 2-4 unit properties, and (vi) that is subject to a Takeout Commitment. For the avoidance of doubt, cash out refinances and investment properties do not qualify as a Jumbo Mortgage Loan (Standard Limit).
LIBOR Floor” shall mean [***].
Litigation Threshold” shall mean [***].
Low FICO Government Mortgage Loan” shall mean an Eligible Government Mortgage Loan which has a FICO score [***].
Manufactured Housing Mortgage Loans” shall mean any first-lien Mortgage Loan (a) with a FICO score [***] and (b) with respect to which the Mortgaged Property is a manufactured dwelling and (i) such Mortgage Loan conforms with the applicable Agency requirements regarding mortgage loans related to manufactured dwellings, (ii) the related manufactured dwelling is permanently affixed to the land, (iii) the related manufactured dwelling and land are subject to a Mortgage properly filed in the appropriate public recording office and naming Seller as mortgagee, (iv) the applicable laws of the jurisdiction in which the related Mortgaged Property is located will deem the manufactured dwelling located on such Mortgaged Property to be a part of the real property on which such dwelling is located, and (v) such Manufactured Housing Mortgage Loan is (A) a qualified mortgage under Section 860G(a)(3) of the Internal Revenue Code of 1986, as amended and (B) secured by manufactured housing treated as a single family residence under Section 25(e)(10) of the Code.
Maximum Purchase Amount” shall mean $[***].
Modified DTI” shall mean the Debt-to-Income Ratio of the Mortgagor that includes income of the Mortgagor that is either (i) passive, or (ii) imputed to the Mortgagor based on the value of Mortgagor’s assets.
Monthly Financial Statement Date” shall mean June 30, 2021.
Net Worth” shall mean,[***]
Post-Default Rate” shall mean [***].

Pricing Spread” shall mean:

-5-


Type of Mortgage LoanPercentage
Conforming Mortgage Loans and Eligible Government Mortgage Loans (excluding Low FICO Government Loans, and 203K Loans)[***]
Jumbo Mortgage Loans[***]
Jumbo Mortgage Loans (Specialty)[***]
Delegated Jumbo Mortgage Loans[***]
Low FICO Government Loans[***]
203K Loans[***]
State Agency Program Loans[***]
Manufactured Housing Mortgage Loans[***]
Aged Mortgage Loans[***]
Mortgage Loans exceeding the applicable Transaction Term Limitation[***]

When a Purchased Mortgage Loan may qualify for two or more Pricing Spreads hereunder, unless otherwise expressly agreed to by the Administrative Agent in writing, such Purchased Mortgage Loan shall be assigned the higher Pricing Spread, as applicable.
Purchase Price” shall mean the price at which each Purchased Mortgage Loan is transferred by Seller to the Administrative Agent, which shall equal:
(a)[***]; and
(b)[***].
Purchase Price Percentage” shall mean:
Type of Mortgage LoanPercentage
Conforming Mortgage Loans and Eligible Government Mortgage Loans (excluding Low FICO Government Loans and 203K Loans)[***]
Jumbo Mortgage Loans[***]
Jumbo Mortgage Loans (Specialty)[***]
Delegated Jumbo Mortgage Loans[***]
Low FICO Government Loans[***]
203K Loans[***]
State Agency Program Loans[***]
Manufactured Housing Mortgage Loans[***]
Aged Mortgage Loans[***]
Aged Jumbo Mortgage Loans[***]
Aged State Agency Program Loan[***]
-6-



When a Purchased Mortgage Loan may qualify for two or more Purchase Price Percentages hereunder, unless otherwise expressly agreed to by the Administrative Agent in writing, such Purchased Mortgage Loan shall be assigned the lower Purchase Price Percentage, as applicable.
Relative” shall mean a spouse, domestic partner, cohabitant, child, stepchild, grandchild, parent, stepparent, mother-in-law, father-in-law, son-in-law, daughter-in-law, grandparent, great grandparent, brother, sister, half-brother, half-sister, stepsibling, brother-in-law, sister-in-law, aunt, great aunt, uncle, great uncle, niece, nephew, or first cousin (that is, a child of an aunt or uncle).
State Agency Program Loan” shall mean a mortgage loan originated by Seller in accordance with the applicable guidelines of, and in anticipation of sale to, state housing authorities, as approved by Administrative Agent in writing in its sole discretion.
Surplus Amount” shall mean $[***].
Termination Date” shall mean shall mean the earliest of (i) November 14, 2022, (ii) such date as the Administrative Agent, at the direction of the Required Buyers, may determine in its sole discretion by written notice to Seller (provided that in the event of such notice of termination, the Repurchase Date with respect to outstanding Transactions shall not be accelerated in the absence of (a) an Event of Default or (b) the occurrence of a termination in accordance with clauses (i) or (iii) of this definition) or (iii) such date as determined by the Buyers pursuant to their rights and remedies under the Agreement.
Test Date” shall mean the last day of each calendar month with respect to Sections 3(a), 3(b) and 3(c) below and the last day of each fiscal quarter with respect to Sections 3(d) below.
Transaction Term Limitation” shall mean for each Transaction, the number of days such Transaction remains outstanding, which shall not exceed (a) with respect to any Mortgage Loan other than an Aged Mortgage Loan, [***] days and (b) with respect to an Aged Mortgage Loan, [***] days.
Warehouse Fees” shall mean those fees listed on Schedule 1 hereto.
Wet Delivery Deadline” shall mean, with respect to each Wet Loan, the date that is [***] Business Days following the related Purchase Date for such Wet Loan.
SECTION 2.No Commitment. The Agreement does not constitute a commitment by the Buyers to enter into Transactions under the Agreement. The parties acknowledge that Buyers will enter into Transactions with Seller, on an uncommitted basis in their sole discretion and subject to satisfaction of all terms and conditions of the Agreement.
SECTION 3.Certain Financial Condition Covenants. Without limiting any provision set forth in the Agreement, Seller shall comply with the following covenants (each a “Financial Condition Covenant” and collectively, the “Financial Condition Covenants”), each to be tested on each Test Date occurring prior to the Termination Date:
a)[***].
b)[***].
-7-


c)[***].
d)[***].
SECTION 4.Defined Terms. Any terms capitalized and not otherwise defined herein should have the respective meanings set forth in the Agreement.
SECTION 5.Fees. The Seller agrees to pay when billed by the Administrative Agent, (a) Buyers’ legal fees in connection with the preparation, negotiation and consummation of this Second Amendment, and (b) the Warehouse Fees as and when required hereunder. There are no other fees payable in connection herewith.
SECTION 6.Severability. Each provision and agreement herein shall be treated as separate and independent from any other provision or agreement herein and shall be enforceable notwithstanding the unenforceability of any such other provision or agreement.
SECTION 7.Limited Affect. Except as amended hereby, the Agreement shall continue in full force and effect in accordance with its terms. Reference to this Second Amendment need not be made in the Agreement or any other instrument or document executed in connection therewith, or in any certificate, letter or communication issued or made pursuant to, or with respect to, the Agreement, any reference in any of such items to the Agreement being sufficient to refer to the Agreement as amended hereby.
SECTION 8.Representations. In order to induce Buyers to execute and deliver this Second Amendment, each Seller hereby represents to Buyers that as of the date hereof, except as otherwise expressly waived by Buyers in writing, such Seller is in full compliance with all of the terms and conditions of the Agreement including without limitation, all of the representations and warranties and all of the affirmative and negative covenants, and no Default or Event of Default has occurred and is continuing under the Agreement.
SECTION 9.Amendments. None of the terms or provisions of this Second Amendment may be waived, amended, supplemented or otherwise modified except by a written instrument executed by the Administrative Agent, Seller and each Buyer.
SECTION 10.Governing Law. This Second Amendment and any claim, controversy or dispute arising under or related to or in connection with this Second Amendment, the relationship of the parties, and/or the interpretation and enforcement of the rights and duties of the parties will be governed by the laws of the State of New York without regard to any conflicts of law principles other than Sections 5-1401 and 5-1402 of the New York General Obligations Law, which shall govern.
SECTION 11.Counterparts. This Second Amendment may be executed in two (2) or more counterparts, each of which shall be deemed an original but all of which together shall constitute but one and the same agreement. This Second Amendment, to the extent signed and delivered by facsimile or other electronic means, shall be treated in all manner and respects as an original agreement and shall be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. No signatory to this Second Amendment shall raise the use of a facsimile machine or other electronic means to deliver a signature or the fact that any signature or agreement was transmitted or communicated through the use of a facsimile machine or other electronic means as a defense to the formation or enforceability of a contract and each such Person forever waives any such defense. The parties agree that this Second Amendment and any addendum or amendment hereto may be accepted, executed or agreed to through the use of an electronic signature in accordance with the E-Sign, the UETA and any applicable state law. Any document accepted, executed or agreed to in
-8-


conformity with such laws will be binding on all parties hereto to the same extent as if it were physically executed and each party hereby consents to the use of any secure third party electronic signature capture service providers, as long as such service providers use system logs and audit trails that establish a temporal and process link between the presentation of identity documents and the electronic signing, together with identifying information that can be used to verify the electronic signature and its attribution to the signer’s identity and evidence of the signer’s agreement to conduct the transaction electronically and of the signer’s execution of each electronic signature.
[Remainder of page intentionally left blank]
-9-


IN WITNESS WHEREOF, Seller, Administrative Agent and the Buyers have caused their names to be signed hereto by their respective officers thereunto duly authorized, as of the date first above written.
TIAA, FSB, as Administrative Agent and as a
Buyer
By: ______/s/ Kate Walton _______
Name:    Kate Walton
Title:    Vice President
SIGNATURE BANK, as a Buyer
By: _______________________________
Name:
Title:
LOANDEPOT.COM, LLC, as Seller
By: _______________________________
Name:
Title:

Signature Page to the Second Amendment to the Amended and Restated Pricing Letter — loanDepot.com



IN WITNESS WHEREOF, Seller, Administrative Agent and the Buyers have caused this First Amendment to be executed and delivered as of the date first above written.
TIAA, FSB, as Administrative Agent and as a Buyer
By: _______________________
Name:
Title:    
SIGNATURE BANK, as a Buyer
By: ___/s/ Kenneth D. Logan____
Name: Kenneth D. Logan
Title: Senior Vice President
LOANDEPOT.COM, LLC, as Seller
By: _____________________________
Name:
Title:

-11-




IN WITNESS WHEREOF, Seller, Administrative Agent and the Buyers have caused this First Amendment to be executed and delivered as of the date first above written.
TIAA, FSB, as Administrative Agent and as a Buyer
By:    ____________________________
Name:    
Title:    
SIGNATURE BANK, as a Buyer
By:    ____________________________
Name:
Title:
LOANDEPOT.COM, LLC, as Seller
By:    ___/s/ Patrick Flanagan ___
Name: Patrick Flanagan
Title: CFO

-12-


SCHEDULE 1

WAREHOUSE FEES
[***]
Sch. 1-1


EXHIBIT A

COMPLIANCE CERTIFICATE

[***]

Exhibit A-1




Exhibit A-2
Exhibit 10.9
EXECUTION
AMENDMENT NUMBER TWO
to the
Second Amended and Restated Mortgage Loan Participation Purchase and Sale Agreement
dated as of February 2, 2022
between
BANK OF AMERICA, N.A.
and
LOANDEPOT.COM, LLC
THIS AMENDMENT NUMBER TWO (this “Amendment”) is made as of July 26, 2022, by and between Bank of America, N.A. (“Purchaser”) and loanDepot.com, LLC (“Seller”) to the Second Amended and Restated Mortgage Loan Participation Purchase and Sale Agreement, dated as of February 2, 2022 (as amended, restated, supplemented or otherwise modified from time to time, the “Agreement”), between Purchaser and Seller.
WHEREAS, Seller has requested and Purchaser agrees to amend the Agreement as more specifically set forth herein; and
WHEREAS, as of the date hereof, Seller represents to Purchaser that, after giving effect to this Amendment, it is in compliance with all of the representations and warranties and all of the affirmative and negative covenants set forth in the Agreement and is not in default under the Agreement.
NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and for the mutual covenants herein contained, the parties hereto hereby agree as follows:
SECTION 1.Amendments. Effective as of the date hereof, the Agreement is hereby amended as follows:
(a)    Section 1 of the Agreement is hereby amended by deleting the definition of “Term SOFR” in its entirety and replacing it with the following:
Term SOFR”: As of any determination date for the calculation of any amount based on the Discount Rate or other amounts, the rate per annum equal to the Term SOFR Screen Rate with a term equivalent of one month, determined as of 8:00 a.m. (New York City time) on such determination date (rounded to three (3) decimal places); provided that if the Term SOFR Screen Rate is not available as of 8:00 a.m. (New York City time) on such determination date, then Term SOFR means the Term SOFR Screen Rate on the first U.S. Government Securities Business Day immediately prior thereto, in each case, plus the SOFR Adjustment.
SECTION 2.Fees and Expenses. The Seller agrees to pay to Purchaser all fees and out of pocket expenses incurred by Purchaser in connection with this Amendment, including all reasonable fees and out of pocket costs and expenses of the legal counsel to Purchaser incurred in connection with this Amendment, in accordance with Section 22(a) of the Agreement.
SECTION 3.Defined Terms. Any terms capitalized but not otherwise defined herein should have the respective meanings set forth in the Agreement.
SECTION 4.Limited Effect. Except as amended hereby, the Agreement shall continue in full force and effect in accordance with its terms. Reference to this Amendment need not be made in the Agreement or any other instrument or document executed in connection therewith, or in any certificate, letter or communication issued or made pursuant to, or with respect to, the



Agreement, any reference in any of such items to the Agreement being sufficient to refer to the Agreement as amended hereby.
SECTION 5.Representations. In order to induce Purchaser to execute and deliver this Amendment, Seller hereby represents to Purchaser that as of the date hereof, after giving effect to this Amendment, (i) Seller is in full compliance with all of the terms and conditions of the Program Documents and remains bound by the terms thereof, and (ii) no Potential Default or Event of Default or servicing termination event (as described in Section 6(f) of the Agreement) has occurred and is continuing under the Program Documents.
SECTION 6.Governing Law. This Amendment shall be construed in accordance with the laws of the State of New York without regard to any conflicts of law provisions (except for Sections 5-1401 and 5-1402 of the New York General Obligations Law) and the obligations, rights and remedies of the parties hereunder shall be determined in accordance with the laws of the State of New York, except to the extent preempted by federal law.
SECTION 7.Severability. Each provision and agreement herein shall be treated as separate and independent from any other provision or agreement herein and shall be enforceable notwithstanding the unenforceability of any such other provision or agreement.
SECTION 8.Counterparts. This Amendment and any document, amendment, approval, consent, information, notice, certificate, request, statement, disclosure or authorization related to this Amendment (each a “Communication”) may be in the form of an Electronic Record and may be executed using Electronic Signatures (including, without limitation, facsimile and .pdf) and shall be considered an original, and shall have the same legal effect, validity and enforceability as a paper record. This Amendment may be executed simultaneously in as many counterparts as necessary or convenient, including both paper and electronic counterparts, but each counterpart shall be deemed to be an original and all such counterparts shall constitute one and the same agreement. For the avoidance of doubt, the authorization under this paragraph may include, without limitation, use or acceptance by Purchaser of a manually signed paper Communication which has been converted into electronic form (such as scanned into PDF format), or an electronically signed Communication converted into another format, for transmission, delivery and/or retention. Electronic Signatures and facsimile signatures shall be deemed valid and binding to the same extent as the original. For purposes hereof, “Electronic Record” and “Electronic Signature” shall have the meanings assigned to them, respectively, by 15 USC §7006, as it may be amended from time to time.
[REMAINDER OF THIS PAGE LEFT INTENTIONALLY BLANK]
-2-


IN WITNESS WHEREOF, Purchaser and Seller have caused this Amendment to be executed and delivered by their duly authorized officers as of the day and year first above written.
BANK OF AMERICA, N.A.,
as Purchaser
By:__/s/ _Adam Robitshek_______
Name: Adam Robitshek
Title: Director
LOANDEPOT.COM, LLC,
as Seller
By:__/s/ Patrick Flanagan__
Name: Patrick Flanagan
Title: CFO


Signature Page to Amendment No. 2 to Second A&R Purchase and Sale Agreement (BANA/loanDepot)
Exhibit 10.10
EXECUTION
AMENDMENT NO. 4 TO
SECOND AMENDED AND RESTATED MASTER REPURCHASE AGREEMENT
THIS AMENDMENT NO 4 TO SECOND AMENDED AND RESTATED MASTER REPURCHASE AGREEMENT (this “Amendment”) is made and entered into as of July 26, 2022, by and between Bank of America, N.A. (“Buyer”) and loanDepot BA Warehouse, LLC (“Seller”), and acknowledged and agreed to by loanDepot.com, LLC, as guarantor and pledgor (“loanDepot” and together with the Seller, each a “loanDepot Party” and collectively, the “loanDepot Parties”). This Amendment amends that certain Second Amended and Restated Master Repurchase Agreement by and between Buyer and Seller, and acknowledged and agreed to by loanDepot, dated as of August 20, 2021 (as amended, restated, supplemented or otherwise modified from time to time, the “Agreement”).
RECITALS
Buyer and loanDepot Parties have previously entered into the Agreement pursuant to which Buyer may, from time to time, purchase certain Eligible Participation Interests from Seller and Seller agrees to sell certain Eligible Participation Interests to Buyer under a master repurchase facility. Buyer and loanDepot Parties hereby agree that the Agreement shall be amended as more fully provided herein.
In consideration of the mutual promises contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Buyer and loanDepot Parties hereby agree as follows
1.Amendments. Effective as of the date hereof, the Agreement is hereby amended as follows:
(a)Definitions. Exhibit A to the Agreement is hereby amended by deleting the definition of “Term SOFR” in its entirety and replacing it with the following:
Term SOFR: As of any determination date for the computation of the Price Differential or other amounts, the rate per annum equal to the Term SOFR Screen Rate with a term equivalent of one month, determined as of 8:00 a.m. (New York City time) on such determination date (rounded to three (3) decimal places); provided that if the Term SOFR Screen Rate is not available as of 8:00 a.m. (New York City time) on such determination date, then Term SOFR means the Term SOFR Screen Rate on the first U.S. Government Securities Business Day immediately prior thereto, in each case, plus the SOFR Adjustment.
2.Fees and Expenses. The Seller agrees to pay to Buyer all fees and out of pocket expenses incurred by Buyer in connection with this Amendment, including all reasonable fees and out of pocket costs and expenses of the legal counsel to Buyer incurred in connection with this Amendment, in accordance with Section 11.7 of the Agreement.
3.No Other Amendments; Conflicts with Previous Amendments. Other than as expressly modified and amended herein, the Agreement shall remain in full force and effect and nothing herein shall affect the rights and remedies of Buyer as provided under the Agreement. To the extent any amendments to the Agreement contained herein conflict with any previous amendments to the Agreement, the amendments contained herein shall control.



4.Capitalized Terms. Any capitalized term used herein and not otherwise defined herein shall have the meaning ascribed to such term in the Agreement.
5.Representations. In order to induce Buyer to execute and deliver this Amendment, loanDepot Parties hereby represent to Buyer that as of the date hereof, after giving effect to this Amendment, (i) loanDepot Parties are in full compliance with all of the terms and conditions of the Principal Agreements and remain bound by the terms thereof, and (ii) no Potential Default or Event of Default has occurred and is continuing under the Principal Agreements.
6.Governing Law. This Amendment shall be construed in accordance with the laws of the State of New York without regard to any conflicts of law provisions (except for Sections 5-1401 and 5-1402 of the New York General Obligations Law which shall govern). All legal actions between or among the parties regarding the Agreement, including, without limitation, legal actions to enforce the Agreement or because of a dispute, breach or default of the Agreement, shall be brought in the federal or state courts located in New York County, New York, which courts shall have sole and exclusive in personam, subject matter and other jurisdiction in connection with such legal actions and the parties acknowledge and agree that venue in such courts shall be convenient and appropriate for all purposes.
7.Severability. Each provision and agreement herein shall be treated as separate and independent from any other provision or agreement herein and shall be enforceable notwithstanding the unenforceability of any such other provision or agreement.
8.Counterparts. This Amendment and any document, amendment, approval, consent, information, notice, certificate, request, statement, disclosure or authorization related to this Amendment (each a “Communication”) may be in the form of an Electronic Record and may be executed using Electronic Signatures (including, without limitation, facsimile and .pdf) and shall be considered an original, and shall have the same legal effect, validity and enforceability as a paper record. This Amendment may be executed simultaneously in as many counterparts as necessary or convenient, including both paper and electronic counterparts, but each counterpart shall be deemed to be an original and all such counterparts shall constitute one and the same agreement. For the avoidance of doubt, the authorization under this paragraph may include, without limitation, use or acceptance by Buyer of a manually signed paper Communication which has been converted into electronic form (such as scanned into PDF format), or an electronically signed Communication converted into another format, for transmission, delivery and/or retention. Electronic Signatures and facsimile signatures shall be deemed valid and binding to the same extent as the original. For purposes hereof, “Electronic Record” and “Electronic Signature” shall have the meanings assigned to them, respectively, by 15 USC §7006, as it may be amended from time to time.
[signature pages follow]
2


IN WITNESS WHEREOF, Buyer and loanDepot Parties have caused their names to be signed hereto by their respective officers thereunto duly authorized as of the date first written above. Buyer shall have no obligation to honor the terms and conditions of this Amendment if loanDepot Parties fail to fully execute and return this document to Buyer within three (3) days after the date hereof.
BANK AMERICA, N.A., as Buyer
LOANDEPOT BA WAREHOUSE, LLC, as Seller
By:    __/s/ Adam Robitshek___
Name:    Adam Robitshek
Title:    Director
By:    ___/s/ Patrick Flanagan___
Name:    Patrick Flanagan
Title:     President
Acknowledged and Agreed to by:
LOANDEPOT COM LLC, as guarantor
By:    ___/s/ Patrick Flanagan___
Name:    Patrick Flanagan
Title:    CFO
LOANDEPOT COM, LLC, as pledgor
By:    ___/s/ Patrick Flanagan____
Name:    Patrick Flanagan
Title:     CFO


Signature Page to Amendment No. 4 to Second A&R MRA (BANA/loanDepot)
Exhibit 10.11
EXECUTION
AMENDMENT NO. 2
TO AMENDED AND RESTATED MASTER REPURCHASE AGREEMENT
Amendment No. 2 to Amended and Restated Master Repurchase Agreement, dated as of July 28, 2022 (this “Amendment”), between UBS AG, by and through its branch office at 1285 Avenue of the Americas, New York, New York (the “Buyer”) and loanDepot.com, LLC (the “Seller”).
RECITALS
The Buyer and Seller are parties to that certain (a) Amended and Restated Master Repurchase Agreement, dated as of August 11, 2021 (as amended by Amendment No. 1, dated as of April 19, 2022, the “Existing Repurchase Agreement”; and as further amended by this Amendment, the “Repurchase Agreement”) and (b) Pricing Letter, dated as of August 11, 2021 (as amended, restated, supplemented or otherwise modified from time to time, the “Pricing Letter”). Capitalized terms used but not otherwise defined herein shall have the meanings given to them in the Existing Repurchase Agreement and Pricing Letter, as applicable.
Accordingly, the Buyer and Seller hereby agree, in consideration of the mutual promises and mutual obligations set forth herein, that the Existing Repurchase Agreement is hereby amended as follows:
SECTION 1.Definitions. Section 2 of the Existing Repurchase Agreement is hereby amended by:
1.1adding the following definitions in their proper alphabetical order:
Benchmark” shall have the meaning specified in the Pricing Letter.
CME Term SOFR Administrator” shall have the meaning specified in the Pricing Letter.
LD Holdings” shall mean LD Holdings Group LLC, a Delaware limited liability company.
Relevant Governmental Body” shall mean the Federal Reserve Board and/or the Federal Reserve Bank of New York, or a committee officially endorsed or convened by the Federal Reserve Board and/or the Federal Reserve Bank of New York, or any successor of any of the foregoing.
Successor Rate Conforming Changes” shall mean with respect to any proposed Successor Rate, any technical, administrative or operational change (including any change to the timing and frequency of determining rates and making payments of interest, timing of borrowing requests or prepayment, conversion or continuation notices, length of lookback periods, the applicability of breakage provisions, and other technical, administrative or operational matters) that the Buyer decides, in its sole good faith discretion, may be appropriate to reflect the adoption and implementation of such Successor Rate and to permit the administration thereof by the Buyer in a manner substantially consistent with market practice (or, if the Buyer decides that adoption of any portion of such market practice is not administratively feasible or if the Buyer determines that no market practice for the administration of such Successor Rate exists, in such other manner of administration as the Buyer decides, in its sole good faith discretion, is reasonably necessary in connection with the administration of this Agreement or any other Program Document).
1


Tax Distributions” shall mean distributions by the Seller for the purpose of enabling LD Holdings to make “Tax Distributions”, as defined and set forth in the limited liability company agreement of LD Holdings.
1.2deleting the definition of “Change in Control” in its entirety and replacing it with the following:
Change in Control” shall mean:
(a)any event or series of events by which any “person” or “group” (as such terms are used in Sections 13(d) and 14(d) of the Exchange Act), but excluding any employee benefit plan of such person or its Subsidiaries, and any person or entity acting in its capacity as trustee, agent or other fiduciary or administrator of any such plan), other than the Permitted Holders becomes the “beneficial owner” (as defined in Rules 13d-3 and 13d-5 under the Exchange Act), directly or indirectly, of 51% or more of the equity securities of loanDepot, Inc., a Delaware corporation, entitled to vote for members of the board of directors or equivalent governing body of Seller on a fully-diluted basis; or
(b)the sale, transfer, or other disposition of all or substantially all of Seller’s assets (excluding any such action taken in connection with any securitization transaction) to a Person that is not a Subsidiary or an Affiliate of Seller; or
(c)there is a change in the majority of the board of directors of Seller during any twelve month period; or
(d)if such Person is a Delaware limited liability company, such Person enters into any transaction or series of transactions to adopt, file, effect or consummate a Division, or otherwise permits any such Division to be adopted, filed, effected or consummated.
1.3deleting the definitions of “Index Rate”, “One-Month LIBOR” and “Overnight LIBOR” and any and all references thereto.
SECTION 2.Collections. Section 5 of the Existing Repurchase Agreement is hereby amended by:
1.4deleting paragraph (i) in its entirety and replacing it with the following:
(a)If on any date, Buyer determines in its sole good faith discretion that, by reason of circumstances affecting the relevant market, (i) adequate and reasonable means do not exist for ascertaining the Benchmark; (ii) the Benchmark is no longer in existence; (iii) continued implementation of the Benchmark is no longer operationally, administratively or technically feasible or no significant market practice for the administration of the Benchmark exists, (iv) the Benchmark will not adequately and fairly reflect the cost to Buyer of purchasing or maintaining Transactions or (v) the Relevant Governmental Body, the CME Term SOFR Administrator or a Governmental Authority having jurisdiction over Buyer has made a public statement identifying a specific date after which the Benchmark shall no longer be made available or used for determining the interest rate of loans, Buyer may give prompt notice thereof to Seller, whereupon the rate for such period that will replace the Benchmark for such period, and for all subsequent periods until such notice has been withdrawn by Buyer, shall be the greater of (x) an alternative benchmark rate (including any mathematical or other adjustments to the benchmark rate (if any) incorporated therein) and (y) zero, together with any proposed Successor Rate Conforming Changes, as determined by Buyer in its sole discretion (any such rate, a “Successor Rate”).
2


1.5adding the following new paragraph at the end thereof:
(a)To the extent Buyer implements a Successor Rate and Successor Rate Conforming Changes it will promptly notify Seller Parties of the effectiveness of any such changes. Any determination of a Successor Rate and the adoption of Successor Rate Conforming Changes shall be made by Buyer in a manner substantially consistent with market practice with respect to similarly situated counterparties with substantially similar assets in similar facilities and any such Successor Rate Conforming Changes will become effective without any further action or consent of Seller Parties to this Agreement or the other Program Documents.
SECTION 3.Covenants. Section 11 of the Existing Repurchase Agreement is hereby amended by deleting subsection (o) in its entirety and replacing it with the following:
(b)Limitation on Dividends and Distributions. Following the occurrence and during the continuance of an Event of Default or if an Event of Default would result therefrom, Seller shall not make any payment on account of, or set apart assets for, a sinking or other analogous fund for the purchase, redemption, defeasance, retirement or other acquisition of any equity interest of Seller, whether now or hereafter outstanding, or make any other distribution or dividend (a “Distribution”) in respect of any of the foregoing, in any instance, to any shareholder or equity owner of Seller, either directly or indirectly, whether in cash or property or in obligations of Seller or any of Seller’s consolidated Subsidiaries; provided, that, notwithstanding the foregoing, the Seller shall be permitted at all times (whether or not an Event of Default exists) to make Tax Distributions. Notwithstanding the foregoing, Seller shall notify Buyer immediately to the extent that any Distribution (excluding Tax Distributions), individually or in the aggregate in any calendar year, exceeds 50% of the Seller’s Net Income for the preceding calendar year.
SECTION 4.Conditions Precedent. This Amendment shall be effective as of the date hereof (the “Amendment Effective Date”), subject to the satisfaction of the following conditions precedent:
1.1Delivered Documents. On the Amendment Effective Date, the Buyer shall have received the following documents, each of which shall be satisfactory to the Buyer in form and substance:
(a)this Amendment, executed and delivered by duly authorized officers of the Buyer and Seller;
(b)Amendment No. 2 to Pricing Letter, dated as of the date hereof, executed and delivered by Buyer and Seller; and
(c)such other documents as the Buyer or counsel to the Buyer may reasonably request.
SECTION 5.Ratification of Agreement. As amended by this Amendment, the Existing Repurchase Agreement is in all respects ratified and confirmed and the Existing Repurchase Agreement as so modified by this Amendment shall be read, taken, and construed as one and the same instrument.
SECTION 6.Representations and Warranties. Seller hereby represents and warrants to the Buyer that it is in compliance with all the terms and provisions set forth in the Repurchase Agreement on its part to be observed or performed, and that no Default or Event of Default has occurred or is continuing, and hereby confirms and reaffirms the representations and
3


warranties contained in Section 10 of the Repurchase Agreement. Seller hereby represents and warrants that this Amendment has been duly and validly executed and delivered by it, and constitutes its legal, valid and binding obligation, enforceable against it in accordance with its terms.
SECTION 7.Limited Effect. Except as expressly amended and modified by this Amendment, the Existing Repurchase Agreement shall continue to be, and shall remain, in full force and effect in accordance with its terms.
SECTION 8.Severability. Each provision and agreement herein shall be treated as separate and independent from any other provision or agreement herein and shall be enforceable notwithstanding the unenforceability of any such other provision or agreement.
SECTION 9.Counterparts. This Amendment may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument, and any of the parties hereto may execute this Amendment by signing any such counterpart. The parties agree that this Amendment, any documents to be delivered pursuant to this Amendment and any notices hereunder may be transmitted between them by email and/or by facsimile. Delivery of an executed counterpart of a signature page of this Amendment in Portable Document Format (PDF) or by facsimile shall be effective as delivery of a manually executed original counterpart of this Amendment. The original documents shall be promptly delivered, if requested. The parties agree that this Amendment, any addendum or amendment hereto or any other document necessary for the consummation of the transactions contemplated by this Amendment may be accepted, executed or agreed to through the use of an electronic signature in accordance with the E-Sign, UETA and any applicable state law. Any document accepted, executed or agreed to in conformity with such laws will be binding on all parties hereto to the same extent as if it were physically executed and each party hereby consents to the use of any secure third party electronic signature capture service providers with appropriate document access tracking, electronic signature tracking and document retention as may be approved by the Buyer in its sole discretion.
SECTION 10.Binding Effect. This Amendment shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns.
SECTION 11.GOVERNING LAW. THIS AMENDMENT AND ANY CLAIM, CONTROVERSY OR DISPUTE ARISING UNDER OR RELATED TO THIS AMENDMENT, THE RELATIONSHIP OF THE PARTIES TO THIS AMENDMENT, AND/OR THE INTERPRETATION AND ENFORCEMENT OF THE RIGHTS AND DUTIES OF THE PARTIES TO THIS AMENDMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE INTERNAL LAWS AND DECISIONS OF THE STATE OF NEW YORK, WITHOUT REGARD TO THE CHOICE OF LAW RULES THEREOF. THE PARTIES HERETO INTEND THAT THE PROVISIONS OF SECTIONS 5-1401 AND 5-1402 OF THE NEW YORK GENERAL OBLIGATIONS LAW SHALL APPLY TO THIS AMENDMENT. NOTWITHSTANDING ANYTHING TO THE CONTRARY, THE EFFECTIVENESS, VALIDITY AND ENFORCEABILITY OF ELECTRONIC CONTRACTS, OTHER RECORDS, ELECTRONIC RECORDS AND ELECTRONIC SIGNATURES USED IN CONNECTION WITH ANY ELECTRONIC TRANSACTION BETWEEN BUYER AND SELLER SHALL BE GOVERNED BY E-SIGN.
[SIGNATURE PAGE FOLLOWS]

4


IN WITNESS WHEREOF, the parties have caused their names to be signed hereto by their respective officers thereunto duly authorized as of the day and year first above written.
UBS AG, BY AND THROUGH ITS BRANCH OFFICE AT 1285 AVENUE OF THE AMERICAS, NEW YORK, NEW YORK, as
Buyer
By:    __/s/ Kathleen Donovan_____
Name: Kathleen Donovan
Title: Managing Director
By:    ___/s/ Chi Ma_______
Name: Chi Ma
Title: Executive Director
LOANDEPOT.COM, LLC, as Seller
By:    ___________________________
Name:
Title:

Signature Page to Amendment No. 2 to Master Repurchase Agreement


IN WITNESS WHEREOF, the parties have caused their names to be signed hereto by their respective officers thereunto duly authorized as of the day and year first above written.
UBS AG, BY AND THROUGH ITS BRANCH
OFFICE AT 1285 AVENUE OF THE
AMERICAS, NEW YORK, NEW YORK,
as Buyer
By:    _________________________________
Name:
Title:
By:    __________________________________
Name:
Title:
LOANDEPOT.COM, LLC, as Seller
By:    ____/s/ Patrick Flanagan________
Name: Patrick Flanagan
Title:
    CFO

Signature Page to Amendment No. 2 to Master Repurchase Agreement
Exhibit 10.12
EXECUTION VERSION


Certain confidential information contained in this document, marked by “[***]”, has been omitted because it is both (i) not material and would be competitively harmful if publicly disclosed or (ii) constitutes a clearly unwarranted invasion of personal privacyimage_1.jpgBarclays Bank PLC
745 Seventh Avenue, 4th Floor
New York, New York 10019

July 28, 2022

VIA ELECTRONIC MAIL
To the Parties identified
    on Schedule A hereto

Omnibus Notice of Termination of Agreements and Release of Lien

Ladies and Gentlemen:

    Reference is made to the following:

(i)that certain Master Repurchase Agreement, dated as of August 25, 2020 (as amended through the date hereof, the “MRA”), by and among loanDepot.com, LLC, as seller (the “Seller”), and Barclays Bank PLC, as purchaser and agent (“Barclays”);
(ii)that certain MRA Pricing Side Letter, dated as of August 25, 2020 (as amended through the date hereof, the “MRA Pricing Side Letter”), by and between the Seller and Barclays;

(iii)that certain Mortgage Loan Participation Purchase and Sale Agreement, dated as of August 25, 2020 (as amended through the date hereof, the “MLPPSA”), by an among the Seller and Barclays;

(iv)that certain MLPPSA Pricing Side Letter, dated as of August 25, 2020 (as amended through the date hereof, the “MLPPSA Pricing Side Letter”), by and between the Seller and Barclays;

(v)that certain Custodial and Disbursement Agreement, dated as of August 25, 2020 (the “Custodial and Disbursement Agreement”), by and among the Seller, Barclays and Deutsche Bank National Trust Company, as custodian and disbursement agent (“DBNTC”);

(vi)that certain Collection Account Control Agreement, dated as of August 25, 2020 (the “Collection ACA”), by and among the Seller, Barclays and DBNTC, as bank.

(vii)that certain Custodial Account Control Agreement, dated as of August 25, 2020 (the “Custodial ACA”), by and among the Seller, Barclays and DBNTC, as bank.

(viii)that certain Electronic Tracking Agreement, dated as of August 25, 2020 (the “ETA”), by and among the Seller, Barclays, MERSCORP Holdings, Inc., as electronic agent (“MERSCORP”), and Mortgage Electronic Registration Systems, Inc. (“MERS”);




(ix)that certain Global Netting and Security Agreement, dated as of August 25, 2020 (the “Netting Agreement”), by and among the Seller, Barclays and Barclays Capital Inc. (“BCI”); and

(x)that certain Cenlar Subservicer Notice, dated as of August 25, 2020 (the “Subservicer Notice”; and collectively with the MRA, the MRA Pricing Side Letter, the MLPPSA, the MLPPSA Pricing Side Letter, the Custodial and Disbursement Agreement, the Collection ACA, the Custodial ACA, the ETA, the Netting Agreement and all other documents executed by Barclays in connection with the MRA and the MLPPSA, the “Agreements”), by and among Seller, Barclays and Cenlar FSB, as subservicer (“Cenlar”).

Capitalized terms used and not defined in this Omnibus Notice of Termination of Agreements and Release of Lien (this “Letter Agreement”) shall have the respective meanings given to such terms in the Agreements, as applicable.

    In consideration of the premises and the other mutual covenants contained in this Letter Agreement, the Seller and Barclays hereby agree that the Agreements are terminated, effective upon the receipt by Barclays of an amount equal to or greater than $[***] (the “Payoff Amount”) as set forth on Exhibit A, as follows:

(a)[***] to:

Bank:                Bank of New York Mellon
Address:            New York, NY
ABA:                [***]
DDA:                [***]
Account Name:        [***]
Ref:                [***]
Attention:            [***]

(b)[***] to:

Bank:                SunTrust Bank, Richmond, VA
Account Name:        Hunton Andrews Kurth LLP Operating
Account Number:        [***]
ABA Transit:            [***]
Swift Code:            [***]    
Information with Wire:    [***]


Promptly upon receipt of the Payoff Amount by Barclays, Barclays shall deliver written notice in the form annexed hereto as Exhibit B (the “Payoff Notice”) to the parties identified on Schedule A thereto confirming its receipt of the Payoff Amount.

Effective as of the date of receipt of the Payoff Amount by Barclays, (i) the MRA and the MLPPSA are hereby terminated; and (ii) the Payoff Notice shall constitute notice to (a) the Custodian and Disbursement Agent of the termination of the Custodial and Disbursement Agreement pursuant to Section 15 thereof; (b) DBNTC of the termination of each the Collection ACA and the Custodial ACA pursuant to Section 10 thereof; (c) MERSCORP and MERS of the termination of each of the ETAs pursuant to Section 16 thereof; (d) BCI of the termination of the Netting Agreement; and (e) Cenlar of the termination of the Subservicer Notice.

Effective immediately upon its receipt in full of the Payoff Amount and without any further action by any party, Barclays hereby (a) releases its security interest in the Purchased



Assets (as defined in the Collection ACA) and Participation Certificates (as defined in the Custodial ACA), and (b) authorizes the Seller to file or caused to be filed any UCC financing statement amendments/terminations or such other documents as it reasonably determines are necessary or appropriate to evidence the release of Barclays’ security interest in the Purchased Assets.

Notwithstanding any other provision of this Letter Agreement, the parties hereto agree that any provision in any of the Agreements that by its express terms survives the termination of the Agreements, including but not limited to provisions relating to indemnity, contribution, reimbursement and limited recourse, shall survive the execution of this Letter Agreement and remain operative and in full force and effect.

    THIS LETTER AGREEMENT SHALL BE CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT REFERENCE TO ITS CONFLICT OF LAWS PROVISIONS EXCEPT SECTIONS 5-1401 AND 5-1402 OF THE NEW YORK GENERAL OBLIGATIONS LAWS, AND THE OBLIGATIONS, RIGHTS AND REMEDIES OF THE PARTIES HEREUNDER SHALL BE DETERMINED IN ACCORDANCE WITH SUCH LAWS.

    This Letter Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original, but all of which together shall constitute one and the same instrument. Delivery of an executed counterpart of a signature page by facsimile or other electronic forms shall be effective as delivery of a manually executed counterpart of this Letter Agreement.


[Signature Pages Follow]




Very Truly Yours,


BARCLAYS BANK PLC,
as Purchaser and Agent


By: /s/ Grace Park        
Name: Grace Park
Title: Managing Director


[Signature Page to Omnibus Notice of Termination of Agreements and Release of Lien]


Accepted and agreed:

LOANDEPOT.COM, LLC,
as Seller


By: /s/ Patrick Flanagan    
Name: Patrick Flanagan
Title: CFO






































[Signature Page to Omnibus Notice of Termination of Agreements and Release of Lien]
Exhibit 10.13

FIFTEENTH AMENDMENT TO CREDIT AND SECURITY AGREEMENT
THIS FIFTEENTH AMENDMENT TO CREDIT AND SECURITY AGREEMENT (this “Amendment”) is entered into as of July 29, 2022, between LOANDEPOT.COM, LLC, a Delaware limited liability company (“Borrower”), and NEXBANK (with its participants, successors and assigns, “Lender”).
RECITALS
A.Borrower and Lender are parties to that certain Credit and Security Agreement dated as of October 29, 2014 (as amended, modified, supplemented, restated or amended and restated from time to time, the “Loan Agreement”). Unless otherwise indicated herein, all terms used with their initial letter capitalized are used herein with their meaning as defined in the Loan Agreement and all Section references are to Sections in the Loan Agreement.
B.Borrower has requested that Lender amend the Loan Agreement as provided below.
C.Borrower and Lender desire to amend the Loan Documents, subject to the terms, conditions, and representations set forth herein, as requested by Borrower.
D.Borrower and Lender agree to the other terms and provisions provided below, subject to the terms, conditions, and representations set forth herein.
NOW, THEREFORE, in consideration of these premises and other valuable consideration, the receipt and adequacy of which are hereby acknowledged, the parties hereto agree, as follows:
1.Amendments to Loan Agreement.
(a)Section 7.1(b) of the Loan Agreement is hereby amended and restated in its entirety to read as follows:
(b)“(b)    Monthly Financial Statements. As soon as available, and in any event within thirty (30) days after the last day of each calendar month of each fiscal year of Borrower and each Obligated Party, a copy of an unaudited financial report of Borrower and each such Obligated Party as of the end of such calendar month and for the portion of the fiscal year then ended, containing, on a consolidated and consolidating basis, balance sheets and statements of income, period of the preceding fiscal year, all in reasonable detail certified by a Responsible Officer to have been prepared in accordance with GAAP and to fairly and accurately present (subject to year-end audit adjustments) the financial condition and results of operations of Borrower and each such Obligated Party, on a consolidated and consolidating basis, as of the dates and for the periods indicated therein;”
(c)Section 7.1(d) of the Loan Agreement is hereby amended and restated in its entirety to read as follows:
“(d)    Compliance Certificate. Concurrently with the delivery of each of the financial statements referred to in Sections 7.1.(a) and, solely for the months ending December, March, June and September, 7.1.(b), a certificate of the chief financial officer of Borrower (i) stating that to the best of such officer’s knowledge, no Default or Event of Default has occurred and is continuing, or if a Default or Event of Default has occurred and is continuing, a statement as to the nature thereof and the action



which is proposed to be taken with respect thereto, and (ii) showing in reasonable detail the calculations demonstrating compliance with the covenants set forth in Section 2 of the Pricing Side Letter;”
2.Conditions Precedent. Notwithstanding any contrary provision, this Amendment shall be effective on the first Business Day upon which all of the following conditions precedent have been satisfied (the “Effective Date”):
(a)Lender shall have received counterparts of this Amendment executed by Borrower, Lender, and each other party set forth on the signature pages hereto;
(b)Lender shall have received counterparts of the Side Letter executed by Borrower;
(c)Lender shall have received satisfactory evidence that Borrower has paid the fees and expenses of counsel described in Section 5;
(d)No Default or Event of Default shall have occurred and be continuing or shall result after giving effect to this Amendment; and
(e)Lender shall have received such other instruments and documents incidental and appropriate to the transactions provided for herein as Lender or its counsel may reasonably request, and all such documents shall be in form and substance satisfactory to Lender (it being agreed that execution of this Amendment by Lender shall evidence that the foregoing conditions have been fulfilled).
3.Reaffirmation of Loan Documents and Liens. Except as amended and modified hereby, any and all of the terms and provisions of the Loan Agreement and the other Loan Documents shall remain in full force and effect and are hereby in all respects ratified and confirmed by Borrower. Borrower hereby agrees that, except as expressly provided in this Amendment, the amendments and modifications herein contained shall in no manner affect or impair the liabilities, duties and obligations of Borrower under the Loan Agreement and the other Loan Documents or the Liens securing the payment and performance thereof Borrower further confirms that the liens and security interests in the Collateral created under the Loan Documents secure, among other indebtedness, Borrower’s obligations under the Loan Documents, and all modifications, amendments, renewals, extensions, and restatements thereof
4.Representations and Warranties. As a material inducement for Lender to enter into this Amendment, Borrower hereby represents and warrants to Lender (with the knowledge and intent that Lender is relying upon the same in consenting to this Amendment) that as of the Effective Date, and after giving effect to the transactions contemplated by this Amendment: (a) all representations and warranties in the Loan Agreement and in all other Loan Documents are true and correct in all material respects, as though made on the date hereof, except to the extent that (i) any of them speak to a different specific date; or (ii) the facts or circumstances on which any of them were based have been changed by transactions or events not prohibited by the Loan Documents; (b) no Default or Event of Default exists under the Loan Documents or will exist after giving effect to this Amendment; (c) this Amendment has been duly authorized and approved by all necessary organizational action and requires the consent of no other Person, and is binding and enforceable against Borrower in accordance with its terms; and (d) the execution, delivery and performance of this Amendment in accordance with its terms, does not and will not, by the passage of time, the giving of notice, or otherwise: (i) require any governmental approval, other than such as have been obtained and are in full force and effect, or violate any applicable law relating to Borrower; (ii) conflict with, result in a breach of, or constitute a default under the Constituent Documents of



Borrower thereof, or any indenture, agreement, or other instrument to which Borrower is a party or by which it or any of its properties may be bound; or (iii) result in or require the creation or imposition of any Lien upon or with respect to any property now owned or hereafter acquired by Borrower.
5.Fees, Costs and Expenses. Borrower agrees to pay promptly the reasonable fees and expenses of counsel to Lender for services rendered in connection with the preparation, negotiation, reproduction, execution, and delivery of this Amendment and all related documents; and
6.Miscellaneous.
(d)This Amendment shall be deemed to constitute a Loan Document for all purposes and in all respects. Each reference in the Loan Agreement to “this Agreement,” “hereunder,” “hereof,” “herein” or words of like import, and each reference in the Loan Agreement or in any other Loan Document, or other agreements, documents or other instruments executed and delivered pursuant to the Loan Agreement to the “Loan Agreement”, shall mean and be a reference to the Loan Agreement as amended by this Amendment.
(e)The Loan Documents shall remain unchanged and in full force and effect, except as provided in this Amendment, and are hereby ratified and confirmed. The execution, delivery, and effectiveness of this Amendment shall not, except as expressly provided herein, operate as a waiver of any rights of Lender under any Loan Document, nor constitute a waiver under any of the Loan Documents.
(f)All of the terms and provisions of this Amendment shall bind and inure to the benefit of the parties hereto and their respective successors and assigns.
(g)This Amendment may be executed in one or more counterparts and by different parties hereto in separate counterparts each of which when so executed and delivered shall be deemed an original, but all such counterparts together shall constitute but one and the same instrument; signature pages may be detached from multiple separate counterparts and attached to a single counterpart so that all signature pages are physically attached to the same document. Facsimiles, documents executed, scanned and transmitted electronically and electronic signatures shall be deemed original signatures for purposes of this Amendment and all matters related thereto, with such facsimile, scanned and electronic signatures having the same legal effect as original signatures. The parties agree that this Amendment may be accepted, executed or agreed to through the use of an electronic signature in accordance with E-SIGN, UETA, and any applicable state law. To the extent this Amendment is accepted, executed or agreed to in conformity with such laws, it will be binding on each party hereto to the same extent as if it were physically executed and each party hereby consents to the use of any third party electronic signature capture service providers as may be reasonably chosen by a signatory hereto.
(h)THIS AMENDMENT, THE LOAN AGREEMENT, AND THE OTHER LOAN DOCUMENTS REPRESENT THE FINAL AGREEMENT BETWEEN THE PARTIES AND MAY NOT BE CONTRADICTED BY EVIDENCE OF PRIOR, CONTEMPORANEOUS OR ORAL AGREEMENTS OF THE PARTIES. THERE ARE NO UNWRITTEN ORAL AGREEMENTS BETWEEN THE PARTIES.
(i)The headings, captions and arrangements used in this Amendment are, unless specified otherwise, for convenience only and shall not be deemed to limit, amplify or modify the terms of this Amendment, nor affect the meaning thereof



(j)Any provision of this Amendment held to be invalid, illegal or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such invalidity, illegality or unenforceability without affecting the validity, legality and enforceability of the remaining provisions hereof; and the invalidity of a particular provision in a particular jurisdiction shall not invalidate such provision in any other jurisdiction.
(k)This Amendment shall be construed in accordance with and governed by the laws of the State of Texas without regard to its principles of conflicts of laws.
[Remainder of Page Intentionally LO Blank; Signature Page Follows]




IN WITNESS WHEREOF, the parties hereto have executed this Amendment in multiple counterparts on the date stated on the signature pages hereto, but effective as of Effective Date.
BORROWER:
loanDepot.com, LLC,
a Delaware limited liability company
By:    __/s/ Patrick Flanagan_______
Name: Patrick Flanagan
Title: Chief Financial Officer
LENDER:
NEXBANK
By:    ______/s/ Kevin Olding_____
Name: Kevin Olding
Title: Senior Vice President

Signature Page to Fifteenth Amendment
EXHIBIT 31.1
CERTIFICATION BY CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13a-14(a) AND 15d-14(a) UNDER THE EXCHANGE ACT

I, Frank Martell, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of loanDepot, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


/s/ Frank Martell
Frank Martell
Chief Executive Officer, President and Director
Date: August 10, 2022

EXHIBIT 31.2
CERTIFICATION BY CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13a-14(a) AND 15d-14(a) UNDER THE EXCHANGE ACT

I, Patrick Flanagan, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of loanDepot, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


/s/ Patrick Flanagan     
Patrick Flanagan
Chief Financial Officer
Date: August 10, 2022

Exhibit 32.1
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350 as Adopted
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Frank Martell, Chief Executive Officer of loanDepot, Inc. (the “Company”), hereby certify, that, to my knowledge:
1.the Quarterly Report on Form 10-Q for the period ended June 30, 2022 (the “Report”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and
2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: August 10, 2022

 /s/ Frank Martell 
 Frank Martell 
 Chief Executive Officer 
 (Principal Executive Officer)

Exhibit 32.2
Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350 as Adopted
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Patrick Flanagan, Chief Financial Officer of loanDepot, Inc. (the “Company”), hereby certify, that, to my knowledge:
1.the Quarterly Report on Form 10-Q for the period ended June 30, 2022 (the “Report”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and
2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: August 10, 2022

 /s/ Patrick Flanagan 
 Patrick Flanagan 
 Chief Financial Officer 
 (Principal Financial Officer)